STUDYID,USUBJID,SUBJID,SITEID,SAFFL,SAFFN,TRTSEQP,TRTSEQPN,TRTSEQA,TRTSEQAN,PART,PARTN,TRTP,TRTPN,TRTA,TRTAN,VSSEQ,EPOCH,ADT,ATM,ADTM,ADY,AVISIT,AVISITN,AVISITL,ATPT,ATPTN,APERIOD,APERIODC,PARAMCD,PARAM,AVAL,AVALC,PCSCAT,PCSCATT,PCSCATL,ABLFL,BASE,BASETYPE,CHG,PCHG,AVALL,TRTL,DTDY
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,45137.0,1836217937.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.8,26.8,,,,Y,26.8,EOT/ET/Followup,nan,nan,26.8,NA,2018-03-09T12:32 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,40869.0,1838719269.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),26.9,26.9,,,,,26.8,EOT/ET/Followup,0.1,0.37313432835820104,26.9,B,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,45720.0,1836218520.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-03-09T12:42 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,Period 1,nan,nan,69,C,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,69.0,Period 1,-3.0,-4.3478260869565215,66,C,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,33780.0,1837502580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,69.0,Period 1,-6.0,-8.695652173913043,63,C,2018-03-24T09:23 (2)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,31980.0,1838019180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 2,nan,nan,74,A,2018-03-30T08:53 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,74.0,Period 2,-3.0,-4.054054054054054,71,A,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,33780.0,1838107380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,74.0,Period 2,10.0,13.513513513513514,84,A,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21274.0,33900.0,1838107500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,74.0,Period 2,6.0,8.108108108108109,80,A,2018-03-31T09:25 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21274.0,33960.0,1838107560.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,74.0,Period 2,2.0,2.7027027027027026,76,A,2018-03-31T09:26 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21280.0,31980.0,1838623980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 3,nan,nan,74,B,2018-04-06T08:53 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,74.0,Period 3,-13.0,-17.56756756756757,61,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,59.0,EOT/ET/Followup,1.0,1.694915254237288,60,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21281.0,33780.0,1838712180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,74.0,Period 3,-13.0,-17.56756756756757,61,B,2018-04-07T09:23 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21252.0,45137.0,1836217937.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),177.0,177,,,,Y,177.0,EOT/ET/Followup,nan,nan,177,NA,2018-03-09T12:32 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21252.0,45720.0,1836218520.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),49.0,49,,,,,nan,EOT/ET/Followup,nan,nan,49,NA,2018-03-09T12:42 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21252.0,45840.0,1836218640.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),50.0,50,,,,Y,50.0,EOT/ET/Followup,nan,nan,50,NA,2018-03-09T12:44 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,nan,Period 1,nan,nan,47,C,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,nan,Period 1,nan,nan,47,C,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,32190.0,1837414590.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),49.0,49,,,,Y,49.0,Period 1,nan,nan,49,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),43.0,43,,,,,49.0,Period 1,-6.0,-12.244897959183673,43,C,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),46.0,46,,,,,49.0,Period 1,-3.0,-6.122448979591836,46,C,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,49.0,Period 1,-2.0,-4.081632653061225,47,C,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21267.0,33780.0,1837502580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,49.0,Period 1,-2.0,-4.081632653061225,47,C,2018-03-24T09:23 (2)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21267.0,33840.0,1837502640.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,49.0,Period 1,-2.0,-4.081632653061225,47,C,2018-03-24T09:24 (2)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21267.0,33927.0,1837502727.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),49.0,49,,,,,49.0,Period 1,0.0,0.0,49,C,2018-03-24T09:25 (2)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21273.0,31980.0,1838019180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),50.0,50,,,,Y,50.0,Period 2,nan,nan,50,A,2018-03-30T08:53 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),43.0,43,,,,,50.0,Period 2,-7.0,-14.000000000000002,43,A,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),42.0,42,,,,,50.0,Period 2,-8.0,-16.0,42,A,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),48.0,48,,,,,50.0,Period 2,-2.0,-4.0,48,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21274.0,33780.0,1838107380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,,50.0,Period 2,4.0,8.0,54,A,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,31980.0,1838623980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),46.0,46,,,,,nan,Period 3,nan,nan,46,B,2018-04-06T08:53 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),49.0,49,,,,,nan,Period 3,nan,nan,49,B,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,32190.0,1838624190.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),48.0,48,,,,Y,48.0,Period 3,nan,nan,48,B,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),46.0,46,,,,,48.0,Period 3,-2.0,-4.166666666666666,46,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),45.0,45,,,,,48.0,Period 3,-3.0,-6.25,45,B,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),45.0,45,,,,,48.0,Period 3,-3.0,-6.25,45,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),58.0,58,,,,,50.0,EOT/ET/Followup,8.0,16.0,58,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21281.0,33780.0,1838712180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),47.0,47,,,,,48.0,Period 3,-1.0,-2.083333333333333,47,B,2018-04-07T09:23 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21281.0,33885.0,1838712285.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,48.0,Period 3,8.0,16.666666666666664,56,B,2018-04-07T09:24 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21281.0,33975.0,1838712375.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),48.0,48,,,,,48.0,Period 3,0.0,0.0,48,B,2018-04-07T09:26 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,45720.0,1836218520.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-09T12:42 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),18.0,18,,,,,14.0,EOT/ET/Followup,4.0,28.57142857142857,18,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21252.0,45720.0,1836218520.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,EOT/ET/Followup,nan,nan,121,NA,2018-03-09T12:42 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 1,nan,nan,122,C,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,122.0,Period 1,-5.0,-4.098360655737705,117,C,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21267.0,33780.0,1837502580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,122.0,Period 1,-13.0,-10.655737704918032,109,C,2018-03-24T09:23 (2)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21273.0,31980.0,1838019180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,Period 2,nan,nan,113,A,2018-03-30T08:53 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,113.0,Period 2,-3.0,-2.6548672566371683,110,A,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,49.0,TREATMENT,21274.0,33780.0,1838107380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),144.0,144,,,,,113.0,Period 2,31.0,27.43362831858407,144,A,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21274.0,33900.0,1838107500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,113.0,Period 2,21.0,18.58407079646018,134,A,2018-03-31T09:25 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21274.0,33960.0,1838107560.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,113.0,Period 2,14.0,12.389380530973451,127,A,2018-03-31T09:26 (9)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21280.0,31980.0,1838623980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 3,nan,nan,121,B,2018-04-06T08:53 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,121.0,Period 3,-14.0,-11.570247933884298,107,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,121.0,EOT/ET/Followup,-15.0,-12.396694214876034,106,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21281.0,33780.0,1838712180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,121.0,Period 3,-12.0,-9.917355371900827,109,B,2018-04-07T09:23 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,56.0,SCREENING,21252.0,45720.0,1836218520.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-03-09T12:42 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,57.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.4,36.4,,,,,35.7,EOT/ET/Followup,0.7,1.9607843137254781,36.4,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,58.0,SCREENING,21252.0,45137.0,1836217937.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),84.0,84,,,,Y,84.0,EOT/ET/Followup,nan,nan,84,NA,2018-03-09T12:32 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,END OF TREATMENT,21281.0,40869.0,1838719269.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),84.4,84.4,,,,,84.0,EOT/ET/Followup,0.4,0.476190476190483,84.4,B,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,44572.0,1836217372.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.6,27.6,,,,Y,27.6,EOT/ET/Followup,nan,nan,27.6,NA,2018-03-09T12:22 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21272.0,60026.0,1837960826.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,BMI,Body Mass Index (kg/m2),27.6,27.6,,,,,27.6,EOT/ET/Followup,0.0,0.0,27.6,C,2018-03-29T16:40 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,45180.0,1836217980.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,EOT/ET/Followup,nan,nan,68,NA,2018-03-09T12:33 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,C,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40860.0,1837423260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,73.0,Period 1,-8.0,-10.95890410958904,65,C,2018-03-23T11:21 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,33360.0,1837502160.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),54.0,54,,,,,73.0,Period 1,-19.0,-26.027397260273972,54,C,2018-03-24T09:16 (2)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,END OF TREATMENT,21272.0,62700.0,1837963500.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,68.0,EOT/ET/Followup,-4.0,-5.88235294117647,64,C,2018-03-29T17:25 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,6.0,SCREENING,21252.0,44572.0,1836217372.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),177.0,177,,,,Y,177.0,EOT/ET/Followup,nan,nan,177,NA,2018-03-09T12:22 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,7.0,SCREENING,21252.0,45180.0,1836217980.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),79.0,79,,,,Y,79.0,EOT/ET/Followup,nan,nan,79,NA,2018-03-09T12:33 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,C,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21266.0,40860.0,1837423260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,61.0,Period 1,-6.0,-9.836065573770492,55,C,2018-03-23T11:21 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21267.0,33360.0,1837502160.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,61.0,Period 1,2.0,3.278688524590164,63,C,2018-03-24T09:16 (2)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21272.0,62700.0,1837963500.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,79.0,EOT/ET/Followup,-10.0,-12.658227848101266,69,C,2018-03-29T17:25 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,45180.0,1836217980.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-09T12:33 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21272.0,62700.0,1837963500.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,16.0,EOT/ET/Followup,0.0,0.0,16,C,2018-03-29T17:25 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21252.0,45180.0,1836217980.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,Y,126.0,EOT/ET/Followup,nan,nan,126,NA,2018-03-09T12:33 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 1,nan,nan,121,C,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21266.0,40860.0,1837423260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,121.0,Period 1,-7.0,-5.785123966942149,114,C,2018-03-23T11:21 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21267.0,33360.0,1837502160.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,121.0,Period 1,-6.0,-4.958677685950414,115,C,2018-03-24T09:16 (2)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,END OF TREATMENT,21272.0,62700.0,1837963500.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,,126.0,EOT/ET/Followup,-2.0,-1.5873015873015872,124,C,2018-03-29T17:25 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,19.0,SCREENING,21252.0,45180.0,1836217980.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-03-09T12:33 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,END OF TREATMENT,21272.0,62700.0,1837963500.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,TEMP,Temperature (C),36.2,36.2,,,,,35.7,EOT/ET/Followup,0.5,1.4005602240896358,36.2,C,2018-03-29T17:25 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21252.0,44572.0,1836217372.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),86.4,86.4,,,,Y,86.4,EOT/ET/Followup,nan,nan,86.4,NA,2018-03-09T12:22 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,END OF TREATMENT,21272.0,60026.0,1837960826.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,WEIGHT,Weight (kg),86.4,86.4,,,,,86.4,EOT/ET/Followup,0.0,0.0,86.4,C,2018-03-29T16:40 (7)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,45559.0,1836218359.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.7,23.7,,,,Y,23.7,EOT/ET/Followup,nan,nan,23.7,NA,2018-03-09T12:39 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,41034.0,1838719434.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.5,23.5,,,,,23.7,EOT/ET/Followup,-0.2,-0.8438818565400814,23.5,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,46380.0,1836219180.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-03-09T12:53 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,Period 1,nan,nan,75,A,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,75.0,Period 1,-1.0,-1.3333333333333335,74,A,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,33840.0,1837502640.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,75.0,Period 1,-17.0,-22.666666666666664,58,A,2018-03-24T09:24 (2)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,C,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,66.0,Period 2,-1.0,-1.5151515151515151,65,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,33840.0,1838107440.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,66.0,Period 2,6.0,9.090909090909092,72,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 3,nan,nan,74,B,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,74.0,Period 3,1.0,1.3513513513513513,75,B,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),56.0,56,,,,,64.0,EOT/ET/Followup,-8.0,-12.5,56,B,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,33840.0,1838712240.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,74.0,Period 3,-11.0,-14.864864864864865,63,B,2018-04-07T09:24 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,45559.0,1836218359.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),169.0,169,,,,Y,169.0,EOT/ET/Followup,nan,nan,169,NA,2018-03-09T12:39 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,46380.0,1836219180.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),50.0,50,,,,Y,50.0,EOT/ET/Followup,nan,nan,50,NA,2018-03-09T12:53 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,Period 1,nan,nan,58,A,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),51.0,51,,,,,58.0,Period 1,-7.0,-12.068965517241379,51,A,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,33840.0,1837502640.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,58.0,Period 1,7.0,12.068965517241379,65,A,2018-03-24T09:24 (2)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 2,nan,nan,61,C,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,,61.0,Period 2,-7.0,-11.475409836065573,54,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,33840.0,1838107440.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,61.0,Period 2,1.0,1.639344262295082,62,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 3,nan,nan,61,B,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,,61.0,Period 3,-2.0,-3.278688524590164,59,B,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),55.0,55,,,,,50.0,EOT/ET/Followup,5.0,10.0,55,B,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,33840.0,1838712240.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),51.0,51,,,,,61.0,Period 3,-10.0,-16.39344262295082,51,B,2018-04-07T09:24 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21252.0,46380.0,1836219180.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-09T12:53 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,B,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21252.0,46380.0,1836219180.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,Y,110.0,EOT/ET/Followup,nan,nan,110,NA,2018-03-09T12:53 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 1,nan,nan,105,A,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,105.0,Period 1,5.0,4.761904761904762,110,A,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,33840.0,1837502640.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,105.0,Period 1,6.0,5.714285714285714,111,A,2018-03-24T09:24 (2)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,Period 2,nan,nan,118,C,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,118.0,Period 2,-16.0,-13.559322033898304,102,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,33840.0,1838107440.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,118.0,Period 2,13.0,11.016949152542372,131,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,Y,103.0,Period 3,nan,nan,103,B,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,103.0,Period 3,8.0,7.766990291262135,111,B,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,110.0,EOT/ET/Followup,9.0,8.181818181818182,119,B,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,33840.0,1838712240.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,103.0,Period 3,31.0,30.097087378640776,134,B,2018-04-07T09:24 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21252.0,46380.0,1836219180.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-09T12:53 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.7,36.7,,,,,36.6,EOT/ET/Followup,0.1,0.27322404371585085,36.7,B,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21252.0,45559.0,1836218359.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),67.6,67.6,,,,Y,67.6,EOT/ET/Followup,nan,nan,67.6,NA,2018-03-09T12:39 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,41034.0,1838719434.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),67.0,67,,,,,67.6,EOT/ET/Followup,-0.6,-0.8875739644970331,67,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,47907.0,1836220707.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.4,27.4,,,,Y,27.4,EOT/ET/Followup,nan,nan,27.4,NA,2018-03-09T13:18 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,41715.0,1838720115.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.5,27.5,,,,,27.4,EOT/ET/Followup,0.1,0.36496350364964025,27.5,C,2018-04-07T11:35 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,49080.0,1836221880.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,EOT/ET/Followup,nan,nan,76,NA,2018-03-09T13:38 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,33060.0,1837415460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,B,2018-03-23T09:11 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,77.0,Period 1,-3.0,-3.896103896103896,74,B,2018-03-23T11:46 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,34860.0,1837503660.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,77.0,Period 1,-8.0,-10.38961038961039,69,B,2018-03-24T09:41 (2)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,33060.0,1838020260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 2,nan,nan,78,A,2018-03-30T09:11 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,42360.0,1838029560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,78.0,Period 2,-3.0,-3.8461538461538463,75,A,2018-03-30T11:46 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,34860.0,1838108460.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,78.0,Period 2,3.0,3.8461538461538463,81,A,2018-03-31T09:41 (9)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,33060.0,1838625060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 3,nan,nan,73,C,2018-04-06T09:11 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,73.0,Period 3,2.0,2.73972602739726,75,C,2018-04-06T11:46 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,41160.0,1838719560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,76.0,EOT/ET/Followup,4.0,5.263157894736842,80,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,34860.0,1838713260.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,73.0,Period 3,6.0,8.21917808219178,79,C,2018-04-07T09:41 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,47907.0,1836220707.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),163.5,163.5,,,,Y,163.5,EOT/ET/Followup,nan,nan,163.5,NA,2018-03-09T13:18 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,49080.0,1836221880.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),95.0,95,,,,Y,95.0,EOT/ET/Followup,nan,nan,95,NA,2018-03-09T13:38 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,33060.0,1837415460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,B,2018-03-23T09:11 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),53.0,53,,,,,77.0,Period 1,-24.0,-31.16883116883117,53,B,2018-03-23T11:46 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,34860.0,1837503660.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,77.0,Period 1,-22.0,-28.57142857142857,55,B,2018-03-24T09:41 (2)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,33060.0,1838020260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,A,2018-03-30T09:11 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,42360.0,1838029560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,,73.0,Period 2,-14.0,-19.17808219178082,59,A,2018-03-30T11:46 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,34860.0,1838108460.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,,73.0,Period 2,-7.0,-9.58904109589041,66,A,2018-03-31T09:41 (9)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,33060.0,1838625060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 3,nan,nan,66,C,2018-04-06T09:11 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,66.0,Period 3,-2.0,-3.0303030303030303,64,C,2018-04-06T11:46 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,41160.0,1838719560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,,95.0,EOT/ET/Followup,-19.0,-20.0,76,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,34860.0,1838713260.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),78.0,78,,,,,66.0,Period 3,12.0,18.181818181818183,78,C,2018-04-07T09:41 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21252.0,49080.0,1836221880.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),10.0,10,,,,Y,10.0,EOT/ET/Followup,nan,nan,10,NA,2018-03-09T13:38 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,41160.0,1838719560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,10.0,EOT/ET/Followup,6.0,60.0,16,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21252.0,49080.0,1836221880.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,Y,134.0,EOT/ET/Followup,nan,nan,134,NA,2018-03-09T13:38 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,33060.0,1837415460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,Y,137.0,Period 1,nan,nan,137,B,2018-03-23T09:11 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,137.0,Period 1,-22.0,-16.05839416058394,115,B,2018-03-23T11:46 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,34860.0,1837503660.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,137.0,Period 1,-19.0,-13.86861313868613,118,B,2018-03-24T09:41 (2)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,33060.0,1838020260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 2,nan,nan,119,A,2018-03-30T09:11 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,42360.0,1838029560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,119.0,Period 2,7.0,5.88235294117647,126,A,2018-03-30T11:46 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,34860.0,1838108460.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,119.0,Period 2,8.0,6.722689075630252,127,A,2018-03-31T09:41 (9)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,33060.0,1838625060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 3,nan,nan,122,C,2018-04-06T09:11 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,122.0,Period 3,-3.0,-2.459016393442623,119,C,2018-04-06T11:46 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,41160.0,1838719560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,134.0,EOT/ET/Followup,-11.0,-8.208955223880597,123,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,34860.0,1838713260.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,122.0,Period 3,-3.0,-2.459016393442623,119,C,2018-04-07T09:41 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21252.0,49080.0,1836221880.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-09T13:38 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,41160.0,1838719560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.6,36.6,,,,,36.6,EOT/ET/Followup,0.0,0.0,36.6,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21252.0,47907.0,1836220707.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),73.2,73.2,,,,Y,73.2,EOT/ET/Followup,nan,nan,73.2,NA,2018-03-09T13:18 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,41715.0,1838720115.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),73.4,73.4,,,,,73.2,EOT/ET/Followup,0.2,0.27322404371585085,73.4,C,2018-04-07T11:35 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,47378.0,1836220178.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.1,25.1,,,,Y,25.1,EOT/ET/Followup,nan,nan,25.1,NA,2018-03-09T13:09 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,39700.0,1838718100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.1,25.1,,,,,25.1,EOT/ET/Followup,0.0,0.0,25.1,C,2018-04-07T11:01 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,47940.0,1836220740.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-03-09T13:19 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,77.0,Period 1,-8.0,-10.38961038961039,69,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,32820.0,1837501620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,77.0,Period 1,-14.0,-18.181818181818183,63,A,2018-03-24T09:07 (2)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,72.0,Period 2,-3.0,-4.166666666666666,69,B,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,32820.0,1838106420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,72.0,Period 2,-13.0,-18.055555555555554,59,B,2018-03-31T09:07 (9)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,40320.0,1838632320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,71.0,Period 3,0.0,0.0,71,C,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,39120.0,1838717520.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,75.0,EOT/ET/Followup,-18.0,-24.0,57,C,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,32820.0,1838711220.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,71.0,Period 3,-12.0,-16.901408450704224,59,C,2018-04-07T09:07 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,47378.0,1836220178.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),189.0,189,,,,Y,189.0,EOT/ET/Followup,nan,nan,189,NA,2018-03-09T13:09 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,47940.0,1836220740.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,EOT/ET/Followup,nan,nan,58,NA,2018-03-09T13:19 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,,61.0,Period 1,-4.0,-6.557377049180328,57,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,32820.0,1837501620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,61.0,Period 1,4.0,6.557377049180328,65,A,2018-03-24T09:07 (2)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,Period 2,nan,nan,54,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),51.0,51,,,,,54.0,Period 2,-3.0,-5.555555555555555,51,B,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,32820.0,1838106420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),60.0,60,,,,,54.0,Period 2,6.0,11.11111111111111,60,B,2018-03-31T09:07 (9)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 3,nan,nan,61,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,40320.0,1838632320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,,61.0,Period 3,-8.0,-13.114754098360656,53,C,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,39120.0,1838717520.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),54.0,54,,,,,58.0,EOT/ET/Followup,-4.0,-6.896551724137931,54,C,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,32820.0,1838711220.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,61.0,Period 3,4.0,6.557377049180328,65,C,2018-04-07T09:07 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21252.0,47940.0,1836220740.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-09T13:19 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,39120.0,1838717520.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,C,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21252.0,47940.0,1836220740.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,EOT/ET/Followup,nan,nan,114,NA,2018-03-09T13:19 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 1,nan,nan,115,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,115.0,Period 1,-4.0,-3.4782608695652173,111,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,32820.0,1837501620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,115.0,Period 1,3.0,2.608695652173913,118,A,2018-03-24T09:07 (2)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,Y,101.0,Period 2,nan,nan,101,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,101.0,Period 2,14.0,13.861386138613863,115,B,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,32820.0,1838106420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,101.0,Period 2,0.0,0.0,101,B,2018-03-31T09:07 (9)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,Period 3,nan,nan,109,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,40320.0,1838632320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,109.0,Period 3,2.0,1.834862385321101,111,C,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,39120.0,1838717520.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,114.0,EOT/ET/Followup,-1.0,-0.8771929824561403,113,C,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,32820.0,1838711220.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,109.0,Period 3,4.0,3.669724770642202,113,C,2018-04-07T09:07 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21252.0,47940.0,1836220740.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-03-09T13:19 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,39120.0,1838717520.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.7,35.7,,,,,35.7,EOT/ET/Followup,0.0,0.0,35.7,C,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21252.0,47378.0,1836220178.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),89.8,89.8,,,,Y,89.8,EOT/ET/Followup,nan,nan,89.8,NA,2018-03-09T13:09 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39700.0,1838718100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),89.5,89.5,,,,,89.8,EOT/ET/Followup,-0.3,-0.3340757238307318,89.5,C,2018-04-07T11:01 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,48810.0,1836221610.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.4,23.4,,,,Y,23.4,EOT/ET/Followup,nan,nan,23.4,NA,2018-03-09T13:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,40076.0,1838718476.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.7,23.7,,,,,23.4,EOT/ET/Followup,0.3,1.282051282051285,23.7,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,49470.0,1836222270.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-09T13:44 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,A,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,77.0,Period 1,-3.0,-3.896103896103896,74,A,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,32880.0,1837501680.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,77.0,Period 1,-17.0,-22.07792207792208,60,A,2018-03-24T09:08 (2)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,31080.0,1838018280.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 2,nan,nan,79,C,2018-03-30T08:38 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,79.0,Period 2,-6.0,-7.59493670886076,73,C,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,32880.0,1838106480.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,79.0,Period 2,2.0,2.5316455696202533,81,C,2018-03-31T09:08 (9)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,31080.0,1838623080.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 3,nan,nan,79,B,2018-04-06T08:38 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,79.0,Period 3,-4.0,-5.063291139240507,75,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,74.0,EOT/ET/Followup,-6.0,-8.108108108108109,68,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,32880.0,1838711280.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,79.0,Period 3,-16.0,-20.253164556962027,63,B,2018-04-07T09:08 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,48810.0,1836221610.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),188.0,188,,,,Y,188.0,EOT/ET/Followup,nan,nan,188,NA,2018-03-09T13:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,49470.0,1836222270.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-03-09T13:44 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,A,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),62.0,62,,,,,61.0,Period 1,1.0,1.639344262295082,62,A,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,32880.0,1837501680.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,61.0,Period 1,10.0,16.39344262295082,71,A,2018-03-24T09:08 (2)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,31080.0,1838018280.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,Period 2,nan,nan,77,C,2018-03-30T08:38 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),52.0,52,,,,,77.0,Period 2,-25.0,-32.467532467532465,52,C,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,32880.0,1838106480.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,77.0,Period 2,-13.0,-16.883116883116884,64,C,2018-03-31T09:08 (9)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,31080.0,1838623080.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,Y,64.0,Period 3,nan,nan,64,B,2018-04-06T08:38 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,,64.0,Period 3,-4.0,-6.25,60,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,64.0,EOT/ET/Followup,1.0,1.5625,65,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,32880.0,1838711280.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,64.0,Period 3,-1.0,-1.5625,63,B,2018-04-07T09:08 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21252.0,49470.0,1836222270.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-09T13:44 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21252.0,49470.0,1836222270.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,EOT/ET/Followup,nan,nan,114,NA,2018-03-09T13:44 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 1,nan,nan,117,A,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,117.0,Period 1,-1.0,-0.8547008547008548,116,A,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,32880.0,1837501680.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,117.0,Period 1,-18.0,-15.384615384615385,99,A,2018-03-24T09:08 (2)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,31080.0,1838018280.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,Period 2,nan,nan,114,C,2018-03-30T08:38 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,114.0,Period 2,14.0,12.280701754385964,128,C,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,32880.0,1838106480.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,114.0,Period 2,2.0,1.7543859649122806,116,C,2018-03-31T09:08 (9)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,31080.0,1838623080.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,Period 3,nan,nan,133,B,2018-04-06T08:38 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,133.0,Period 3,-14.0,-10.526315789473683,119,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,114.0,EOT/ET/Followup,0.0,0.0,114,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,32880.0,1838711280.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,133.0,Period 3,-22.0,-16.541353383458645,111,B,2018-04-07T09:08 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21252.0,49470.0,1836222270.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-03-09T13:44 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.4,36.4,,,,,36.4,EOT/ET/Followup,0.0,0.0,36.4,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21252.0,48810.0,1836221610.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),82.6,82.6,,,,Y,82.6,EOT/ET/Followup,nan,nan,82.6,NA,2018-03-09T13:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40076.0,1838718476.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),83.9,83.9,,,,,82.6,EOT/ET/Followup,1.3,1.5738498789346387,83.9,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21252.0,51532.0,1836224332.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.7,27.7,,,,Y,27.7,EOT/ET/Followup,nan,nan,27.7,NA,2018-03-09T14:18 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,42066.0,1838720466.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.4,27.4,,,,,27.7,EOT/ET/Followup,-0.3,-1.0830324909747318,27.4,B,2018-04-07T11:41 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,52200.0,1836225000.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,EOT/ET/Followup,nan,nan,70,NA,2018-03-09T14:30 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,33120.0,1837415520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 1,nan,nan,70,A,2018-03-23T09:12 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,70.0,Period 1,-4.0,-5.714285714285714,66,A,2018-03-23T11:47 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,34920.0,1837503720.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,70.0,Period 1,-6.0,-8.571428571428571,64,A,2018-03-24T09:42 (2)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,42420.0,1838029620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,65.0,Period 2,13.0,20.0,78,C,2018-03-30T11:47 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,34920.0,1838108520.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,65.0,Period 2,-6.0,-9.230769230769232,59,C,2018-03-31T09:42 (9)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,33120.0,1838625120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,Y,59.0,Period 3,nan,nan,59,B,2018-04-06T09:12 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,42420.0,1838634420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,59.0,Period 3,7.0,11.864406779661017,66,B,2018-04-06T11:47 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,41220.0,1838719620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),55.0,55,,,,,70.0,EOT/ET/Followup,-15.0,-21.428571428571427,55,B,2018-04-07T11:27 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,34920.0,1838713320.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,59.0,Period 3,-1.0,-1.694915254237288,58,B,2018-04-07T09:42 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21252.0,51532.0,1836224332.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),160.0,160,,,,Y,160.0,EOT/ET/Followup,nan,nan,160,NA,2018-03-09T14:18 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,52200.0,1836225000.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),69.0,69,,,,Y,69.0,EOT/ET/Followup,nan,nan,69,NA,2018-03-09T14:30 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,33120.0,1837415520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,A,2018-03-23T09:12 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),59.0,59,,,,,63.0,Period 1,-4.0,-6.349206349206349,59,A,2018-03-23T11:47 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,34920.0,1837503720.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,63.0,Period 1,7.0,11.11111111111111,70,A,2018-03-24T09:42 (2)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,42420.0,1838029620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),58.0,58,,,,,65.0,Period 2,-7.0,-10.76923076923077,58,C,2018-03-30T11:47 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,34920.0,1838108520.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,65.0,Period 2,2.0,3.076923076923077,67,C,2018-03-31T09:42 (9)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,33120.0,1838625120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 3,nan,nan,63,B,2018-04-06T09:12 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,42420.0,1838634420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,,63.0,Period 3,-4.0,-6.349206349206349,59,B,2018-04-06T11:47 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,41220.0,1838719620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,69.0,EOT/ET/Followup,-1.0,-1.4492753623188406,68,B,2018-04-07T11:27 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,34920.0,1838713320.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,63.0,Period 3,14.0,22.22222222222222,77,B,2018-04-07T09:42 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21252.0,52200.0,1836225000.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-09T14:30 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,41220.0,1838719620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,12.0,EOT/ET/Followup,0.0,0.0,12,B,2018-04-07T11:27 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21252.0,52200.0,1836225000.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,EOT/ET/Followup,nan,nan,115,NA,2018-03-09T14:30 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,33120.0,1837415520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 1,nan,nan,111,A,2018-03-23T09:12 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,111.0,Period 1,-4.0,-3.6036036036036037,107,A,2018-03-23T11:47 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,34920.0,1837503720.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,111.0,Period 1,-3.0,-2.7027027027027026,108,A,2018-03-24T09:42 (2)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,Y,107.0,Period 2,nan,nan,107,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,42420.0,1838029620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,107.0,Period 2,15.0,14.018691588785046,122,C,2018-03-30T11:47 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,34920.0,1838108520.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,107.0,Period 2,7.0,6.5420560747663545,114,C,2018-03-31T09:42 (9)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,33120.0,1838625120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,Y,100.0,Period 3,nan,nan,100,B,2018-04-06T09:12 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,42420.0,1838634420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,100.0,Period 3,12.0,12.0,112,B,2018-04-06T11:47 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,41220.0,1838719620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,115.0,EOT/ET/Followup,-13.0,-11.304347826086957,102,B,2018-04-07T11:27 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,34920.0,1838713320.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,100.0,Period 3,-1.0,-1.0,99,B,2018-04-07T09:42 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21252.0,52200.0,1836225000.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-09T14:30 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,41220.0,1838719620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.6,36.6,,,,,36.6,EOT/ET/Followup,0.0,0.0,36.6,B,2018-04-07T11:27 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21252.0,51532.0,1836224332.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-09T14:18 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,42066.0,1838720466.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),70.2,70.2,,,,,71.0,EOT/ET/Followup,-0.8,-1.1267605633802777,70.2,B,2018-04-07T11:41 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,49966.0,1836481966.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.4,26.4,,,,Y,26.4,EOT/ET/Followup,nan,nan,26.4,NA,2018-03-12T13:52 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,41576.0,1838719976.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.9,25.9,,,,,26.4,EOT/ET/Followup,-0.5,-1.893939393939394,25.9,A,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,50681.0,1836482681.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),54.0,54,,,,Y,54.0,EOT/ET/Followup,nan,nan,54,NA,2018-03-12T14:04 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 1,nan,nan,72,B,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,72.0,Period 1,-5.0,-6.944444444444445,67,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,33900.0,1837502700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,72.0,Period 1,-3.0,-4.166666666666666,69,B,2018-03-24T09:25 (2)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,32207.0,1838019407.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,C,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,70.0,Period 2,-7.0,-10.0,63,C,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,33900.0,1838107500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,70.0,Period 2,-8.0,-11.428571428571429,62,C,2018-03-31T09:25 (9)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 3,nan,nan,73,A,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,73.0,Period 3,-15.0,-20.54794520547945,58,A,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,54.0,EOT/ET/Followup,7.0,12.962962962962962,61,A,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,33900.0,1838712300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,73.0,Period 3,-3.0,-4.10958904109589,70,A,2018-04-07T09:25 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,49966.0,1836481966.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),162.0,162,,,,Y,162.0,EOT/ET/Followup,nan,nan,162,NA,2018-03-12T13:52 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,50681.0,1836482681.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-03-12T14:04 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,B,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,71.0,Period 1,-1.0,-1.4084507042253522,70,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,33900.0,1837502700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,71.0,Period 1,-2.0,-2.8169014084507045,69,B,2018-03-24T09:25 (2)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,32207.0,1838019407.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,C,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),57.0,57,,,,,72.0,Period 2,-15.0,-20.833333333333336,57,C,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,33900.0,1838107500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,72.0,Period 2,-5.0,-6.944444444444445,67,C,2018-03-31T09:25 (9)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,Period 3,nan,nan,74,A,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,,74.0,Period 3,-14.0,-18.91891891891892,60,A,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,,59.0,EOT/ET/Followup,12.0,20.33898305084746,71,A,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21281.0,33900.0,1838712300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),90.0,90,,,,,74.0,Period 3,16.0,21.62162162162162,90,A,2018-04-07T09:25 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,50681.0,1836482681.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-12T14:04 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,16.0,EOT/ET/Followup,-4.0,-25.0,12,A,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,50681.0,1836482681.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,Y,107.0,EOT/ET/Followup,nan,nan,107,NA,2018-03-12T14:04 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,Period 1,nan,nan,109,B,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,109.0,Period 1,0.0,0.0,109,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,33900.0,1837502700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,109.0,Period 1,7.0,6.422018348623854,116,B,2018-03-24T09:25 (2)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,32207.0,1838019407.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,Y,110.0,Period 2,nan,nan,110,C,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,110.0,Period 2,-8.0,-7.2727272727272725,102,C,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,33900.0,1838107500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,110.0,Period 2,4.0,3.6363636363636362,114,C,2018-03-31T09:25 (9)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 3,nan,nan,105,A,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,105.0,Period 3,-4.0,-3.8095238095238098,101,A,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,107.0,EOT/ET/Followup,-6.0,-5.607476635514018,101,A,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21281.0,33900.0,1838712300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,105.0,Period 3,4.0,3.8095238095238098,109,A,2018-04-07T09:25 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,50681.0,1836482681.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.8,35.8,,,,Y,35.8,EOT/ET/Followup,nan,nan,35.8,NA,2018-03-12T14:04 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,35.8,EOT/ET/Followup,0.4,1.1173184357542059,36.2,A,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,49966.0,1836481966.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),69.2,69.2,,,,Y,69.2,EOT/ET/Followup,nan,nan,69.2,NA,2018-03-12T13:52 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,41576.0,1838719976.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),68.1,68.1,,,,,69.2,EOT/ET/Followup,-1.1,-1.5895953757225558,68.1,A,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,44989.0,1836476989.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.2,25.2,,,,Y,25.2,EOT/ET/Followup,nan,nan,25.2,NA,2018-03-12T12:29 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,41655.0,1838720055.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),24.5,24.5,,,,,25.2,EOT/ET/Followup,-0.7,-2.777777777777775,24.5,C,2018-04-07T11:34 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,46680.0,1836478680.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,nan,EOT/ET/Followup,nan,nan,72,NA,2018-03-12T12:58 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,2.0,SCREENING,21255.0,46800.0,1836478800.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,nan,EOT/ET/Followup,nan,nan,68,NA,2018-03-12T13:00 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,3.0,SCREENING,21255.0,46920.0,1836478920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,EOT/ET/Followup,nan,nan,70,NA,2018-03-12T13:02 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21266.0,32160.0,1837414560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,B,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21266.0,41460.0,1837423860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,71.0,Period 1,-5.0,-7.042253521126761,66,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21267.0,33960.0,1837502760.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,71.0,Period 1,-4.0,-5.633802816901409,67,B,2018-03-24T09:26 (2)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,nan,Period 2,nan,nan,77,A,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),87.0,87,,,,,nan,Period 2,nan,nan,87,A,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21273.0,32665.0,1838019865.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),91.0,91,,,,Y,91.0,Period 2,nan,nan,91,A,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),88.0,88,,,,,91.0,Period 2,-3.0,-3.296703296703297,88,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,91.0,Period 2,-11.0,-12.087912087912088,80,A,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,91.0,Period 2,-14.0,-15.384615384615385,77,A,2018-03-30T11:34 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21274.0,33960.0,1838107560.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,91.0,Period 2,-22.0,-24.175824175824175,69,A,2018-03-31T09:26 (9)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,,nan,Period 3,nan,nan,86,C,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,nan,Period 3,nan,nan,73,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21280.0,32490.0,1838624490.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),94.0,94,,,,Y,94.0,Period 3,nan,nan,94,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,94.0,Period 3,-23.0,-24.46808510638298,71,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,70.0,EOT/ET/Followup,-3.0,-4.285714285714286,67,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21281.0,33960.0,1838712360.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,94.0,Period 3,-33.0,-35.1063829787234,61,C,2018-04-07T09:26 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,20.0,SCREENING,21255.0,44989.0,1836476989.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),185.5,185.5,,,,Y,185.5,EOT/ET/Followup,nan,nan,185.5,NA,2018-03-12T12:29 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21255.0,46680.0,1836478680.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),94.0,94,,,,Y,94.0,EOT/ET/Followup,nan,nan,94,NA,2018-03-12T12:58 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21266.0,32160.0,1837414560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),131.0,131,,,,,nan,Period 1,nan,nan,131,B,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),107.0,107,,,,,nan,Period 1,nan,nan,107,B,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),108.0,108,,,,Y,108.0,Period 1,nan,nan,108,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,TREATMENT,21266.0,41460.0,1837423860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,108.0,Period 1,-41.0,-37.96296296296296,67,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21267.0,33960.0,1837502760.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,108.0,Period 1,-44.0,-40.74074074074074,64,B,2018-03-24T09:26 (2)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),105.0,105,,,,,nan,Period 2,nan,nan,105,A,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),113.0,113,,,,,nan,Period 2,nan,nan,113,A,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,32665.0,1838019865.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),117.0,117,,,,Y,117.0,Period 2,nan,nan,117,A,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,117.0,Period 2,-45.0,-38.46153846153847,72,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21274.0,33960.0,1838107560.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),91.0,91,,,,,117.0,Period 2,-26.0,-22.22222222222222,91,A,2018-03-31T09:26 (9)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),123.0,123,,,,,nan,Period 3,nan,nan,123,C,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),129.0,129,,,,,nan,Period 3,nan,nan,129,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,32490.0,1838624490.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),121.0,121,,,,Y,121.0,Period 3,nan,nan,121,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),85.0,85,,,,,121.0,Period 3,-36.0,-29.75206611570248,85,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,94.0,EOT/ET/Followup,-29.0,-30.851063829787233,65,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21281.0,33960.0,1838712360.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,121.0,Period 3,-56.0,-46.28099173553719,65,C,2018-04-07T09:26 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,38.0,SCREENING,21255.0,46680.0,1836478680.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-12T12:58 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,40.0,SCREENING,21255.0,46680.0,1836478680.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),147.0,147,,,,,nan,EOT/ET/Followup,nan,nan,147,NA,2018-03-12T12:58 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,46800.0,1836478800.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),147.0,147,,,,,nan,EOT/ET/Followup,nan,nan,147,NA,2018-03-12T13:00 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,42.0,SCREENING,21255.0,46920.0,1836478920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,Y,139.0,EOT/ET/Followup,nan,nan,139,NA,2018-03-12T13:02 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,32160.0,1837414560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,Y,137.0,Period 1,nan,nan,137,B,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21266.0,41460.0,1837423860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,137.0,Period 1,-15.0,-10.948905109489052,122,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21267.0,33960.0,1837502760.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,137.0,Period 1,-7.0,-5.109489051094891,130,B,2018-03-24T09:26 (2)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),162.0,162,,,,,nan,Period 2,nan,nan,162,A,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),140.0,140,,,,,nan,Period 2,nan,nan,140,A,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,TREATMENT,21273.0,32665.0,1838019865.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),154.0,154,,,,Y,154.0,Period 2,nan,nan,154,A,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,49.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),156.0,156,,,,,154.0,Period 2,2.0,1.2987012987012987,156,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,154.0,Period 2,-24.0,-15.584415584415584,130,A,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,154.0,Period 2,-20.0,-12.987012987012985,134,A,2018-03-30T11:34 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21274.0,33960.0,1838107560.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,154.0,Period 2,-25.0,-16.233766233766232,129,A,2018-03-31T09:26 (9)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),165.0,165,,,,,nan,Period 3,nan,nan,165,C,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),147.0,147,,,,,nan,Period 3,nan,nan,147,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,32490.0,1838624490.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),161.0,161,,,,Y,161.0,Period 3,nan,nan,161,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,161.0,Period 3,-26.0,-16.149068322981368,135,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,,139.0,EOT/ET/Followup,-2.0,-1.4388489208633095,137,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,57.0,TREATMENT,21281.0,33960.0,1838712360.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),136.0,136,,,,,161.0,Period 3,-25.0,-15.527950310559005,136,C,2018-04-07T09:26 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,59.0,SCREENING,21255.0,46680.0,1836478680.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-12T12:58 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.9,36.9,,,,,36.6,EOT/ET/Followup,0.3,0.8196721311475332,36.9,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,61.0,SCREENING,21255.0,44989.0,1836476989.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),86.6,86.6,,,,Y,86.6,EOT/ET/Followup,nan,nan,86.6,NA,2018-03-12T12:29 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,END OF TREATMENT,21281.0,41655.0,1838720055.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),84.4,84.4,,,,,86.6,EOT/ET/Followup,-2.2,-2.540415704387978,84.4,C,2018-04-07T11:34 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,44258.0,1836476258.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.9,24.9,,,,Y,24.9,EOT/ET/Followup,nan,nan,24.9,NA,2018-03-12T12:17 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,40339.0,1838718739.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.2,25.2,,,,,24.9,EOT/ET/Followup,0.3,1.2048192771084365,25.2,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,44880.0,1836476880.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-03-12T12:28 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31140.0,1837413540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,C,2018-03-23T08:39 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,63.0,Period 1,7.0,11.11111111111111,70,C,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,32940.0,1837501740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,63.0,Period 1,-1.0,-1.5873015873015872,62,C,2018-03-24T09:09 (2)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,31140.0,1838018340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,Period 2,nan,nan,68,B,2018-03-30T08:39 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,68.0,Period 2,0.0,0.0,68,B,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,32940.0,1838106540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,68.0,Period 2,0.0,0.0,68,B,2018-03-31T09:09 (9)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,31140.0,1838623140.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 3,nan,nan,72,A,2018-04-06T08:39 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,72.0,Period 3,-4.0,-5.555555555555555,68,A,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,59.0,EOT/ET/Followup,17.0,28.8135593220339,76,A,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,END OF TREATMENT,21281.0,39408.0,1838717808.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,59.0,EOT/ET/Followup,17.0,28.8135593220339,76,A,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,END OF TREATMENT,21281.0,39621.0,1838718021.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,59.0,EOT/ET/Followup,16.0,27.11864406779661,75,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,32940.0,1838711340.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,72.0,Period 3,-11.0,-15.277777777777779,61,A,2018-04-07T09:09 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21255.0,44258.0,1836476258.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),177.5,177.5,,,,Y,177.5,EOT/ET/Followup,nan,nan,177.5,NA,2018-03-12T12:17 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21255.0,44880.0,1836476880.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),52.0,52,,,,Y,52.0,EOT/ET/Followup,nan,nan,52,NA,2018-03-12T12:28 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21266.0,31140.0,1837413540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,C,2018-03-23T08:39 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),53.0,53,,,,,57.0,Period 1,-4.0,-7.017543859649122,53,C,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21267.0,32940.0,1837501740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,,57.0,Period 1,11.0,19.298245614035086,68,C,2018-03-24T09:09 (2)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21273.0,31140.0,1838018340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),56.0,56,,,,Y,56.0,Period 2,nan,nan,56,B,2018-03-30T08:39 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),46.0,46,,,,,56.0,Period 2,-10.0,-17.857142857142858,46,B,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40500.0,1838027700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),49.0,49,,,,,56.0,Period 2,-7.0,-12.5,49,B,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),51.0,51,,,,,56.0,Period 2,-5.0,-8.928571428571429,51,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21274.0,32940.0,1838106540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,,56.0,Period 2,3.0,5.357142857142857,59,B,2018-03-31T09:09 (9)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21280.0,31140.0,1838623140.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,Period 3,nan,nan,59,A,2018-04-06T08:39 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,,59.0,Period 3,-6.0,-10.16949152542373,53,A,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,,52.0,EOT/ET/Followup,8.0,15.384615384615385,60,A,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21281.0,32940.0,1838711340.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,59.0,Period 3,-3.0,-5.084745762711865,56,A,2018-04-07T09:09 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21255.0,44880.0,1836476880.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-12T12:28 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,A,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21255.0,44880.0,1836476880.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,EOT/ET/Followup,nan,nan,113,NA,2018-03-12T12:28 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21266.0,31140.0,1837413540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 1,nan,nan,119,C,2018-03-23T08:39 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,119.0,Period 1,-2.0,-1.680672268907563,117,C,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21267.0,32940.0,1837501740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,119.0,Period 1,0.0,0.0,119,C,2018-03-24T09:09 (2)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21273.0,31140.0,1838018340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,Period 2,nan,nan,120,B,2018-03-30T08:39 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,120.0,Period 2,-1.0,-0.8333333333333334,119,B,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21274.0,32940.0,1838106540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,120.0,Period 2,2.0,1.6666666666666667,122,B,2018-03-31T09:09 (9)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21280.0,31140.0,1838623140.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 3,nan,nan,116,A,2018-04-06T08:39 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,116.0,Period 3,2.0,1.7241379310344827,118,A,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),146.0,146,,,,,113.0,EOT/ET/Followup,33.0,29.20353982300885,146,A,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,41.0,END OF TREATMENT,21281.0,39408.0,1838717808.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),145.0,145,,,,,113.0,EOT/ET/Followup,32.0,28.31858407079646,145,A,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,END OF TREATMENT,21281.0,39621.0,1838718021.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,,113.0,EOT/ET/Followup,25.0,22.123893805309734,138,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21281.0,32940.0,1838711340.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,116.0,Period 3,3.0,2.586206896551724,119,A,2018-04-07T09:09 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21255.0,44880.0,1836476880.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.6,35.6,,,,Y,35.6,EOT/ET/Followup,nan,nan,35.6,NA,2018-03-12T12:28 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.6,35.6,,,,,35.6,EOT/ET/Followup,0.0,0.0,35.6,A,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,45.0,SCREENING,21255.0,44258.0,1836476258.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),78.4,78.4,,,,Y,78.4,EOT/ET/Followup,nan,nan,78.4,NA,2018-03-12T12:17 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,END OF TREATMENT,21281.0,40339.0,1838718739.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.4,79.4,,,,,78.4,EOT/ET/Followup,1.0,1.2755102040816324,79.4,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,45808.0,1836477808.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.8,23.8,,,,Y,23.8,EOT/ET/Followup,nan,nan,23.8,NA,2018-03-12T12:43 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,42139.0,1838720539.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.8,23.8,,,,,23.8,EOT/ET/Followup,0.0,0.0,23.8,B,2018-04-07T11:42 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,48360.0,1836480360.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,EOT/ET/Followup,nan,nan,78,NA,2018-03-12T13:26 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 1,nan,nan,79,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,42480.0,1837424880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,79.0,Period 1,0.0,0.0,79,C,2018-03-23T11:48 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34980.0,1837503780.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,79.0,Period 1,-13.0,-16.455696202531644,66,C,2018-03-24T09:43 (2)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,33180.0,1838020380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,Period 2,nan,nan,76,A,2018-03-30T09:13 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,42480.0,1838029680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,76.0,Period 2,8.0,10.526315789473683,84,A,2018-03-30T11:48 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,34980.0,1838108580.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,76.0,Period 2,-8.0,-10.526315789473683,68,A,2018-03-31T09:43 (9)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,33180.0,1838625180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 3,nan,nan,82,B,2018-04-06T09:13 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,42480.0,1838634480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,82.0,Period 3,-7.0,-8.536585365853659,75,B,2018-04-06T11:48 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,41280.0,1838719680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,78.0,EOT/ET/Followup,-15.0,-19.230769230769234,63,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,34980.0,1838713380.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,82.0,Period 3,-7.0,-8.536585365853659,75,B,2018-04-07T09:43 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,45808.0,1836477808.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),162.0,162,,,,Y,162.0,EOT/ET/Followup,nan,nan,162,NA,2018-03-12T12:43 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,48360.0,1836480360.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-12T13:26 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),81.0,81,,,,Y,81.0,Period 1,nan,nan,81,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,42480.0,1837424880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),66.0,66,,,,,81.0,Period 1,-15.0,-18.51851851851852,66,C,2018-03-23T11:48 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,34980.0,1837503780.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),77.0,77,,,,,81.0,Period 1,-4.0,-4.938271604938271,77,C,2018-03-24T09:43 (2)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,33180.0,1838020380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,A,2018-03-30T09:13 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,42480.0,1838029680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,72.0,Period 2,2.0,2.7777777777777777,74,A,2018-03-30T11:48 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,34980.0,1838108580.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),76.0,76,,,,,72.0,Period 2,4.0,5.555555555555555,76,A,2018-03-31T09:43 (9)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,33180.0,1838625180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),82.0,82,,,,Y,82.0,Period 3,nan,nan,82,B,2018-04-06T09:13 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,42480.0,1838634480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,82.0,Period 3,-15.0,-18.29268292682927,67,B,2018-04-06T11:48 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,41280.0,1838719680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,74.0,EOT/ET/Followup,3.0,4.054054054054054,77,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,34980.0,1838713380.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,,82.0,Period 3,-10.0,-12.195121951219512,72,B,2018-04-07T09:43 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,48360.0,1836480360.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),13.0,13,,,,Y,13.0,EOT/ET/Followup,nan,nan,13,NA,2018-03-12T13:26 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,41280.0,1838719680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,13.0,EOT/ET/Followup,1.0,7.6923076923076925,14,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,48360.0,1836480360.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-03-12T13:26 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,Y,126.0,Period 1,nan,nan,126,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,42480.0,1837424880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,126.0,Period 1,-10.0,-7.936507936507936,116,C,2018-03-23T11:48 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,34980.0,1837503780.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,126.0,Period 1,-14.0,-11.11111111111111,112,C,2018-03-24T09:43 (2)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,33180.0,1838020380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,Period 2,nan,nan,113,A,2018-03-30T09:13 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,42480.0,1838029680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,113.0,Period 2,22.0,19.469026548672566,135,A,2018-03-30T11:48 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,34980.0,1838108580.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),98.0,98,,,,,113.0,Period 2,-15.0,-13.274336283185843,98,A,2018-03-31T09:43 (9)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,33180.0,1838625180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,Y,126.0,Period 3,nan,nan,126,B,2018-04-06T09:13 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,42480.0,1838634480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,126.0,Period 3,-18.0,-14.285714285714285,108,B,2018-04-06T11:48 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,41280.0,1838719680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,118.0,EOT/ET/Followup,-11.0,-9.322033898305085,107,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,34980.0,1838713380.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,126.0,Period 3,-14.0,-11.11111111111111,112,B,2018-04-07T09:43 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,48360.0,1836480360.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-12T13:26 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,41280.0,1838719680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.7,36.7,,,,,36.3,EOT/ET/Followup,0.4,1.1019283746556632,36.7,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,45808.0,1836477808.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),62.4,62.4,,,,Y,62.4,EOT/ET/Followup,nan,nan,62.4,NA,2018-03-12T12:43 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,42139.0,1838720539.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),62.5,62.5,,,,,62.4,EOT/ET/Followup,0.1,0.16025641025641252,62.5,B,2018-04-07T11:42 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,43827.0,1836475827.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),21.8,21.8,,,,Y,21.8,EOT/ET/Followup,nan,nan,21.8,NA,2018-03-12T12:10 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,40650.0,1838719050.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),20.9,20.9,,,,,21.8,EOT/ET/Followup,-0.9,-4.128440366972487,20.9,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,44640.0,1836476640.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,EOT/ET/Followup,nan,nan,68,NA,2018-03-12T12:24 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,A,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,71.0,Period 1,6.0,8.450704225352112,77,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,33420.0,1837502220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,71.0,Period 1,1.0,1.4084507042253522,72,A,2018-03-24T09:17 (2)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,Period 2,nan,nan,76,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,76.0,Period 2,-3.0,-3.9473684210526314,73,B,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,33420.0,1838107020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,76.0,Period 2,-5.0,-6.578947368421052,71,B,2018-03-31T09:17 (9)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,31620.0,1838623620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 3,nan,nan,77,C,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,40920.0,1838632920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,77.0,Period 3,-7.0,-9.090909090909092,70,C,2018-04-06T11:22 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,39720.0,1838718120.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,68.0,EOT/ET/Followup,0.0,0.0,68,C,2018-04-07T11:02 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,33420.0,1838711820.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,77.0,Period 3,-4.0,-5.194805194805195,73,C,2018-04-07T09:17 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,43827.0,1836475827.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),171.0,171,,,,Y,171.0,EOT/ET/Followup,nan,nan,171,NA,2018-03-12T12:10 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,44640.0,1836476640.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),51.0,51,,,,Y,51.0,EOT/ET/Followup,nan,nan,51,NA,2018-03-12T12:24 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),53.0,53,,,,Y,53.0,Period 1,nan,nan,53,A,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),51.0,51,,,,,53.0,Period 1,-2.0,-3.7735849056603774,51,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,33420.0,1837502220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),54.0,54,,,,,53.0,Period 1,1.0,1.8867924528301887,54,A,2018-03-24T09:17 (2)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),53.0,53,,,,Y,53.0,Period 2,nan,nan,53,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),52.0,52,,,,,53.0,Period 2,-1.0,-1.8867924528301887,52,B,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,33420.0,1838107020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),56.0,56,,,,,53.0,Period 2,3.0,5.660377358490567,56,B,2018-03-31T09:17 (9)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,31620.0,1838623620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,Y,53.0,Period 3,nan,nan,53,C,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,40920.0,1838632920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,,53.0,Period 3,0.0,0.0,53,C,2018-04-06T11:22 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,39720.0,1838718120.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),55.0,55,,,,,51.0,EOT/ET/Followup,4.0,7.8431372549019605,55,C,2018-04-07T11:02 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,33420.0,1838711820.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,53.0,Period 3,3.0,5.660377358490567,56,C,2018-04-07T09:17 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,44640.0,1836476640.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),15.0,15,,,,Y,15.0,EOT/ET/Followup,nan,nan,15,NA,2018-03-12T12:24 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,39720.0,1838718120.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,15.0,EOT/ET/Followup,-1.0,-6.666666666666667,14,C,2018-04-07T11:02 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,44640.0,1836476640.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,Y,106.0,EOT/ET/Followup,nan,nan,106,NA,2018-03-12T12:24 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,Y,108.0,Period 1,nan,nan,108,A,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,108.0,Period 1,10.0,9.25925925925926,118,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,33420.0,1837502220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,108.0,Period 1,4.0,3.7037037037037033,112,A,2018-03-24T09:17 (2)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 2,nan,nan,121,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,121.0,Period 2,0.0,0.0,121,B,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,33420.0,1838107020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,121.0,Period 2,-15.0,-12.396694214876034,106,B,2018-03-31T09:17 (9)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,31620.0,1838623620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 3,nan,nan,121,C,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,40920.0,1838632920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,121.0,Period 3,-13.0,-10.743801652892563,108,C,2018-04-06T11:22 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,39720.0,1838718120.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,106.0,EOT/ET/Followup,4.0,3.7735849056603774,110,C,2018-04-07T11:02 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,33420.0,1838711820.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,121.0,Period 3,-1.0,-0.8264462809917356,120,C,2018-04-07T09:17 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,44640.0,1836476640.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-12T12:24 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,39720.0,1838718120.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.2,35.2,,,,,36.3,EOT/ET/Followup,-1.1,-3.0303030303030147,35.2,C,2018-04-07T11:02 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,43827.0,1836475827.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),63.8,63.8,,,,Y,63.8,EOT/ET/Followup,nan,nan,63.8,NA,2018-03-12T12:10 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,40650.0,1838719050.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),61.1,61.1,,,,,63.8,EOT/ET/Followup,-2.7,-4.231974921630088,61.1,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,47528.0,1836479528.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),18.7,18.7,,,,Y,18.7,EOT/ET/Followup,nan,nan,18.7,NA,2018-03-12T13:12 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,41115.0,1838719515.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),18.0,18.0,,,,,18.7,EOT/ET/Followup,-0.7,-3.7433155080213867,18.0,A,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,48605.0,1836480605.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-03-12T13:30 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,73.0,Period 1,-4.0,-5.47945205479452,69,C,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34020.0,1837502820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,73.0,Period 1,-8.0,-10.95890410958904,65,C,2018-03-24T09:27 (2)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 2,nan,nan,77,B,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,77.0,Period 2,-7.0,-9.090909090909092,70,B,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,34020.0,1838107620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),56.0,56,,,,,77.0,Period 2,-21.0,-27.27272727272727,56,B,2018-03-31T09:27 (9)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,Y,67.0,Period 3,nan,nan,67,A,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,67.0,Period 3,5.0,7.462686567164178,72,A,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,65.0,EOT/ET/Followup,-5.0,-7.6923076923076925,60,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,34020.0,1838712420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,67.0,Period 3,2.0,2.9850746268656714,69,A,2018-04-07T09:27 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,47528.0,1836479528.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),181.0,181,,,,Y,181.0,EOT/ET/Followup,nan,nan,181,NA,2018-03-12T13:12 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,48605.0,1836480605.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,EOT/ET/Followup,nan,nan,63,NA,2018-03-12T13:30 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,68.0,Period 1,-3.0,-4.411764705882353,65,C,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,34020.0,1837502820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,68.0,Period 1,3.0,4.411764705882353,71,C,2018-03-24T09:27 (2)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,B,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,65.0,Period 2,-3.0,-4.615384615384616,62,B,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,34020.0,1838107620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,65.0,Period 2,4.0,6.153846153846154,69,B,2018-03-31T09:27 (9)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 3,nan,nan,68,A,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,,68.0,Period 3,-8.0,-11.76470588235294,60,A,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,63.0,EOT/ET/Followup,5.0,7.936507936507936,68,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21281.0,34020.0,1838712420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,,68.0,Period 3,4.0,5.88235294117647,72,A,2018-04-07T09:27 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,48605.0,1836480605.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),18.0,18,,,,Y,18.0,EOT/ET/Followup,nan,nan,18,NA,2018-03-12T13:30 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,18.0,EOT/ET/Followup,-2.0,-11.11111111111111,16,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,48605.0,1836480605.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,EOT/ET/Followup,nan,nan,112,NA,2018-03-12T13:30 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 1,nan,nan,121,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,121.0,Period 1,-12.0,-9.917355371900827,109,C,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,34020.0,1837502820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,121.0,Period 1,-10.0,-8.264462809917356,111,C,2018-03-24T09:27 (2)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,Period 2,nan,nan,114,B,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,114.0,Period 2,-3.0,-2.631578947368421,111,B,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,34020.0,1838107620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,114.0,Period 2,-12.0,-10.526315789473683,102,B,2018-03-31T09:27 (9)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 3,nan,nan,105,A,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,105.0,Period 3,8.0,7.6190476190476195,113,A,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,112.0,EOT/ET/Followup,-13.0,-11.607142857142858,99,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21281.0,34020.0,1838712420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,105.0,Period 3,10.0,9.523809523809524,115,A,2018-04-07T09:27 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,48605.0,1836480605.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.8,36.8,,,,Y,36.8,EOT/ET/Followup,nan,nan,36.8,NA,2018-03-12T13:30 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.4,36.4,,,,,36.8,EOT/ET/Followup,-0.4,-1.0869565217391266,36.4,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,47528.0,1836479528.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),61.4,61.4,,,,Y,61.4,EOT/ET/Followup,nan,nan,61.4,NA,2018-03-12T13:12 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,41115.0,1838719515.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),58.9,58.9,,,,,61.4,EOT/ET/Followup,-2.5,-4.071661237785016,58.9,A,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,47907.0,1836479907.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.4,25.4,,,,Y,25.4,EOT/ET/Followup,nan,nan,25.4,NA,2018-03-12T13:18 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,41889.0,1838720289.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.3,25.3,,,,,25.4,EOT/ET/Followup,-0.1,-0.39370078740156644,25.3,C,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,48872.0,1836480872.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-03-12T13:34 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,Period 1,nan,nan,80,A,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,42000.0,1837424400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,80.0,Period 1,-5.0,-6.25,75,A,2018-03-23T11:40 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,34500.0,1837503300.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,80.0,Period 1,-18.0,-22.5,62,A,2018-03-24T09:35 (2)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,Period 2,nan,nan,83,B,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,42000.0,1838029200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,83.0,Period 2,-11.0,-13.253012048192772,72,B,2018-03-30T11:40 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,34500.0,1838108100.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,83.0,Period 2,-20.0,-24.096385542168676,63,B,2018-03-31T09:35 (9)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,32700.0,1838624700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,Y,81.0,Period 3,nan,nan,81,C,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,42000.0,1838634000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,81.0,Period 3,0.0,0.0,81,C,2018-04-06T11:40 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,40800.0,1838719200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,73.0,EOT/ET/Followup,-2.0,-2.73972602739726,71,C,2018-04-07T11:20 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,34500.0,1838712900.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,81.0,Period 3,-20.0,-24.691358024691358,61,C,2018-04-07T09:35 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,47907.0,1836479907.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),185.5,185.5,,,,Y,185.5,EOT/ET/Followup,nan,nan,185.5,NA,2018-03-12T13:18 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,48872.0,1836480872.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,EOT/ET/Followup,nan,nan,62,NA,2018-03-12T13:34 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,A,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,42000.0,1837424400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),66.0,66,,,,,71.0,Period 1,-5.0,-7.042253521126761,66,A,2018-03-23T11:40 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,34500.0,1837503300.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),80.0,80,,,,,71.0,Period 1,9.0,12.676056338028168,80,A,2018-03-24T09:35 (2)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,Y,67.0,Period 2,nan,nan,67,B,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,42000.0,1838029200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,67.0,Period 2,-5.0,-7.462686567164178,62,B,2018-03-30T11:40 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,34500.0,1838108100.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,67.0,Period 2,0.0,0.0,67,B,2018-03-31T09:35 (9)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,32700.0,1838624700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 3,nan,nan,75,C,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,42000.0,1838634000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,,75.0,Period 3,-15.0,-20.0,60,C,2018-04-06T11:40 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,40800.0,1838719200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),70.0,70,,,,,62.0,EOT/ET/Followup,8.0,12.903225806451612,70,C,2018-04-07T11:20 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,34500.0,1838712900.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,,75.0,Period 3,-1.0,-1.3333333333333335,74,C,2018-04-07T09:35 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,48872.0,1836480872.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-12T13:34 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,40800.0,1838719200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),15.0,15,,,,,12.0,EOT/ET/Followup,3.0,25.0,15,C,2018-04-07T11:20 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,48872.0,1836480872.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,EOT/ET/Followup,nan,nan,114,NA,2018-03-12T13:34 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,Y,123.0,Period 1,nan,nan,123,A,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,42000.0,1837424400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,123.0,Period 1,-11.0,-8.94308943089431,112,A,2018-03-23T11:40 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,34500.0,1837503300.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,123.0,Period 1,-6.0,-4.878048780487805,117,A,2018-03-24T09:35 (2)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 2,nan,nan,122,B,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,42000.0,1838029200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,122.0,Period 2,-5.0,-4.098360655737705,117,B,2018-03-30T11:40 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,34500.0,1838108100.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,122.0,Period 2,-10.0,-8.19672131147541,112,B,2018-03-31T09:35 (9)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,32700.0,1838624700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,Period 3,nan,nan,129,C,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,42000.0,1838634000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,129.0,Period 3,-2.0,-1.550387596899225,127,C,2018-04-06T11:40 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,40800.0,1838719200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,114.0,EOT/ET/Followup,9.0,7.894736842105263,123,C,2018-04-07T11:20 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,34500.0,1838712900.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,129.0,Period 3,5.0,3.875968992248062,134,C,2018-04-07T09:35 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,48872.0,1836480872.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.7,36.7,,,,Y,36.7,EOT/ET/Followup,nan,nan,36.7,NA,2018-03-12T13:34 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,40800.0,1838719200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.4,36.4,,,,,36.7,EOT/ET/Followup,-0.3,-0.8174386920981042,36.4,C,2018-04-07T11:20 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,47907.0,1836479907.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),87.4,87.4,,,,Y,87.4,EOT/ET/Followup,nan,nan,87.4,NA,2018-03-12T13:18 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,41889.0,1838720289.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),87.0,87,,,,,87.4,EOT/ET/Followup,-0.4,-0.4576659038901667,87,C,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,52369.0,1836484369.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.8,24.8,,,,Y,24.8,EOT/ET/Followup,nan,nan,24.8,NA,2018-03-12T14:32 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,40043.0,1838718443.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),24.8,24.8,,,,,24.8,EOT/ET/Followup,0.0,0.0,24.8,C,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,53049.0,1836485049.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,EOT/ET/Followup,nan,nan,78,NA,2018-03-12T14:44 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),88.0,88,,,,,nan,Period 1,nan,nan,88,B,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,31305.0,1837413705.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,nan,Period 1,nan,nan,84,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21266.0,31365.0,1837413765.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,B,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,73.0,Period 1,1.0,1.36986301369863,74,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21267.0,33000.0,1837501800.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,73.0,Period 1,-1.0,-1.36986301369863,72,B,2018-03-24T09:10 (2)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),88.0,88,,,,Y,88.0,Period 2,nan,nan,88,A,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21273.0,40500.0,1838027700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,88.0,Period 2,-13.0,-14.772727272727273,75,A,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21274.0,33000.0,1838106600.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,88.0,Period 2,-9.0,-10.227272727272728,79,A,2018-03-31T09:10 (9)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 3,nan,nan,79,C,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21280.0,40500.0,1838632500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,79.0,Period 3,-4.0,-5.063291139240507,75,C,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,78.0,EOT/ET/Followup,-17.0,-21.794871794871796,61,C,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21281.0,33000.0,1838711400.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,79.0,Period 3,1.0,1.2658227848101267,80,C,2018-04-07T09:10 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21255.0,52369.0,1836484369.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),179.0,179,,,,Y,179.0,EOT/ET/Followup,nan,nan,179,NA,2018-03-12T14:32 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21255.0,53049.0,1836485049.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),50.0,50,,,,Y,50.0,EOT/ET/Followup,nan,nan,50,NA,2018-03-12T14:44 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,,nan,Period 1,nan,nan,61,B,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21266.0,31305.0,1837413705.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,,nan,Period 1,nan,nan,61,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31365.0,1837413765.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,B,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),53.0,53,,,,,63.0,Period 1,-10.0,-15.873015873015872,53,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21267.0,33000.0,1837501800.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,63.0,Period 1,-8.0,-12.698412698412698,55,B,2018-03-24T09:10 (2)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),55.0,55,,,,Y,55.0,Period 2,nan,nan,55,A,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21273.0,40500.0,1838027700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),50.0,50,,,,,55.0,Period 2,-5.0,-9.090909090909092,50,A,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21274.0,33000.0,1838106600.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,,55.0,Period 2,4.0,7.2727272727272725,59,A,2018-03-31T09:10 (9)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,Period 3,nan,nan,60,C,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21280.0,40500.0,1838632500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),50.0,50,,,,,60.0,Period 3,-10.0,-16.666666666666664,50,C,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,50.0,EOT/ET/Followup,6.0,12.0,56,C,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21281.0,33000.0,1838711400.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),62.0,62,,,,,60.0,Period 3,2.0,3.3333333333333335,62,C,2018-04-07T09:10 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21255.0,53049.0,1836485049.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-12T14:44 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,C,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21255.0,53049.0,1836485049.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,Y,125.0,EOT/ET/Followup,nan,nan,125,NA,2018-03-12T14:44 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),141.0,141,,,,,nan,Period 1,nan,nan,141,B,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21266.0,31305.0,1837413705.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,nan,Period 1,nan,nan,135,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21266.0,31365.0,1837413765.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 1,nan,nan,119,B,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,119.0,Period 1,2.0,1.680672268907563,121,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21267.0,33000.0,1837501800.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,119.0,Period 1,9.0,7.563025210084033,128,B,2018-03-24T09:10 (2)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,Y,138.0,Period 2,nan,nan,138,A,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,40500.0,1838027700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,138.0,Period 2,-10.0,-7.246376811594203,128,A,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21274.0,33000.0,1838106600.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,138.0,Period 2,-9.0,-6.521739130434782,129,A,2018-03-31T09:10 (9)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,Y,124.0,Period 3,nan,nan,124,C,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,TREATMENT,21280.0,40500.0,1838632500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,124.0,Period 3,-6.0,-4.838709677419355,118,C,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,125.0,EOT/ET/Followup,-4.0,-3.2,121,C,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,41.0,TREATMENT,21281.0,33000.0,1838711400.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,124.0,Period 3,2.0,1.6129032258064515,126,C,2018-04-07T09:10 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21255.0,53049.0,1836485049.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-12T14:44 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.9,35.9,,,,,36.2,EOT/ET/Followup,-0.3,-0.8287292817679676,35.9,C,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,45.0,SCREENING,21255.0,52369.0,1836484369.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),79.6,79.6,,,,Y,79.6,EOT/ET/Followup,nan,nan,79.6,NA,2018-03-12T14:32 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,END OF TREATMENT,21281.0,40043.0,1838718443.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.6,79.6,,,,,79.6,EOT/ET/Followup,0.0,0.0,79.6,C,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,52923.0,1836484923.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.3,24.3,,,,Y,24.3,EOT/ET/Followup,nan,nan,24.3,NA,2018-03-12T14:42 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,40211.0,1838718611.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.1,23.1,,,,,24.3,EOT/ET/Followup,-1.2,-4.938271604938269,23.1,B,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,54205.0,1836486205.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,EOT/ET/Followup,nan,nan,63,NA,2018-03-12T15:03 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,A,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,63.0,Period 1,2.0,3.1746031746031744,65,A,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,33060.0,1837501860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,63.0,Period 1,-2.0,-3.1746031746031744,61,A,2018-03-24T09:11 (2)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 2,nan,nan,79,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,,79.0,Period 2,7.0,8.860759493670885,86,C,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,33060.0,1838106660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,79.0,Period 2,-4.0,-5.063291139240507,75,C,2018-03-31T09:11 (9)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 3,nan,nan,72,B,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,72.0,Period 3,-5.0,-6.944444444444445,67,B,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,63.0,EOT/ET/Followup,-4.0,-6.349206349206349,59,B,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,33060.0,1838711460.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,72.0,Period 3,-14.0,-19.444444444444446,58,B,2018-04-07T09:11 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,52923.0,1836484923.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),173.5,173.5,,,,Y,173.5,EOT/ET/Followup,nan,nan,173.5,NA,2018-03-12T14:42 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,54205.0,1836486205.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,EOT/ET/Followup,nan,nan,66,NA,2018-03-12T15:03 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),88.0,88,,,,Y,88.0,Period 1,nan,nan,88,A,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,88.0,Period 1,-16.0,-18.181818181818183,72,A,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,33060.0,1837501860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,,88.0,Period 1,-4.0,-4.545454545454546,84,A,2018-03-24T09:11 (2)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),95.0,95,,,,Y,95.0,Period 2,nan,nan,95,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,,95.0,Period 2,-25.0,-26.31578947368421,70,C,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,33060.0,1838106660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),79.0,79,,,,,95.0,Period 2,-16.0,-16.842105263157894,79,C,2018-03-31T09:11 (9)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),81.0,81,,,,Y,81.0,Period 3,nan,nan,81,B,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,,81.0,Period 3,-5.0,-6.172839506172839,76,B,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),93.0,93,,,,,66.0,EOT/ET/Followup,27.0,40.909090909090914,93,B,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,33060.0,1838711460.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),92.0,92,,,,,81.0,Period 3,11.0,13.580246913580247,92,B,2018-04-07T09:11 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,54205.0,1836486205.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-12T15:03 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,12.0,EOT/ET/Followup,2.0,16.666666666666664,14,B,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,54205.0,1836486205.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,EOT/ET/Followup,nan,nan,113,NA,2018-03-12T15:03 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,Y,99.0,Period 1,nan,nan,99,A,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,99.0,Period 1,15.0,15.151515151515152,114,A,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,33060.0,1837501860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,99.0,Period 1,8.0,8.080808080808081,107,A,2018-03-24T09:11 (2)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,Y,123.0,Period 2,nan,nan,123,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,123.0,Period 2,12.0,9.75609756097561,135,C,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,33060.0,1838106660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,123.0,Period 2,-8.0,-6.504065040650407,115,C,2018-03-31T09:11 (9)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 3,nan,nan,119,B,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,119.0,Period 3,-7.0,-5.88235294117647,112,B,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,113.0,EOT/ET/Followup,-2.0,-1.7699115044247788,111,B,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,33060.0,1838711460.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,119.0,Period 3,-7.0,-5.88235294117647,112,B,2018-04-07T09:11 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,54205.0,1836486205.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),37.4,37.4,,,,Y,37.4,EOT/ET/Followup,nan,nan,37.4,NA,2018-03-12T15:03 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.8,36.8,,,,,37.4,EOT/ET/Followup,-0.6,-1.6042780748663141,36.8,B,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,52923.0,1836484923.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),73.2,73.2,,,,Y,73.2,EOT/ET/Followup,nan,nan,73.2,NA,2018-03-12T14:42 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40211.0,1838718611.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),69.4,69.4,,,,,73.2,EOT/ET/Followup,-3.8,-5.191256830601089,69.4,B,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,45469.0,1836477469.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.9,24.9,,,,Y,24.9,EOT/ET/Followup,nan,nan,24.9,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,40231.0,1838718631.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.0,25.0,,,,,24.9,EOT/ET/Followup,0.1,0.4016064257028169,25.0,B,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,46500.0,1836478500.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),56.0,56,,,,Y,56.0,EOT/ET/Followup,nan,nan,56,NA,2018-03-12T12:55 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,Period 1,nan,nan,80,C,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,80.0,Period 1,-20.0,-25.0,60,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,33120.0,1837501920.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,80.0,Period 1,-16.0,-20.0,64,C,2018-03-24T09:12 (2)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,Y,60.0,Period 2,nan,nan,60,A,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,60.0,Period 2,-3.0,-5.0,57,A,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,33120.0,1838106720.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,60.0,Period 2,-3.0,-5.0,57,A,2018-03-31T09:12 (9)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,nan,Period 3,nan,nan,84,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,nan,Period 3,nan,nan,90,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,Period 3,nan,nan,83,B,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),55.0,55,,,,,83.0,Period 3,-28.0,-33.734939759036145,55,B,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),47.0,47,,,,,56.0,EOT/ET/Followup,-9.0,-16.071428571428573,47,B,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,END OF TREATMENT,21281.0,39656.0,1838718056.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,56.0,EOT/ET/Followup,4.0,7.142857142857142,60,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,END OF TREATMENT,21281.0,45480.0,1838723880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,56.0,EOT/ET/Followup,7.0,12.5,63,B,2018-04-07T12:38 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21281.0,33120.0,1838711520.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,83.0,Period 3,-18.0,-21.686746987951807,65,B,2018-04-07T09:12 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21255.0,45469.0,1836477469.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),178.5,178.5,,,,Y,178.5,EOT/ET/Followup,nan,nan,178.5,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,46500.0,1836478500.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),69.0,69,,,,Y,69.0,EOT/ET/Followup,nan,nan,69,NA,2018-03-12T12:55 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,C,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),59.0,59,,,,,68.0,Period 1,-9.0,-13.23529411764706,59,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21267.0,33120.0,1837501920.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,68.0,Period 1,1.0,1.4705882352941175,69,C,2018-03-24T09:12 (2)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,A,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),56.0,56,,,,,66.0,Period 2,-10.0,-15.151515151515152,56,A,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21274.0,33120.0,1838106720.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,,66.0,Period 2,2.0,3.0303030303030303,68,A,2018-03-31T09:12 (9)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,nan,Period 3,nan,nan,67,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,,nan,Period 3,nan,nan,76,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,Y,76.0,Period 3,nan,nan,76,B,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,76.0,Period 3,-11.0,-14.473684210526317,65,B,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,,69.0,EOT/ET/Followup,-3.0,-4.3478260869565215,66,B,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21281.0,33120.0,1838711520.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,76.0,Period 3,-11.0,-14.473684210526317,65,B,2018-04-07T09:12 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21255.0,46500.0,1836478500.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-12T12:55 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,16.0,EOT/ET/Followup,0.0,0.0,16,B,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,32.0,SCREENING,21255.0,46500.0,1836478500.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,EOT/ET/Followup,nan,nan,129,NA,2018-03-12T12:55 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,Y,138.0,Period 1,nan,nan,138,C,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,138.0,Period 1,-7.0,-5.072463768115942,131,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21267.0,33120.0,1837501920.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,138.0,Period 1,-13.0,-9.420289855072465,125,C,2018-03-24T09:12 (2)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,Y,130.0,Period 2,nan,nan,130,A,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,130.0,Period 2,-17.0,-13.076923076923078,113,A,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21274.0,33120.0,1838106720.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,130.0,Period 2,-23.0,-17.692307692307693,107,A,2018-03-31T09:12 (9)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),158.0,158,,,,,nan,Period 3,nan,nan,158,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),152.0,152,,,,,nan,Period 3,nan,nan,152,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,41.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),159.0,159,,,,Y,159.0,Period 3,nan,nan,159,B,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,159.0,Period 3,-36.0,-22.641509433962266,123,B,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),96.0,96,,,,,129.0,EOT/ET/Followup,-33.0,-25.581395348837212,96,B,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,END OF TREATMENT,21281.0,39656.0,1838718056.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,129.0,EOT/ET/Followup,-25.0,-19.379844961240313,104,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,END OF TREATMENT,21281.0,45480.0,1838723880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,129.0,EOT/ET/Followup,-4.0,-3.10077519379845,125,B,2018-04-07T12:38 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21281.0,33120.0,1838711520.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,159.0,Period 3,-49.0,-30.81761006289308,110,B,2018-04-07T09:12 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,47.0,SCREENING,21255.0,46500.0,1836478500.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-12T12:55 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.4,36.4,,,,,36.6,EOT/ET/Followup,-0.2,-0.5464480874317017,36.4,B,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,45469.0,1836477469.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),79.4,79.4,,,,Y,79.4,EOT/ET/Followup,nan,nan,79.4,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,END OF TREATMENT,21281.0,40231.0,1838718631.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.7,79.7,,,,,79.4,EOT/ET/Followup,0.3,0.377833753148611,79.7,B,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,55631.0,1836487631.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.6,28.6,,,,Y,28.6,EOT/ET/Followup,nan,nan,28.6,NA,2018-03-12T15:27 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,40780.0,1838719180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),28.3,28.3,,,,,28.6,EOT/ET/Followup,-0.3,-1.0489510489510514,28.3,B,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,56700.0,1836488700.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,Y,67.0,EOT/ET/Followup,nan,nan,67,NA,2018-03-12T15:45 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 1,nan,nan,82,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,82.0,Period 1,-6.0,-7.317073170731707,76,A,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,33720.0,1837502520.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,82.0,Period 1,-11.0,-13.414634146341465,71,A,2018-03-24T09:22 (2)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,Period 2,nan,nan,85,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,85.0,Period 2,-5.0,-5.88235294117647,80,C,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,33720.0,1838107320.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,85.0,Period 2,-15.0,-17.647058823529413,70,C,2018-03-31T09:22 (9)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 3,nan,nan,77,B,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,77.0,Period 3,-1.0,-1.2987012987012987,76,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,67.0,EOT/ET/Followup,0.0,0.0,67,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,77.0,Period 3,-9.0,-11.688311688311687,68,B,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,55631.0,1836487631.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),169.0,169,,,,Y,169.0,EOT/ET/Followup,nan,nan,169,NA,2018-03-12T15:27 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,56700.0,1836488700.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,EOT/ET/Followup,nan,nan,66,NA,2018-03-12T15:45 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),52.0,52,,,,,57.0,Period 1,-5.0,-8.771929824561402,52,A,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,33720.0,1837502520.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,57.0,Period 1,7.0,12.280701754385964,64,A,2018-03-24T09:22 (2)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,Period 2,nan,nan,58,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),58.0,58,,,,,58.0,Period 2,0.0,0.0,58,C,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,33720.0,1838107320.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,,58.0,Period 2,1.0,1.7241379310344827,59,C,2018-03-31T09:22 (9)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,Period 3,nan,nan,54,B,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),57.0,57,,,,,54.0,Period 3,3.0,5.555555555555555,57,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,,66.0,EOT/ET/Followup,-5.0,-7.575757575757576,61,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,,54.0,Period 3,5.0,9.25925925925926,59,B,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21255.0,56700.0,1836488700.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),15.0,15,,,,Y,15.0,EOT/ET/Followup,nan,nan,15,NA,2018-03-12T15:45 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,15.0,EOT/ET/Followup,1.0,6.666666666666667,16,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21255.0,56700.0,1836488700.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,EOT/ET/Followup,nan,nan,121,NA,2018-03-12T15:45 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,Y,128.0,Period 1,nan,nan,128,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,128.0,Period 1,-3.0,-2.34375,125,A,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,33720.0,1837502520.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,128.0,Period 1,-10.0,-7.8125,118,A,2018-03-24T09:22 (2)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,Period 2,nan,nan,135,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,135.0,Period 2,-14.0,-10.37037037037037,121,C,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,33720.0,1838107320.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,,135.0,Period 2,-11.0,-8.148148148148149,124,C,2018-03-31T09:22 (9)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 3,nan,nan,121,B,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,121.0,Period 3,4.0,3.3057851239669422,125,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,121.0,EOT/ET/Followup,7.0,5.785123966942149,128,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,,121.0,Period 3,12.0,9.917355371900827,133,B,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21255.0,56700.0,1836488700.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-12T15:45 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.3,EOT/ET/Followup,-0.1,-0.2754820936638962,36.2,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21255.0,55631.0,1836487631.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),81.6,81.6,,,,Y,81.6,EOT/ET/Followup,nan,nan,81.6,NA,2018-03-12T15:27 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40780.0,1838719180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),80.7,80.7,,,,,81.6,EOT/ET/Followup,-0.9,-1.1029411764705779,80.7,B,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,57052.0,1836489052.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.8,27.8,,,,Y,27.8,EOT/ET/Followup,nan,nan,27.8,NA,2018-03-12T15:50 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21272.0,63747.0,1837964547.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,BMI,Body Mass Index (kg/m2),27.7,27.7,,,,,27.8,EOT/ET/Followup,-0.1,-0.35971223021583243,27.7,C,2018-03-29T17:42 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,57775.0,1836489775.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-03-12T16:02 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 1,nan,nan,74,C,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40980.0,1837423380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,74.0,Period 1,-2.0,-2.7027027027027026,72,C,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,33480.0,1837502280.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,74.0,Period 1,-2.0,-2.7027027027027026,72,C,2018-03-24T09:18 (2)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,END OF TREATMENT,21272.0,63060.0,1837963860.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,73.0,EOT/ET/Followup,-2.0,-2.73972602739726,71,C,2018-03-29T17:31 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,6.0,SCREENING,21255.0,57052.0,1836489052.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),184.0,184,,,,Y,184.0,EOT/ET/Followup,nan,nan,184,NA,2018-03-12T15:50 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,7.0,SCREENING,21255.0,57775.0,1836489775.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,EOT/ET/Followup,nan,nan,77,NA,2018-03-12T16:02 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,C,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21266.0,40980.0,1837423380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),75.0,75,,,,,68.0,Period 1,7.0,10.294117647058822,75,C,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21267.0,33480.0,1837502280.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,68.0,Period 1,4.0,5.88235294117647,72,C,2018-03-24T09:18 (2)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21272.0,63060.0,1837963860.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,77.0,EOT/ET/Followup,-8.0,-10.38961038961039,69,C,2018-03-29T17:31 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,57775.0,1836489775.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-12T16:02 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21272.0,63060.0,1837963860.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,14.0,EOT/ET/Followup,-2.0,-14.285714285714285,12,C,2018-03-29T17:31 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21255.0,57775.0,1836489775.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-03-12T16:02 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 1,nan,nan,116,C,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21266.0,40980.0,1837423380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,116.0,Period 1,9.0,7.758620689655173,125,C,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21267.0,33480.0,1837502280.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,116.0,Period 1,-10.0,-8.620689655172415,106,C,2018-03-24T09:18 (2)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,END OF TREATMENT,21272.0,63060.0,1837963860.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,118.0,EOT/ET/Followup,11.0,9.322033898305085,129,C,2018-03-29T17:31 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,19.0,SCREENING,21255.0,57775.0,1836489775.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-12T16:02 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,END OF TREATMENT,21272.0,63060.0,1837963860.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,TEMP,Temperature (C),35.8,35.8,,,,,36.3,EOT/ET/Followup,-0.5,-1.3774104683195594,35.8,C,2018-03-29T17:31 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21255.0,57052.0,1836489052.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),94.2,94.2,,,,Y,94.2,EOT/ET/Followup,nan,nan,94.2,NA,2018-03-12T15:50 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,END OF TREATMENT,21272.0,63747.0,1837964547.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,WEIGHT,Weight (kg),93.8,93.8,,,,,94.2,EOT/ET/Followup,-0.4,-0.4246284501061632,93.8,C,2018-03-29T17:42 (7)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21255.0,55337.0,1836487337.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.6,23.6,,,,Y,23.6,EOT/ET/Followup,nan,nan,23.6,NA,2018-03-12T15:22 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,55920.0,1836487920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-12T15:32 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,33240.0,1837415640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 1,nan,nan,70,A,2018-03-23T09:14 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,42540.0,1837424940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,70.0,Period 1,5.0,7.142857142857142,75,A,2018-03-23T11:49 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,4.0,SCREENING,21255.0,55337.0,1836487337.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),158.0,158,,,,Y,158.0,EOT/ET/Followup,nan,nan,158,NA,2018-03-12T15:22 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,5.0,SCREENING,21255.0,55920.0,1836487920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-12T15:32 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21266.0,33240.0,1837415640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,Y,67.0,Period 1,nan,nan,67,A,2018-03-23T09:14 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21266.0,42540.0,1837424940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,67.0,Period 1,3.0,4.477611940298507,70,A,2018-03-23T11:49 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,8.0,SCREENING,21255.0,55920.0,1836487920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-12T15:32 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,55920.0,1836487920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-03-12T15:32 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,33240.0,1837415640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,Y,108.0,Period 1,nan,nan,108,A,2018-03-23T09:14 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,42540.0,1837424940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,108.0,Period 1,13.0,12.037037037037036,121,A,2018-03-23T11:49 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21255.0,55920.0,1836487920.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.7,36.7,,,,Y,36.7,EOT/ET/Followup,nan,nan,36.7,NA,2018-03-12T15:32 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,55337.0,1836487337.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-03-12T15:22 (-11)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21256.0,45097.0,1836563497.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.6,24.6,,,,Y,24.6,EOT/ET/Followup,nan,nan,24.6,NA,2018-03-13T12:31 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,41199.0,1838719599.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),24.4,24.4,,,,,24.6,EOT/ET/Followup,-0.2,-0.8130081300813123,24.4,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,45855.0,1836564255.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-03-13T12:44 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,Y,67.0,Period 1,nan,nan,67,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,67.0,Period 1,-8.0,-11.940298507462686,59,A,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,34080.0,1837502880.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,67.0,Period 1,-6.0,-8.955223880597014,61,A,2018-03-24T09:28 (2)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,B,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,72.0,Period 2,-2.0,-2.7777777777777777,70,B,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,34080.0,1838107680.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,72.0,Period 2,-3.0,-4.166666666666666,69,B,2018-03-31T09:28 (9)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,nan,Period 3,nan,nan,82,C,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,nan,Period 3,nan,nan,80,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 3,nan,nan,74,C,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,74.0,Period 3,-5.0,-6.756756756756757,69,C,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,64.0,EOT/ET/Followup,-7.0,-10.9375,57,C,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21281.0,34080.0,1838712480.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,74.0,Period 3,-16.0,-21.62162162162162,58,C,2018-04-07T09:28 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21256.0,45097.0,1836563497.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),181.0,181,,,,Y,181.0,EOT/ET/Followup,nan,nan,181,NA,2018-03-13T12:31 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21256.0,45855.0,1836564255.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,EOT/ET/Followup,nan,nan,60,NA,2018-03-13T12:44 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 1,nan,nan,65,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),60.0,60,,,,,65.0,Period 1,-5.0,-7.6923076923076925,60,A,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21267.0,34080.0,1837502880.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,65.0,Period 1,5.0,7.6923076923076925,70,A,2018-03-24T09:28 (2)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),78.0,78,,,,Y,78.0,Period 2,nan,nan,78,B,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,78.0,Period 2,-14.0,-17.94871794871795,64,B,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21274.0,34080.0,1838107680.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),79.0,79,,,,,78.0,Period 2,1.0,1.282051282051282,79,B,2018-03-31T09:28 (9)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,,nan,Period 3,nan,nan,72,C,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,nan,Period 3,nan,nan,77,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),78.0,78,,,,Y,78.0,Period 3,nan,nan,78,C,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,,78.0,Period 3,-12.0,-15.384615384615385,66,C,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,,60.0,EOT/ET/Followup,6.0,10.0,66,C,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21281.0,34080.0,1838712480.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),73.0,73,,,,,78.0,Period 3,-5.0,-6.41025641025641,73,C,2018-04-07T09:28 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21256.0,45855.0,1836564255.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),18.0,18,,,,Y,18.0,EOT/ET/Followup,nan,nan,18,NA,2018-03-13T12:44 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,18.0,EOT/ET/Followup,-6.0,-33.33333333333333,12,C,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21256.0,45855.0,1836564255.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,EOT/ET/Followup,nan,nan,114,NA,2018-03-13T12:44 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 1,nan,nan,117,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,117.0,Period 1,-13.0,-11.11111111111111,104,A,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21267.0,34080.0,1837502880.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,117.0,Period 1,-4.0,-3.418803418803419,113,A,2018-03-24T09:28 (2)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,Period 2,nan,nan,113,B,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,113.0,Period 2,6.0,5.3097345132743365,119,B,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21274.0,34080.0,1838107680.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,113.0,Period 2,1.0,0.8849557522123894,114,B,2018-03-31T09:28 (9)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),140.0,140,,,,,nan,Period 3,nan,nan,140,C,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,nan,Period 3,nan,nan,129,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,Period 3,nan,nan,135,C,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,135.0,Period 3,-18.0,-13.333333333333334,117,C,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,114.0,EOT/ET/Followup,4.0,3.508771929824561,118,C,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,41.0,TREATMENT,21281.0,34080.0,1838712480.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,,135.0,Period 3,-11.0,-8.148148148148149,124,C,2018-04-07T09:28 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21256.0,45855.0,1836564255.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.9,35.9,,,,Y,35.9,EOT/ET/Followup,nan,nan,35.9,NA,2018-03-13T12:44 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.3,36.3,,,,,35.9,EOT/ET/Followup,0.4,1.1142061281337008,36.3,C,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,45.0,SCREENING,21256.0,45097.0,1836563497.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),80.6,80.6,,,,Y,80.6,EOT/ET/Followup,nan,nan,80.6,NA,2018-03-13T12:31 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,END OF TREATMENT,21281.0,41199.0,1838719599.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.8,79.8,,,,,80.6,EOT/ET/Followup,-0.8,-0.9925558312655052,79.8,C,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21256.0,44485.0,1836562885.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.8,25.8,,,,Y,25.8,EOT/ET/Followup,nan,nan,25.8,NA,2018-03-13T12:21 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,41444.0,1838719844.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.4,25.4,,,,,25.8,EOT/ET/Followup,-0.4,-1.5503875968992331,25.4,C,2018-04-07T11:30 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,45180.0,1836563580.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-03-13T12:33 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,A,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,73.0,Period 1,-2.0,-2.73972602739726,71,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,34140.0,1837502940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,73.0,Period 1,-8.0,-10.95890410958904,65,A,2018-03-24T09:29 (2)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,B,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,75.0,Period 2,-9.0,-12.0,66,B,2018-03-30T11:34 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,34140.0,1838107740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,75.0,Period 2,-9.0,-12.0,66,B,2018-03-31T09:29 (9)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 3,nan,nan,70,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,41640.0,1838633640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,70.0,Period 3,-4.0,-5.714285714285714,66,C,2018-04-06T11:34 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,40440.0,1838718840.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,73.0,EOT/ET/Followup,-12.0,-16.43835616438356,61,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,34140.0,1838712540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,70.0,Period 3,-10.0,-14.285714285714285,60,C,2018-04-07T09:29 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21256.0,44485.0,1836562885.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),189.0,189,,,,Y,189.0,EOT/ET/Followup,nan,nan,189,NA,2018-03-13T12:21 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21256.0,45180.0,1836563580.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,EOT/ET/Followup,nan,nan,84,NA,2018-03-13T12:33 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,A,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,73.0,Period 1,-9.0,-12.32876712328767,64,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21267.0,34140.0,1837502940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),81.0,81,,,,,73.0,Period 1,8.0,10.95890410958904,81,A,2018-03-24T09:29 (2)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,B,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,71.0,Period 2,-7.0,-9.859154929577464,64,B,2018-03-30T11:34 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,34140.0,1838107740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,,71.0,Period 2,4.0,5.633802816901409,75,B,2018-03-31T09:29 (9)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 3,nan,nan,68,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,41640.0,1838633640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,68.0,Period 3,-4.0,-5.88235294117647,64,C,2018-04-06T11:34 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,40440.0,1838718840.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),73.0,73,,,,,84.0,EOT/ET/Followup,-11.0,-13.095238095238097,73,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,34140.0,1838712540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),69.0,69,,,,,68.0,Period 3,1.0,1.4705882352941175,69,C,2018-04-07T09:29 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21256.0,45180.0,1836563580.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-13T12:33 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,40440.0,1838718840.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),18.0,18,,,,,16.0,EOT/ET/Followup,2.0,12.5,18,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21256.0,45180.0,1836563580.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,EOT/ET/Followup,nan,nan,122,NA,2018-03-13T12:33 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,Y,124.0,Period 1,nan,nan,124,A,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,124.0,Period 1,-9.0,-7.258064516129033,115,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21267.0,34140.0,1837502940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,124.0,Period 1,-9.0,-7.258064516129033,115,A,2018-03-24T09:29 (2)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 2,nan,nan,121,B,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,121.0,Period 2,-12.0,-9.917355371900827,109,B,2018-03-30T11:34 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,34140.0,1838107740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,121.0,Period 2,-7.0,-5.785123966942149,114,B,2018-03-31T09:29 (9)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 3,nan,nan,115,C,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,41640.0,1838633640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,115.0,Period 3,-8.0,-6.956521739130435,107,C,2018-04-06T11:34 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,40440.0,1838718840.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,122.0,EOT/ET/Followup,-18.0,-14.754098360655737,104,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,34140.0,1838712540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,115.0,Period 3,1.0,0.8695652173913043,116,C,2018-04-07T09:29 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21256.0,45180.0,1836563580.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.8,36.8,,,,Y,36.8,EOT/ET/Followup,nan,nan,36.8,NA,2018-03-13T12:33 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,40440.0,1838718840.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.1,36.1,,,,,36.8,EOT/ET/Followup,-0.7,-1.902173913043467,36.1,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21256.0,44485.0,1836562885.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),92.2,92.2,,,,Y,92.2,EOT/ET/Followup,nan,nan,92.2,NA,2018-03-13T12:21 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,41444.0,1838719844.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),90.7,90.7,,,,,92.2,EOT/ET/Followup,-1.5,-1.6268980477223427,90.7,C,2018-04-07T11:30 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21256.0,48317.0,1836566717.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.3,27.3,,,,Y,27.3,EOT/ET/Followup,nan,nan,27.3,NA,2018-03-13T13:25 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,42250.0,1838720650.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.6,27.6,,,,,27.3,EOT/ET/Followup,0.3,1.0989010989011014,27.6,C,2018-04-07T11:44 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,48720.0,1836567120.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,EOT/ET/Followup,nan,nan,85,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,33540.0,1837415940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,Period 1,nan,nan,85,B,2018-03-23T09:19 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42720.0,1837425120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,,85.0,Period 1,4.0,4.705882352941177,89,B,2018-03-23T11:52 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,35220.0,1837504020.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,85.0,Period 1,-10.0,-11.76470588235294,75,B,2018-03-24T09:47 (2)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,33420.0,1838020620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,Period 2,nan,nan,83,A,2018-03-30T09:17 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,42720.0,1838029920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,83.0,Period 2,-3.0,-3.614457831325301,80,A,2018-03-30T11:52 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,35220.0,1838108820.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,83.0,Period 2,-6.0,-7.228915662650602,77,A,2018-03-31T09:47 (9)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,33420.0,1838625420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),104.0,104,,,,,nan,Period 3,nan,nan,104,C,2018-04-06T09:17 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,33750.0,1838625750.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),106.0,106,,,,,nan,Period 3,nan,nan,106,C,2018-04-06T09:22 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21280.0,33850.0,1838625850.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,Period 3,nan,nan,112,C,2018-04-06T09:24 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21280.0,42720.0,1838634720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,,112.0,Period 3,-23.0,-20.535714285714285,89,C,2018-04-06T11:52 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21281.0,41520.0,1838719920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,85.0,EOT/ET/Followup,7.0,8.235294117647058,92,C,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,END OF TREATMENT,21281.0,41700.0,1838720100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),93.0,93,,,,,85.0,EOT/ET/Followup,8.0,9.411764705882353,93,C,2018-04-07T11:35 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,END OF TREATMENT,21281.0,41880.0,1838720280.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,85.0,EOT/ET/Followup,7.0,8.235294117647058,92,C,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21281.0,35220.0,1838713620.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,,112.0,Period 3,-23.0,-20.535714285714285,89,C,2018-04-07T09:47 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21256.0,48317.0,1836566717.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),174.5,174.5,,,,Y,174.5,EOT/ET/Followup,nan,nan,174.5,NA,2018-03-13T13:25 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,48720.0,1836567120.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,EOT/ET/Followup,nan,nan,62,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,33540.0,1837415940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,Period 1,nan,nan,62,B,2018-03-23T09:19 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,42720.0,1837425120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),62.0,62,,,,,62.0,Period 1,0.0,0.0,62,B,2018-03-23T11:52 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21267.0,35220.0,1837504020.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,,62.0,Period 1,6.0,9.67741935483871,68,B,2018-03-24T09:47 (2)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,33420.0,1838020620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,A,2018-03-30T09:17 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21273.0,42720.0,1838029920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,72.0,Period 2,-10.0,-13.88888888888889,62,A,2018-03-30T11:52 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21274.0,35220.0,1838108820.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),94.0,94,,,,,72.0,Period 2,22.0,30.555555555555557,94,A,2018-03-31T09:47 (9)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21280.0,33420.0,1838625420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,nan,Period 3,nan,nan,67,C,2018-04-06T09:17 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21280.0,33750.0,1838625750.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),75.0,75,,,,,nan,Period 3,nan,nan,75,C,2018-04-06T09:22 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21280.0,33850.0,1838625850.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,Y,76.0,Period 3,nan,nan,76,C,2018-04-06T09:24 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21280.0,42720.0,1838634720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),70.0,70,,,,,76.0,Period 3,-6.0,-7.894736842105263,70,C,2018-04-06T11:52 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,END OF TREATMENT,21281.0,41520.0,1838719920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,,62.0,EOT/ET/Followup,9.0,14.516129032258066,71,C,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21281.0,35220.0,1838713620.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,76.0,Period 3,1.0,1.3157894736842104,77,C,2018-04-07T09:47 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21256.0,48720.0,1836567120.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),13.0,13,,,,Y,13.0,EOT/ET/Followup,nan,nan,13,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,END OF TREATMENT,21281.0,41520.0,1838719920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,13.0,EOT/ET/Followup,1.0,7.6923076923076925,14,C,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,32.0,SCREENING,21256.0,48720.0,1836567120.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,EOT/ET/Followup,nan,nan,120,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21266.0,33540.0,1837415940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,Y,132.0,Period 1,nan,nan,132,B,2018-03-23T09:19 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,42720.0,1837425120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,132.0,Period 1,-3.0,-2.272727272727273,129,B,2018-03-23T11:52 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21267.0,35220.0,1837504020.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,132.0,Period 1,-9.0,-6.8181818181818175,123,B,2018-03-24T09:47 (2)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,33420.0,1838020620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,Y,125.0,Period 2,nan,nan,125,A,2018-03-30T09:17 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,42720.0,1838029920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,,125.0,Period 2,14.0,11.200000000000001,139,A,2018-03-30T11:52 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21274.0,35220.0,1838108820.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,125.0,Period 2,4.0,3.2,129,A,2018-03-31T09:47 (9)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,33420.0,1838625420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),145.0,145,,,,,nan,Period 3,nan,nan,145,C,2018-04-06T09:17 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,TREATMENT,21280.0,33750.0,1838625750.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),151.0,151,,,,,nan,Period 3,nan,nan,151,C,2018-04-06T09:22 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,41.0,TREATMENT,21280.0,33850.0,1838625850.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),157.0,157,,,,Y,157.0,Period 3,nan,nan,157,C,2018-04-06T09:24 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21280.0,42720.0,1838634720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,157.0,Period 3,-34.0,-21.656050955414013,123,C,2018-04-06T11:52 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,END OF TREATMENT,21281.0,41520.0,1838719920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,120.0,EOT/ET/Followup,3.0,2.5,123,C,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,END OF TREATMENT,21281.0,41700.0,1838720100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,120.0,EOT/ET/Followup,7.0,5.833333333333333,127,C,2018-04-07T11:35 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,END OF TREATMENT,21281.0,41880.0,1838720280.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,120.0,EOT/ET/Followup,8.0,6.666666666666667,128,C,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21281.0,35220.0,1838713620.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,157.0,Period 3,-22.0,-14.012738853503185,135,C,2018-04-07T09:47 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,47.0,SCREENING,21256.0,48720.0,1836567120.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.8,35.8,,,,Y,35.8,EOT/ET/Followup,nan,nan,35.8,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,41520.0,1838719920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.6,35.6,,,,,35.8,EOT/ET/Followup,-0.2,-0.5586592178770831,35.6,C,2018-04-07T11:32 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,48317.0,1836566717.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),83.0,83,,,,Y,83.0,EOT/ET/Followup,nan,nan,83,NA,2018-03-13T13:25 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,END OF TREATMENT,21281.0,42250.0,1838720650.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),83.9,83.9,,,,,83.0,EOT/ET/Followup,0.9,1.0843373493975972,83.9,C,2018-04-07T11:44 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21256.0,48749.0,1836567149.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.3,23.3,,,,Y,23.3,EOT/ET/Followup,nan,nan,23.3,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,41945.0,1838720345.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.3,23.3,,,,,23.3,EOT/ET/Followup,0.0,0.0,23.3,B,2018-04-07T11:39 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,49200.0,1836567600.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,EOT/ET/Followup,nan,nan,69,NA,2018-03-13T13:40 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,C,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,78.0,Period 1,-4.0,-5.128205128205128,74,C,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34200.0,1837503000.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,78.0,Period 1,-11.0,-14.102564102564102,67,C,2018-03-24T09:30 (2)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,75.0,Period 2,-15.0,-20.0,60,A,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,34200.0,1838107800.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,75.0,Period 2,1.0,1.3333333333333335,76,A,2018-03-31T09:30 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,75.0,Period 2,2.0,2.666666666666667,77,A,2018-03-31T09:32 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,75.0,Period 2,0.0,0.0,75,A,2018-03-31T09:34 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 3,nan,nan,73,B,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21280.0,41700.0,1838633700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,73.0,Period 3,-4.0,-5.47945205479452,69,B,2018-04-06T11:35 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21280.0,41840.0,1838633840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,73.0,Period 3,-6.0,-8.21917808219178,67,B,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21280.0,41970.0,1838633970.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,73.0,Period 3,5.0,6.8493150684931505,78,B,2018-04-06T11:39 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,END OF TREATMENT,21281.0,40500.0,1838718900.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,69.0,EOT/ET/Followup,-7.0,-10.144927536231885,62,B,2018-04-07T11:15 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21281.0,34200.0,1838712600.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,73.0,Period 3,-12.0,-16.43835616438356,61,B,2018-04-07T09:30 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21256.0,48749.0,1836567149.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),175.5,175.5,,,,Y,175.5,EOT/ET/Followup,nan,nan,175.5,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,49200.0,1836567600.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-13T13:40 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,Y,69.0,Period 1,nan,nan,69,C,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),59.0,59,,,,,69.0,Period 1,-10.0,-14.492753623188406,59,C,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21267.0,34200.0,1837503000.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,69.0,Period 1,3.0,4.3478260869565215,72,C,2018-03-24T09:30 (2)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),80.0,80,,,,Y,80.0,Period 2,nan,nan,80,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,80.0,Period 2,-18.0,-22.5,62,A,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21274.0,34200.0,1838107800.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),80.0,80,,,,,80.0,Period 2,0.0,0.0,80,A,2018-03-31T09:30 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 3,nan,nan,68,B,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,TREATMENT,21280.0,41700.0,1838633700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,68.0,Period 3,-3.0,-4.411764705882353,65,B,2018-04-06T11:35 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,END OF TREATMENT,21281.0,40500.0,1838718900.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,,71.0,EOT/ET/Followup,5.0,7.042253521126761,76,B,2018-04-07T11:15 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21281.0,34200.0,1838712600.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,,68.0,Period 3,4.0,5.88235294117647,72,B,2018-04-07T09:30 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21256.0,49200.0,1836567600.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-13T13:40 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,END OF TREATMENT,21281.0,40500.0,1838718900.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,12.0,EOT/ET/Followup,2.0,16.666666666666664,14,B,2018-04-07T11:15 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21256.0,49200.0,1836567600.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,EOT/ET/Followup,nan,nan,112,NA,2018-03-13T13:40 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,Y,128.0,Period 1,nan,nan,128,C,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,128.0,Period 1,-18.0,-14.0625,110,C,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21267.0,34200.0,1837503000.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,128.0,Period 1,-9.0,-7.03125,119,C,2018-03-24T09:30 (2)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 2,nan,nan,122,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,122.0,Period 2,-5.0,-4.098360655737705,117,A,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21274.0,34200.0,1838107800.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,122.0,Period 2,20.0,16.39344262295082,142,A,2018-03-31T09:30 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,,122.0,Period 2,15.0,12.295081967213115,137,A,2018-03-31T09:32 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),144.0,144,,,,,122.0,Period 2,22.0,18.0327868852459,144,A,2018-03-31T09:34 (9)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,Period 3,nan,nan,114,B,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,TREATMENT,21280.0,41700.0,1838633700.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,114.0,Period 3,28.0,24.561403508771928,142,B,2018-04-06T11:35 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,41.0,TREATMENT,21280.0,41840.0,1838633840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,,114.0,Period 3,19.0,16.666666666666664,133,B,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21280.0,41970.0,1838633970.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),141.0,141,,,,,114.0,Period 3,27.0,23.684210526315788,141,B,2018-04-06T11:39 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,END OF TREATMENT,21281.0,40500.0,1838718900.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,112.0,EOT/ET/Followup,4.0,3.571428571428571,116,B,2018-04-07T11:15 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21281.0,34200.0,1838712600.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,114.0,Period 3,0.0,0.0,114,B,2018-04-07T09:30 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,45.0,SCREENING,21256.0,49200.0,1836567600.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-03-13T13:40 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,END OF TREATMENT,21281.0,40500.0,1838718900.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.1,36.1,,,,,35.7,EOT/ET/Followup,0.4,1.1204481792717045,36.1,B,2018-04-07T11:15 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,47.0,SCREENING,21256.0,48749.0,1836567149.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),71.8,71.8,,,,Y,71.8,EOT/ET/Followup,nan,nan,71.8,NA,2018-03-13T13:32 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,41945.0,1838720345.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),71.8,71.8,,,,,71.8,EOT/ET/Followup,0.0,0.0,71.8,B,2018-04-07T11:39 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21256.0,51224.0,1836569624.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.3,26.3,,,,Y,26.3,EOT/ET/Followup,nan,nan,26.3,NA,2018-03-13T14:13 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,42219.0,1838720619.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),26.4,26.4,,,,,26.3,EOT/ET/Followup,0.1,0.38022813688212115,26.4,A,2018-04-07T11:43 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,51600.0,1836570000.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,EOT/ET/Followup,nan,nan,78,NA,2018-03-13T14:20 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,33480.0,1837415880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,Y,89.0,Period 1,nan,nan,89,B,2018-03-23T09:18 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42780.0,1837425180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,89.0,Period 1,-15.0,-16.853932584269664,74,B,2018-03-23T11:53 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,35280.0,1837504080.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,89.0,Period 1,-19.0,-21.34831460674157,70,B,2018-03-24T09:48 (2)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,33480.0,1838020680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,Period 2,nan,nan,85,C,2018-03-30T09:18 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,42780.0,1838029980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,85.0,Period 2,-6.0,-7.0588235294117645,79,C,2018-03-30T11:53 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,35280.0,1838108880.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,85.0,Period 2,-14.0,-16.470588235294116,71,C,2018-03-31T09:48 (9)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,33480.0,1838625480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,Y,84.0,Period 3,nan,nan,84,A,2018-04-06T09:18 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,42780.0,1838634780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,84.0,Period 3,0.0,0.0,84,A,2018-04-06T11:53 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,41580.0,1838719980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,78.0,EOT/ET/Followup,6.0,7.6923076923076925,84,A,2018-04-07T11:33 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,35280.0,1838713680.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,,84.0,Period 3,-1.0,-1.1904761904761905,83,A,2018-04-07T09:48 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21256.0,51224.0,1836569624.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),174.5,174.5,,,,Y,174.5,EOT/ET/Followup,nan,nan,174.5,NA,2018-03-13T14:13 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21256.0,51600.0,1836570000.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,EOT/ET/Followup,nan,nan,58,NA,2018-03-13T14:20 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,33480.0,1837415880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,B,2018-03-23T09:18 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,42780.0,1837425180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,,57.0,Period 1,4.0,7.017543859649122,61,B,2018-03-23T11:53 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,35280.0,1837504080.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,57.0,Period 1,28.0,49.122807017543856,85,B,2018-03-24T09:48 (2)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,33480.0,1838020680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,Period 2,nan,nan,62,C,2018-03-30T09:18 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,42780.0,1838029980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),56.0,56,,,,,62.0,Period 2,-6.0,-9.67741935483871,56,C,2018-03-30T11:53 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,35280.0,1838108880.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,62.0,Period 2,7.0,11.29032258064516,69,C,2018-03-31T09:48 (9)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21280.0,33480.0,1838625480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 3,nan,nan,66,A,2018-04-06T09:18 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21280.0,42780.0,1838634780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,66.0,Period 3,2.0,3.0303030303030303,68,A,2018-04-06T11:53 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21281.0,41580.0,1838719980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),79.0,79,,,,,58.0,EOT/ET/Followup,21.0,36.206896551724135,79,A,2018-04-07T11:33 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21281.0,35280.0,1838713680.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),55.0,55,,,,,66.0,Period 3,-11.0,-16.666666666666664,55,A,2018-04-07T09:48 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21256.0,51600.0,1836570000.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-13T14:20 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,41580.0,1838719980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),15.0,15,,,,,12.0,EOT/ET/Followup,3.0,25.0,15,A,2018-04-07T11:33 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21256.0,51600.0,1836570000.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,EOT/ET/Followup,nan,nan,119,NA,2018-03-13T14:20 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,33480.0,1837415880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,Y,134.0,Period 1,nan,nan,134,B,2018-03-23T09:18 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,42780.0,1837425180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,134.0,Period 1,-17.0,-12.686567164179104,117,B,2018-03-23T11:53 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,35280.0,1837504080.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,134.0,Period 1,-8.0,-5.970149253731343,126,B,2018-03-24T09:48 (2)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,33480.0,1838020680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 2,nan,nan,111,C,2018-03-30T09:18 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,42780.0,1838029980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,111.0,Period 2,18.0,16.216216216216218,129,C,2018-03-30T11:53 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,35280.0,1838108880.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,111.0,Period 2,3.0,2.7027027027027026,114,C,2018-03-31T09:48 (9)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,33480.0,1838625480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,Period 3,nan,nan,129,A,2018-04-06T09:18 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21280.0,42780.0,1838634780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,129.0,Period 3,-10.0,-7.751937984496124,119,A,2018-04-06T11:53 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21281.0,41580.0,1838719980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,119.0,EOT/ET/Followup,0.0,0.0,119,A,2018-04-07T11:33 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21281.0,35280.0,1838713680.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,129.0,Period 3,-8.0,-6.2015503875969,121,A,2018-04-07T09:48 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21256.0,51600.0,1836570000.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-13T14:20 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21281.0,41580.0,1838719980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.5,36.5,,,,,36.2,EOT/ET/Followup,0.3,0.8287292817679479,36.5,A,2018-04-07T11:33 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21256.0,51224.0,1836569624.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),80.2,80.2,,,,Y,80.2,EOT/ET/Followup,nan,nan,80.2,NA,2018-03-13T14:13 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,42219.0,1838720619.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),80.4,80.4,,,,,80.2,EOT/ET/Followup,0.2,0.24937655860349484,80.4,A,2018-04-07T11:43 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,37050.0,1836814650.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.9,28.9,,,,Y,28.9,EOT/ET/Followup,nan,nan,28.9,NA,2018-03-16T10:17 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,40719.0,1838719119.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),28.4,28.4,,,,,28.9,EOT/ET/Followup,-0.5,-1.7301038062283738,28.4,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,37560.0,1836815160.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,Y,84.0,EOT/ET/Followup,nan,nan,84,NA,2018-03-16T10:26 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,78.0,Period 1,-17.0,-21.794871794871796,61,C,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,33600.0,1837502400.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,78.0,Period 1,-10.0,-12.82051282051282,68,C,2018-03-24T09:20 (2)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),98.0,98,,,,,nan,Period 2,nan,nan,98,B,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),100.0,100,,,,,nan,Period 2,nan,nan,100,B,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),100.0,100,,,,Y,100.0,Period 2,nan,nan,100,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,100.0,Period 2,-26.0,-26.0,74,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21274.0,33600.0,1838107200.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,100.0,Period 2,-22.0,-22.0,78,B,2018-03-31T09:20 (9)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 3,nan,nan,82,A,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,82.0,Period 3,-7.0,-8.536585365853659,75,A,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,84.0,EOT/ET/Followup,-10.0,-11.904761904761903,74,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,82.0,Period 3,-2.0,-2.4390243902439024,80,A,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21259.0,37050.0,1836814650.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),200.6,200.6,,,,Y,200.6,EOT/ET/Followup,nan,nan,200.6,NA,2018-03-16T10:17 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21259.0,37560.0,1836815160.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,EOT/ET/Followup,nan,nan,60,NA,2018-03-16T10:26 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,63.0,Period 1,-8.0,-12.698412698412698,55,C,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21267.0,33600.0,1837502400.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),54.0,54,,,,,63.0,Period 1,-9.0,-14.285714285714285,54,C,2018-03-24T09:20 (2)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 2,nan,nan,61,B,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),52.0,52,,,,,61.0,Period 2,-9.0,-14.754098360655737,52,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21274.0,33600.0,1838107200.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,61.0,Period 2,8.0,13.114754098360656,69,B,2018-03-31T09:20 (9)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),76.0,76,,,,Y,76.0,Period 3,nan,nan,76,A,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,,76.0,Period 3,-23.0,-30.263157894736842,53,A,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,,60.0,EOT/ET/Followup,1.0,1.6666666666666667,61,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,76.0,Period 3,-9.0,-11.842105263157894,67,A,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,37560.0,1836815160.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T10:26 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21259.0,37560.0,1836815160.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,Y,128.0,EOT/ET/Followup,nan,nan,128,NA,2018-03-16T10:26 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,Y,125.0,Period 1,nan,nan,125,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,125.0,Period 1,0.0,0.0,125,C,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21267.0,33600.0,1837502400.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,125.0,Period 1,-4.0,-3.2,121,C,2018-03-24T09:20 (2)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,nan,Period 2,nan,nan,131,B,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),154.0,154,,,,,nan,Period 2,nan,nan,154,B,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),143.0,143,,,,Y,143.0,Period 2,nan,nan,143,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,143.0,Period 2,-26.0,-18.181818181818183,117,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21274.0,33600.0,1838107200.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,143.0,Period 2,-23.0,-16.083916083916083,120,B,2018-03-31T09:20 (9)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,Y,127.0,Period 3,nan,nan,127,A,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,127.0,Period 3,-19.0,-14.960629921259844,108,A,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,128.0,EOT/ET/Followup,3.0,2.34375,131,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21281.0,33720.0,1838712120.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,127.0,Period 3,3.0,2.3622047244094486,130,A,2018-04-07T09:22 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,37560.0,1836815160.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.8,35.8,,,,Y,35.8,EOT/ET/Followup,nan,nan,35.8,NA,2018-03-16T10:26 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.8,36.8,,,,,35.8,EOT/ET/Followup,1.0,2.7932960893854752,36.8,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21259.0,37050.0,1836814650.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),116.4,116.4,,,,Y,116.4,EOT/ET/Followup,nan,nan,116.4,NA,2018-03-16T10:17 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,END OF TREATMENT,21281.0,40719.0,1838719119.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),114.3,114.3,,,,,116.4,EOT/ET/Followup,-2.1,-1.8041237113402133,114.3,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,46330.0,1836823930.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.9,24.9,,,,Y,24.9,EOT/ET/Followup,nan,nan,24.9,NA,2018-03-16T12:52 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,41857.0,1838720257.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),24.5,24.5,,,,,24.9,EOT/ET/Followup,-0.4,-1.6064257028112392,24.5,A,2018-04-07T11:37 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,47040.0,1836824640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,EOT/ET/Followup,nan,nan,70,NA,2018-03-16T13:04 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 1,nan,nan,82,C,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41940.0,1837424340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,82.0,Period 1,-5.0,-6.097560975609756,77,C,2018-03-23T11:39 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34440.0,1837503240.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,82.0,Period 1,-10.0,-12.195121951219512,72,C,2018-03-24T09:34 (2)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32640.0,1838019840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,B,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,41940.0,1838029140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,73.0,Period 2,1.0,1.36986301369863,74,B,2018-03-30T11:39 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,73.0,Period 2,-2.0,-2.73972602739726,71,B,2018-03-31T09:34 (9)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,32640.0,1838624640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,A,2018-04-06T09:04 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,41940.0,1838633940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,71.0,Period 3,0.0,0.0,71,A,2018-04-06T11:39 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,40740.0,1838719140.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,70.0,EOT/ET/Followup,-6.0,-8.571428571428571,64,A,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,34440.0,1838712840.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,71.0,Period 3,-3.0,-4.225352112676056,68,A,2018-04-07T09:34 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21259.0,46330.0,1836823930.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),184.5,184.5,,,,Y,184.5,EOT/ET/Followup,nan,nan,184.5,NA,2018-03-16T12:52 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21259.0,47040.0,1836824640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),51.0,51,,,,Y,51.0,EOT/ET/Followup,nan,nan,51,NA,2018-03-16T13:04 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,C,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,41940.0,1837424340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,57.0,Period 1,-2.0,-3.508771929824561,55,C,2018-03-23T11:39 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,34440.0,1837503240.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,57.0,Period 1,14.0,24.561403508771928,71,C,2018-03-24T09:34 (2)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,32640.0,1838019840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,Period 2,nan,nan,54,B,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,41940.0,1838029140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),52.0,52,,,,,54.0,Period 2,-2.0,-3.7037037037037033,52,B,2018-03-30T11:39 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,54.0,Period 2,13.0,24.074074074074073,67,B,2018-03-31T09:34 (9)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21280.0,32640.0,1838624640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,Y,56.0,Period 3,nan,nan,56,A,2018-04-06T09:04 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21280.0,41940.0,1838633940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),55.0,55,,,,,56.0,Period 3,-1.0,-1.7857142857142856,55,A,2018-04-06T11:39 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21281.0,40740.0,1838719140.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),52.0,52,,,,,51.0,EOT/ET/Followup,1.0,1.9607843137254901,52,A,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21281.0,34440.0,1838712840.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,56.0,Period 3,0.0,0.0,56,A,2018-04-07T09:34 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21259.0,47040.0,1836824640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T13:04 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,40740.0,1838719140.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,A,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,47040.0,1836824640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,EOT/ET/Followup,nan,nan,117,NA,2018-03-16T13:04 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 1,nan,nan,121,C,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,41940.0,1837424340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,121.0,Period 1,-4.0,-3.3057851239669422,117,C,2018-03-23T11:39 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,34440.0,1837503240.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,121.0,Period 1,-3.0,-2.479338842975207,118,C,2018-03-24T09:34 (2)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,32640.0,1838019840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,Period 2,nan,nan,112,B,2018-03-30T09:04 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,41940.0,1838029140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,112.0,Period 2,8.0,7.142857142857142,120,B,2018-03-30T11:39 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,112.0,Period 2,3.0,2.6785714285714284,115,B,2018-03-31T09:34 (9)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,32640.0,1838624640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 3,nan,nan,117,A,2018-04-06T09:04 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21280.0,41940.0,1838633940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,117.0,Period 3,-7.0,-5.982905982905983,110,A,2018-04-06T11:39 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21281.0,40740.0,1838719140.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,117.0,EOT/ET/Followup,0.0,0.0,117,A,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21281.0,34440.0,1838712840.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,117.0,Period 3,-4.0,-3.418803418803419,113,A,2018-04-07T09:34 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21259.0,47040.0,1836824640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-16T13:04 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21281.0,40740.0,1838719140.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.3,36.3,,,,,36.3,EOT/ET/Followup,0.0,0.0,36.3,A,2018-04-07T11:19 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21259.0,46330.0,1836823930.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),84.8,84.8,,,,Y,84.8,EOT/ET/Followup,nan,nan,84.8,NA,2018-03-16T12:52 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,41857.0,1838720257.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),83.4,83.4,,,,,84.8,EOT/ET/Followup,-1.4,-1.650943396226405,83.4,A,2018-04-07T11:37 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,46029.0,1836823629.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.9,28.9,,,,Y,28.9,EOT/ET/Followup,nan,nan,28.9,NA,2018-03-16T12:47 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,41951.0,1838720351.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),29.1,29.1,,,,,28.9,EOT/ET/Followup,0.2,0.6920415224913594,29.1,B,2018-04-07T11:39 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,46620.0,1836824220.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-03-16T12:57 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 1,nan,nan,72,C,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,42120.0,1837424520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,72.0,Period 1,-10.0,-13.88888888888889,62,C,2018-03-23T11:42 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34620.0,1837503420.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,72.0,Period 1,-15.0,-20.833333333333336,57,C,2018-03-24T09:37 (2)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 2,nan,nan,74,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,42120.0,1838029320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,74.0,Period 2,-15.0,-20.27027027027027,59,A,2018-03-30T11:42 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,34620.0,1838108220.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,74.0,Period 2,-2.0,-2.7027027027027026,72,A,2018-03-31T09:37 (9)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,Y,66.0,Period 3,nan,nan,66,B,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,42120.0,1838634120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,66.0,Period 3,4.0,6.0606060606060606,70,B,2018-04-06T11:42 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,40920.0,1838719320.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,64.0,EOT/ET/Followup,5.0,7.8125,69,B,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,34620.0,1838713020.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,66.0,Period 3,-3.0,-4.545454545454546,63,B,2018-04-07T09:37 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21259.0,46029.0,1836823629.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),170.0,170,,,,Y,170.0,EOT/ET/Followup,nan,nan,170,NA,2018-03-16T12:47 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21259.0,46620.0,1836824220.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-03-16T12:57 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,C,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,42120.0,1837424520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,71.0,Period 1,0.0,0.0,71,C,2018-03-23T11:42 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,34620.0,1837503420.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,71.0,Period 1,14.0,19.718309859154928,85,C,2018-03-24T09:37 (2)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,42120.0,1838029320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,,71.0,Period 2,-6.0,-8.450704225352112,65,A,2018-03-30T11:42 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,34620.0,1838108220.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,71.0,Period 2,3.0,4.225352112676056,74,A,2018-03-31T09:37 (9)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,Period 3,nan,nan,84,B,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,42120.0,1838634120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,84.0,Period 3,-21.0,-25.0,63,B,2018-04-06T11:42 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,40920.0,1838719320.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,75.0,EOT/ET/Followup,2.0,2.666666666666667,77,B,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,34620.0,1838713020.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),82.0,82,,,,,84.0,Period 3,-2.0,-2.380952380952381,82,B,2018-04-07T09:37 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21259.0,46620.0,1836824220.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T12:57 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,40920.0,1838719320.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,B,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,46620.0,1836824220.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,EOT/ET/Followup,nan,nan,113,NA,2018-03-16T12:57 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,Period 1,nan,nan,109,C,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,42120.0,1837424520.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,109.0,Period 1,4.0,3.669724770642202,113,C,2018-03-23T11:42 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,34620.0,1837503420.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,,109.0,Period 1,-4.0,-3.669724770642202,105,C,2018-03-24T09:37 (2)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 2,nan,nan,115,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,42120.0,1838029320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,115.0,Period 2,-4.0,-3.4782608695652173,111,A,2018-03-30T11:42 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,34620.0,1838108220.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,115.0,Period 2,2.0,1.7391304347826086,117,A,2018-03-31T09:37 (9)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 3,nan,nan,111,B,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,42120.0,1838634120.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,111.0,Period 3,-1.0,-0.9009009009009009,110,B,2018-04-06T11:42 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,40920.0,1838719320.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,113.0,EOT/ET/Followup,-4.0,-3.5398230088495577,109,B,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,34620.0,1838713020.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,111.0,Period 3,-10.0,-9.00900900900901,101,B,2018-04-07T09:37 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21259.0,46620.0,1836824220.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-16T12:57 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,40920.0,1838719320.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.2,EOT/ET/Followup,0.0,0.0,36.2,B,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21259.0,46029.0,1836823629.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),83.6,83.6,,,,Y,83.6,EOT/ET/Followup,nan,nan,83.6,NA,2018-03-16T12:47 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,41951.0,1838720351.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),84.2,84.2,,,,,83.6,EOT/ET/Followup,0.6,0.717703349282307,84.2,B,2018-04-07T11:39 (16)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,49437.0,1836827037.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),21.2,21.2,,,,Y,21.2,EOT/ET/Followup,nan,nan,21.2,NA,2018-03-16T13:43 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21280.0,56963.0,1838648963.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),21.2,21.2,,,,,21.2,EOT/ET/Followup,0.0,0.0,21.2,C,2018-04-06T15:49 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,50040.0,1836827640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-16T13:54 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,73.0,Period 1,-6.0,-8.21917808219178,67,A,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,34320.0,1837503120.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,73.0,Period 1,-11.0,-15.068493150684931,62,A,2018-03-24T09:32 (2)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,70.0,Period 2,-8.0,-11.428571428571429,62,C,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,70.0,Period 2,-4.0,-5.714285714285714,66,C,2018-03-31T09:32 (9)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,END OF TREATMENT,21280.0,55800.0,1838647800.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,74.0,EOT/ET/Followup,3.0,4.054054054054054,77,C,2018-04-06T15:30 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,8.0,TREATMENT,21280.0,32714.0,1838624714.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,nan,,nan,nan,57,NA,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,10.0,SCREENING,21259.0,49437.0,1836827037.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),193.5,193.5,,,,Y,193.5,EOT/ET/Followup,nan,nan,193.5,NA,2018-03-16T13:43 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,11.0,SCREENING,21259.0,50040.0,1836827640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-16T13:54 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,71.0,Period 1,-8.0,-11.267605633802818,63,A,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21267.0,34320.0,1837503120.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),80.0,80,,,,,71.0,Period 1,9.0,12.676056338028168,80,A,2018-03-24T09:32 (2)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,75.0,Period 2,-13.0,-17.333333333333336,62,C,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,75.0,Period 2,-3.0,-4.0,72,C,2018-03-31T09:32 (9)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,END OF TREATMENT,21280.0,55800.0,1838647800.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),76.0,76,,,,,74.0,EOT/ET/Followup,2.0,2.7027027027027026,76,C,2018-04-06T15:30 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,18.0,TREATMENT,21280.0,32714.0,1838624714.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,PULSE,Pulse Rate (beats/min),59.0,59,,,,,nan,,nan,nan,59,NA,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,20.0,SCREENING,21259.0,50040.0,1836827640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),18.0,18,,,,Y,18.0,EOT/ET/Followup,nan,nan,18,NA,2018-03-16T13:54 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,END OF TREATMENT,21280.0,55800.0,1838647800.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),17.0,17,,,,,18.0,EOT/ET/Followup,-1.0,-5.555555555555555,17,C,2018-04-06T15:30 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,22.0,SCREENING,21259.0,50040.0,1836827640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,EOT/ET/Followup,nan,nan,120,NA,2018-03-16T13:54 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 1,nan,nan,117,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,117.0,Period 1,-6.0,-5.128205128205128,111,A,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21267.0,34320.0,1837503120.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,117.0,Period 1,1.0,0.8547008547008548,118,A,2018-03-24T09:32 (2)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 2,nan,nan,116,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,116.0,Period 2,2.0,1.7241379310344827,118,C,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,116.0,Period 2,-1.0,-0.8620689655172413,115,C,2018-03-31T09:32 (9)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,END OF TREATMENT,21280.0,55800.0,1838647800.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,120.0,EOT/ET/Followup,1.0,0.8333333333333334,121,C,2018-04-06T15:30 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,29.0,TREATMENT,21280.0,32714.0,1838624714.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,nan,,nan,nan,106,NA,2018-04-06T09:05 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,31.0,SCREENING,21259.0,50040.0,1836827640.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.1,36.1,,,,Y,36.1,EOT/ET/Followup,nan,nan,36.1,NA,2018-03-16T13:54 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21280.0,55800.0,1838647800.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,TEMP,Temperature (C),35.8,35.8,,,,,36.1,EOT/ET/Followup,-0.3,-0.8310249307479343,35.8,C,2018-04-06T15:30 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,49437.0,1836827037.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),79.2,79.2,,,,Y,79.2,EOT/ET/Followup,nan,nan,79.2,NA,2018-03-16T13:43 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,END OF TREATMENT,21280.0,56963.0,1838648963.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,WEIGHT,Weight (kg),79.5,79.5,,,,,79.2,EOT/ET/Followup,0.3,0.3787878787878752,79.5,C,2018-04-06T15:49 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,49754.0,1836827354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),30.0,30.0,,,,Y,30.0,EOT/ET/Followup,nan,nan,30.0,NA,2018-03-16T13:49 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,40358.0,1838718758.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),29.4,29.4,,,,,30.0,EOT/ET/Followup,-0.6,-2.000000000000005,29.4,C,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,50400.0,1836828000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-16T14:00 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,B,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,71.0,Period 1,-6.0,-8.450704225352112,65,B,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,33180.0,1837501980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,71.0,Period 1,-9.0,-12.676056338028168,62,B,2018-03-24T09:13 (2)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,Y,67.0,Period 2,nan,nan,67,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,67.0,Period 2,-6.0,-8.955223880597014,61,A,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,33180.0,1838106780.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,67.0,Period 2,-7.0,-10.44776119402985,60,A,2018-03-31T09:13 (9)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 3,nan,nan,70,C,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,70.0,Period 3,-9.0,-12.857142857142856,61,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,71.0,EOT/ET/Followup,-9.0,-12.676056338028168,62,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,33180.0,1838711580.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,70.0,Period 3,-9.0,-12.857142857142856,61,C,2018-04-07T09:13 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21259.0,49754.0,1836827354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),180.5,180.5,,,,Y,180.5,EOT/ET/Followup,nan,nan,180.5,NA,2018-03-16T13:49 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21259.0,50400.0,1836828000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-03-16T14:00 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,B,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,68.0,Period 1,-4.0,-5.88235294117647,64,B,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,33180.0,1837501980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,68.0,Period 1,17.0,25.0,85,B,2018-03-24T09:13 (2)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,,65.0,Period 2,0.0,0.0,65,A,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,33180.0,1838106780.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),82.0,82,,,,,65.0,Period 2,17.0,26.153846153846157,82,A,2018-03-31T09:13 (9)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 3,nan,nan,72,C,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,72.0,Period 3,-4.0,-5.555555555555555,68,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),75.0,75,,,,,73.0,EOT/ET/Followup,2.0,2.73972602739726,75,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,33180.0,1838711580.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),81.0,81,,,,,72.0,Period 3,9.0,12.5,81,C,2018-04-07T09:13 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21259.0,50400.0,1836828000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T14:00 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,50400.0,1836828000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,EOT/ET/Followup,nan,nan,115,NA,2018-03-16T14:00 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,Y,106.0,Period 1,nan,nan,106,B,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,106.0,Period 1,8.0,7.547169811320755,114,B,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,33180.0,1837501980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,106.0,Period 1,2.0,1.8867924528301887,108,B,2018-03-24T09:13 (2)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,Period 2,nan,nan,109,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,109.0,Period 2,-1.0,-0.9174311926605505,108,A,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,33180.0,1838106780.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,109.0,Period 2,-6.0,-5.5045871559633035,103,A,2018-03-31T09:13 (9)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,Y,108.0,Period 3,nan,nan,108,C,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,108.0,Period 3,-5.0,-4.62962962962963,103,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,115.0,EOT/ET/Followup,-7.0,-6.086956521739131,108,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,33180.0,1838711580.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,108.0,Period 3,5.0,4.62962962962963,113,C,2018-04-07T09:13 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21259.0,50400.0,1836828000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.2,35.2,,,,Y,35.2,EOT/ET/Followup,nan,nan,35.2,NA,2018-03-16T14:00 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,35.2,EOT/ET/Followup,1.0,2.840909090909091,36.2,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21259.0,49754.0,1836827354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),97.8,97.8,,,,Y,97.8,EOT/ET/Followup,nan,nan,97.8,NA,2018-03-16T13:49 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,40358.0,1838718758.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),95.7,95.7,,,,,97.8,EOT/ET/Followup,-2.1,-2.1472392638036752,95.7,C,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,52142.0,1836829742.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.8,28.8,,,,Y,28.8,EOT/ET/Followup,nan,nan,28.8,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21288.0,42000.0,1839325200.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),28.6,28.6,,,,,28.8,EOT/ET/Followup,-0.2,-0.694444444444442,28.6,A,2018-04-14T11:40 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,53520.0,1836831120.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,EOT/ET/Followup,nan,nan,69,NA,2018-03-16T14:52 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,33300.0,1837415700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 1,nan,nan,70,B,2018-03-23T09:15 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42600.0,1837425000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,70.0,Period 1,6.0,8.571428571428571,76,B,2018-03-23T11:50 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,35100.0,1837503900.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,70.0,Period 1,-9.0,-12.857142857142856,61,B,2018-03-24T09:45 (2)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,33300.0,1838020500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,C,2018-03-30T09:15 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,42600.0,1838029800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,65.0,Period 2,-5.0,-7.6923076923076925,60,C,2018-03-30T11:50 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,35100.0,1838108700.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,65.0,Period 2,7.0,10.76923076923077,72,C,2018-03-31T09:45 (9)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21287.0,33300.0,1839230100.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,Period 3,nan,nan,63,A,2018-04-13T09:15 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21287.0,42600.0,1839239400.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,63.0,Period 3,7.0,11.11111111111111,70,A,2018-04-13T11:50 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21288.0,41400.0,1839324600.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,69.0,EOT/ET/Followup,-5.0,-7.246376811594203,64,A,2018-04-14T11:30 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21288.0,35100.0,1839318300.0,23.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,63.0,Period 3,4.0,6.349206349206349,67,A,2018-04-14T09:45 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21259.0,52142.0,1836829742.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),170.5,170.5,,,,Y,170.5,EOT/ET/Followup,nan,nan,170.5,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21259.0,53520.0,1836831120.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-16T14:52 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,33300.0,1837415700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,Y,70.0,Period 1,nan,nan,70,B,2018-03-23T09:15 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,42600.0,1837425000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,70.0,Period 1,-3.0,-4.285714285714286,67,B,2018-03-23T11:50 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,35100.0,1837503900.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),82.0,82,,,,,70.0,Period 1,12.0,17.142857142857142,82,B,2018-03-24T09:45 (2)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21273.0,33300.0,1838020500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),79.0,79,,,,Y,79.0,Period 2,nan,nan,79,C,2018-03-30T09:15 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,42600.0,1838029800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,79.0,Period 2,-5.0,-6.329113924050633,74,C,2018-03-30T11:50 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21274.0,35100.0,1838108700.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),86.0,86,,,,,79.0,Period 2,7.0,8.860759493670885,86,C,2018-03-31T09:45 (9)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21287.0,33300.0,1839230100.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 3,nan,nan,75,A,2018-04-13T09:15 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21287.0,42600.0,1839239400.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,,75.0,Period 3,-14.0,-18.666666666666668,61,A,2018-04-13T11:50 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21288.0,41400.0,1839324600.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,,74.0,EOT/ET/Followup,0.0,0.0,74,A,2018-04-14T11:30 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21288.0,35100.0,1839318300.0,23.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),82.0,82,,,,,75.0,Period 3,7.0,9.333333333333334,82,A,2018-04-14T09:45 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21259.0,53520.0,1836831120.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T14:52 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21288.0,41400.0,1839324600.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,A,2018-04-14T11:30 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,53520.0,1836831120.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,EOT/ET/Followup,nan,nan,111,NA,2018-03-16T14:52 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,33300.0,1837415700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,Y,110.0,Period 1,nan,nan,110,B,2018-03-23T09:15 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,42600.0,1837425000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,110.0,Period 1,2.0,1.8181818181818181,112,B,2018-03-23T11:50 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,35100.0,1837503900.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,110.0,Period 1,-3.0,-2.727272727272727,107,B,2018-03-24T09:45 (2)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21273.0,33300.0,1838020500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,Period 2,nan,nan,114,C,2018-03-30T09:15 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21273.0,42600.0,1838029800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,114.0,Period 2,-13.0,-11.403508771929824,101,C,2018-03-30T11:50 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21274.0,35100.0,1838108700.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,114.0,Period 2,1.0,0.8771929824561403,115,C,2018-03-31T09:45 (9)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21287.0,33300.0,1839230100.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,Y,102.0,Period 3,nan,nan,102,A,2018-04-13T09:15 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21287.0,42600.0,1839239400.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,102.0,Period 3,7.0,6.862745098039216,109,A,2018-04-13T11:50 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21288.0,41400.0,1839324600.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,111.0,EOT/ET/Followup,-3.0,-2.7027027027027026,108,A,2018-04-14T11:30 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21288.0,35100.0,1839318300.0,23.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,102.0,Period 3,10.0,9.803921568627452,112,A,2018-04-14T09:45 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21259.0,53520.0,1836831120.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-03-16T14:52 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21288.0,41400.0,1839324600.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.6,36.6,,,,,36.4,EOT/ET/Followup,0.2,0.5494505494505573,36.6,A,2018-04-14T11:30 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21259.0,52142.0,1836829742.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),83.8,83.8,,,,Y,83.8,EOT/ET/Followup,nan,nan,83.8,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21288.0,42000.0,1839325200.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),83.1,83.1,,,,,83.8,EOT/ET/Followup,-0.7,-0.8353221957040607,83.1,A,2018-04-14T11:40 (23)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,52525.0,1836830125.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.7,24.7,,,,Y,24.7,EOT/ET/Followup,nan,nan,24.7,NA,2018-03-16T14:35 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,40499.0,1838718899.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.3,25.3,,,,,24.7,EOT/ET/Followup,0.6,2.4291497975708563,25.3,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,52980.0,1836830580.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-16T14:43 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,68.0,Period 1,-7.0,-10.294117647058822,61,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21267.0,33240.0,1837502040.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,68.0,Period 1,7.0,10.294117647058822,75,A,2018-03-24T09:14 (2)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 2,nan,nan,78,B,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,78.0,Period 2,12.0,15.384615384615385,90,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,78.0,Period 2,3.0,3.8461538461538463,81,B,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21273.0,40860.0,1838028060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,78.0,Period 2,6.0,7.6923076923076925,84,B,2018-03-30T11:21 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21274.0,33240.0,1838106840.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,78.0,Period 2,-19.0,-24.358974358974358,59,B,2018-03-31T09:14 (9)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,Y,66.0,Period 3,nan,nan,66,C,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,66.0,Period 3,-3.0,-4.545454545454546,63,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,END OF TREATMENT,21281.0,39540.0,1838717940.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,71.0,EOT/ET/Followup,-7.0,-9.859154929577464,64,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21281.0,33240.0,1838711640.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,66.0,Period 3,-4.0,-6.0606060606060606,62,C,2018-04-07T09:14 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21259.0,52525.0,1836830125.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),186.0,186,,,,Y,186.0,EOT/ET/Followup,nan,nan,186,NA,2018-03-16T14:35 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21259.0,52980.0,1836830580.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,EOT/ET/Followup,nan,nan,54,NA,2018-03-16T14:43 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,Period 1,nan,nan,84,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,84.0,Period 1,-20.0,-23.809523809523807,64,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21267.0,33240.0,1837502040.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,84.0,Period 1,1.0,1.1904761904761905,85,A,2018-03-24T09:14 (2)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),82.0,82,,,,Y,82.0,Period 2,nan,nan,82,B,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),57.0,57,,,,,82.0,Period 2,-25.0,-30.48780487804878,57,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21274.0,33240.0,1838106840.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),81.0,81,,,,,82.0,Period 2,-1.0,-1.2195121951219512,81,B,2018-03-31T09:14 (9)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,C,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,71.0,Period 3,-15.0,-21.12676056338028,56,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,39540.0,1838717940.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,,54.0,EOT/ET/Followup,17.0,31.48148148148148,71,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21281.0,33240.0,1838711640.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),73.0,73,,,,,71.0,Period 3,2.0,2.8169014084507045,73,C,2018-04-07T09:14 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,52980.0,1836830580.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-16T14:43 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,END OF TREATMENT,21281.0,39540.0,1838717940.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21259.0,52980.0,1836830580.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-03-16T14:43 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,Y,106.0,Period 1,nan,nan,106,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,,106.0,Period 1,-1.0,-0.9433962264150944,105,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21267.0,33240.0,1837502040.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,106.0,Period 1,12.0,11.320754716981133,118,A,2018-03-24T09:14 (2)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,Period 2,nan,nan,133,B,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,133.0,Period 2,1.0,0.7518796992481203,134,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,,133.0,Period 2,4.0,3.007518796992481,137,B,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21273.0,40860.0,1838028060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),136.0,136,,,,,133.0,Period 2,3.0,2.2556390977443606,136,B,2018-03-30T11:21 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21274.0,33240.0,1838106840.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,133.0,Period 2,-32.0,-24.06015037593985,101,B,2018-03-31T09:14 (9)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 3,nan,nan,116,C,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,116.0,Period 3,-13.0,-11.206896551724139,103,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39540.0,1838717940.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,118.0,EOT/ET/Followup,-7.0,-5.932203389830509,111,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21281.0,33240.0,1838711640.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,,116.0,Period 3,-16.0,-13.793103448275861,100,C,2018-04-07T09:14 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,52980.0,1836830580.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-03-16T14:43 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,END OF TREATMENT,21281.0,39540.0,1838717940.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.8,36.8,,,,,36.4,EOT/ET/Followup,0.4,1.098901098901095,36.8,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21259.0,52525.0,1836830125.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),85.4,85.4,,,,Y,85.4,EOT/ET/Followup,nan,nan,85.4,NA,2018-03-16T14:35 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,END OF TREATMENT,21281.0,40499.0,1838718899.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),87.7,87.7,,,,,85.4,EOT/ET/Followup,2.3,2.6932084309133453,87.7,C,2018-04-07T11:14 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21259.0,58754.0,1836836354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.0,24.0,,,,Y,24.0,EOT/ET/Followup,nan,nan,24.0,NA,2018-03-16T16:19 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21281.0,42019.0,1838720419.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.8,23.8,,,,,24.0,EOT/ET/Followup,-0.2,-0.8333333333333304,23.8,C,2018-04-07T11:40 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,59400.0,1836837000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,Y,67.0,EOT/ET/Followup,nan,nan,67,NA,2018-03-16T16:30 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,33000.0,1837415400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 1,nan,nan,72,B,2018-03-23T09:10 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42300.0,1837424700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,72.0,Period 1,-3.0,-4.166666666666666,69,B,2018-03-23T11:45 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,34800.0,1837503600.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,72.0,Period 1,-12.0,-16.666666666666664,60,B,2018-03-24T09:40 (2)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,33000.0,1838020200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,Period 2,nan,nan,69,A,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,69.0,Period 2,-4.0,-5.797101449275362,65,A,2018-03-30T11:45 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,34800.0,1838108400.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,69.0,Period 2,-4.0,-5.797101449275362,65,A,2018-03-31T09:40 (9)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21280.0,33000.0,1838625000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 3,nan,nan,65,C,2018-04-06T09:10 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21280.0,42300.0,1838634300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,65.0,Period 3,-3.0,-4.615384615384616,62,C,2018-04-06T11:45 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21281.0,41100.0,1838719500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,67.0,EOT/ET/Followup,-2.0,-2.9850746268656714,65,C,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21281.0,34800.0,1838713200.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,65.0,Period 3,8.0,12.307692307692308,73,C,2018-04-07T09:40 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21259.0,58754.0,1836836354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),165.0,165,,,,Y,165.0,EOT/ET/Followup,nan,nan,165,NA,2018-03-16T16:19 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21259.0,59400.0,1836837000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),76.0,76,,,,Y,76.0,EOT/ET/Followup,nan,nan,76,NA,2018-03-16T16:30 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,33000.0,1837415400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 1,nan,nan,75,B,2018-03-23T09:10 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,42300.0,1837424700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),58.0,58,,,,,75.0,Period 1,-17.0,-22.666666666666664,58,B,2018-03-23T11:45 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21267.0,34800.0,1837503600.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,75.0,Period 1,-4.0,-5.333333333333334,71,B,2018-03-24T09:40 (2)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,33000.0,1838020200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,A,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,,66.0,Period 2,4.0,6.0606060606060606,70,A,2018-03-30T11:45 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,34800.0,1838108400.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),82.0,82,,,,,66.0,Period 2,16.0,24.242424242424242,82,A,2018-03-31T09:40 (9)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21280.0,33000.0,1838625000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),80.0,80,,,,Y,80.0,Period 3,nan,nan,80,C,2018-04-06T09:10 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21280.0,42300.0,1838634300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,80.0,Period 3,-17.0,-21.25,63,C,2018-04-06T11:45 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21281.0,41100.0,1838719500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),80.0,80,,,,,76.0,EOT/ET/Followup,4.0,5.263157894736842,80,C,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21281.0,34800.0,1838713200.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),91.0,91,,,,,80.0,Period 3,11.0,13.750000000000002,91,C,2018-04-07T09:40 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21259.0,59400.0,1836837000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-16T16:30 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21281.0,41100.0,1838719500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,12.0,EOT/ET/Followup,2.0,16.666666666666664,14,C,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21259.0,59400.0,1836837000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,EOT/ET/Followup,nan,nan,120,NA,2018-03-16T16:30 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,33000.0,1837415400.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 1,nan,nan,115,B,2018-03-23T09:10 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21266.0,42300.0,1837424700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,115.0,Period 1,-6.0,-5.217391304347826,109,B,2018-03-23T11:45 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21267.0,34800.0,1837503600.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),95.0,95,,,,,115.0,Period 1,-20.0,-17.391304347826086,95,B,2018-03-24T09:40 (2)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,33000.0,1838020200.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,Period 2,nan,nan,113,A,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,113.0,Period 2,-1.0,-0.8849557522123894,112,A,2018-03-30T11:45 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,34800.0,1838108400.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),97.0,97,,,,,113.0,Period 2,-16.0,-14.15929203539823,97,A,2018-03-31T09:40 (9)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21280.0,33000.0,1838625000.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,Period 3,nan,nan,112,C,2018-04-06T09:10 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21280.0,42300.0,1838634300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,112.0,Period 3,4.0,3.571428571428571,116,C,2018-04-06T11:45 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21281.0,41100.0,1838719500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,120.0,EOT/ET/Followup,-17.0,-14.166666666666666,103,C,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21281.0,34800.0,1838713200.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,112.0,Period 3,10.0,8.928571428571429,122,C,2018-04-07T09:40 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21259.0,59400.0,1836837000.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.7,36.7,,,,Y,36.7,EOT/ET/Followup,nan,nan,36.7,NA,2018-03-16T16:30 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21281.0,41100.0,1838719500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.7,36.7,,,,,36.7,EOT/ET/Followup,0.0,0.0,36.7,C,2018-04-07T11:25 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21259.0,58754.0,1836836354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),65.4,65.4,,,,Y,65.4,EOT/ET/Followup,nan,nan,65.4,NA,2018-03-16T16:19 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,42019.0,1838720419.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),64.8,64.8,,,,,65.4,EOT/ET/Followup,-0.6,-0.9174311926605634,64.8,C,2018-04-07T11:40 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,31061.0,1837067861.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.7,25.7,,,,Y,25.7,EOT/ET/Followup,nan,nan,25.7,NA,2018-03-19T08:37 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,40937.0,1838719337.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.6,25.6,,,,,25.7,EOT/ET/Followup,-0.1,-0.3891050583657505,25.6,A,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,31620.0,1837068420.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,EOT/ET/Followup,nan,nan,76,NA,2018-03-19T08:47 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31860.0,1837414260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,Y,89.0,Period 1,nan,nan,89,B,2018-03-23T08:51 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,89.0,Period 1,-5.0,-5.617977528089887,84,B,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,33660.0,1837502460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,,89.0,Period 1,-3.0,-3.3707865168539324,86,B,2018-03-24T09:21 (2)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,31860.0,1838019060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),97.0,97,,,,,nan,Period 2,nan,nan,97,C,2018-03-30T08:51 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,31980.0,1838019180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),93.0,93,,,,,nan,Period 2,nan,nan,93,C,2018-03-30T08:53 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),94.0,94,,,,Y,94.0,Period 2,nan,nan,94,C,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,,94.0,Period 2,-9.0,-9.574468085106384,85,C,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21274.0,33660.0,1838107260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),88.0,88,,,,,94.0,Period 2,-6.0,-6.382978723404255,88,C,2018-03-31T09:21 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21274.0,33786.0,1838107386.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,94.0,Period 2,-2.0,-2.127659574468085,92,C,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21274.0,33874.0,1838107474.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,94.0,Period 2,-4.0,-4.25531914893617,90,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21280.0,31860.0,1838623860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),97.0,97,,,,,nan,Period 3,nan,nan,97,A,2018-04-06T08:51 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),91.0,91,,,,,nan,Period 3,nan,nan,91,A,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),96.0,96,,,,Y,96.0,Period 3,nan,nan,96,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,96.0,Period 3,-15.0,-15.625,81,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),99.0,99,,,,,76.0,EOT/ET/Followup,23.0,30.263157894736842,99,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,END OF TREATMENT,21281.0,40192.0,1838718592.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),101.0,101,,,,,76.0,EOT/ET/Followup,25.0,32.89473684210527,101,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,END OF TREATMENT,21281.0,40342.0,1838718742.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),96.0,96,,,,,76.0,EOT/ET/Followup,20.0,26.31578947368421,96,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21281.0,33660.0,1838712060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,,96.0,Period 3,-10.0,-10.416666666666668,86,A,2018-04-07T09:21 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,20.0,SCREENING,21262.0,31061.0,1837067861.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),167.5,167.5,,,,Y,167.5,EOT/ET/Followup,nan,nan,167.5,NA,2018-03-19T08:37 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21262.0,31620.0,1837068420.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-03-19T08:47 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21266.0,31860.0,1837414260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,Y,69.0,Period 1,nan,nan,69,B,2018-03-23T08:51 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,69.0,Period 1,-2.0,-2.898550724637681,67,B,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,TREATMENT,21267.0,33660.0,1837502460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),81.0,81,,,,,69.0,Period 1,12.0,17.391304347826086,81,B,2018-03-24T09:21 (2)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21273.0,31860.0,1838019060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,C,2018-03-30T08:51 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,72.0,Period 2,-5.0,-6.944444444444445,67,C,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21274.0,33660.0,1838107260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),101.0,101,,,,,72.0,Period 2,29.0,40.27777777777778,101,C,2018-03-31T09:21 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21274.0,33786.0,1838107386.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),97.0,97,,,,,72.0,Period 2,25.0,34.72222222222222,97,C,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21274.0,33874.0,1838107474.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),99.0,99,,,,,72.0,Period 2,27.0,37.5,99,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,31860.0,1838623860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,,nan,Period 3,nan,nan,74,A,2018-04-06T08:51 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),70.0,70,,,,,nan,Period 3,nan,nan,70,A,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,71.0,Period 3,-4.0,-5.633802816901409,67,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),87.0,87,,,,,73.0,EOT/ET/Followup,14.0,19.17808219178082,87,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21281.0,33660.0,1838712060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),87.0,87,,,,,71.0,Period 3,16.0,22.535211267605636,87,A,2018-04-07T09:21 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,36.0,SCREENING,21262.0,31620.0,1837068420.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-19T08:47 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,38.0,SCREENING,21262.0,31620.0,1837068420.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,EOT/ET/Followup,nan,nan,121,NA,2018-03-19T08:47 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21266.0,31860.0,1837414260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,Y,130.0,Period 1,nan,nan,130,B,2018-03-23T08:51 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,130.0,Period 1,-8.0,-6.153846153846154,122,B,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,41.0,TREATMENT,21267.0,33660.0,1837502460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,,130.0,Period 1,9.0,6.923076923076923,139,B,2018-03-24T09:21 (2)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21273.0,31860.0,1838019060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,nan,Period 2,nan,nan,135,C,2018-03-30T08:51 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21273.0,31980.0,1838019180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,nan,Period 2,nan,nan,135,C,2018-03-30T08:53 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,Y,128.0,Period 2,nan,nan,128,C,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,128.0,Period 2,-11.0,-8.59375,117,C,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21274.0,33660.0,1838107260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),145.0,145,,,,,128.0,Period 2,17.0,13.28125,145,C,2018-03-31T09:21 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21274.0,33786.0,1838107386.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,,128.0,Period 2,7.0,5.46875,135,C,2018-03-31T09:23 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,TREATMENT,21274.0,33874.0,1838107474.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),136.0,136,,,,,128.0,Period 2,8.0,6.25,136,C,2018-03-31T09:24 (9)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,49.0,TREATMENT,21280.0,31860.0,1838623860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,nan,Period 3,nan,nan,130,A,2018-04-06T08:51 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,nan,Period 3,nan,nan,131,A,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,Y,131.0,Period 3,nan,nan,131,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,131.0,Period 3,-16.0,-12.213740458015266,115,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),148.0,148,,,,,121.0,EOT/ET/Followup,27.0,22.31404958677686,148,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,END OF TREATMENT,21281.0,40192.0,1838718592.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),152.0,152,,,,,121.0,EOT/ET/Followup,31.0,25.6198347107438,152,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,40342.0,1838718742.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),157.0,157,,,,,121.0,EOT/ET/Followup,36.0,29.75206611570248,157,A,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21281.0,33660.0,1838712060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,,131.0,Period 3,1.0,0.7633587786259541,132,A,2018-04-07T09:21 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,31620.0,1837068420.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-03-19T08:47 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.9,35.9,,,,,36.4,EOT/ET/Followup,-0.5,-1.3736263736263736,35.9,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,59.0,SCREENING,21262.0,31061.0,1837067861.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),72.0,72,,,,Y,72.0,EOT/ET/Followup,nan,nan,72,NA,2018-03-19T08:37 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,END OF TREATMENT,21281.0,40937.0,1838719337.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),71.7,71.7,,,,,72.0,EOT/ET/Followup,-0.3,-0.41666666666666274,71.7,A,2018-04-07T11:22 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,37003.0,1837073803.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.2,25.2,,,,Y,25.2,EOT/ET/Followup,nan,nan,25.2,NA,2018-03-19T10:16 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,40572.0,1838718972.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.2,25.2,,,,,25.2,EOT/ET/Followup,0.0,0.0,25.2,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,36780.0,1837073580.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,EOT/ET/Followup,nan,nan,72,NA,2018-03-19T10:13 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,Y,86.0,Period 1,nan,nan,86,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,86.0,Period 1,-6.0,-6.976744186046512,80,B,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,33300.0,1837502100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,86.0,Period 1,-14.0,-16.27906976744186,72,B,2018-03-24T09:15 (2)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 2,nan,nan,82,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,82.0,Period 2,-11.0,-13.414634146341465,71,C,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,33300.0,1838106900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),99.0,99,,,,,82.0,Period 2,17.0,20.73170731707317,99,C,2018-03-31T09:15 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21274.0,33420.0,1838107020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),98.0,98,,,,,82.0,Period 2,16.0,19.51219512195122,98,C,2018-03-31T09:17 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21274.0,33540.0,1838107140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),98.0,98,,,,,82.0,Period 2,16.0,19.51219512195122,98,C,2018-03-31T09:19 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,nan,Period 3,nan,nan,90,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21280.0,31590.0,1838623590.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,nan,Period 3,nan,nan,92,A,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21280.0,31815.0,1838623815.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,Y,92.0,Period 3,nan,nan,92,A,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21280.0,40800.0,1838632800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,92.0,Period 3,-21.0,-22.82608695652174,71,A,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,72.0,EOT/ET/Followup,1.0,1.3888888888888888,73,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21281.0,33300.0,1838711700.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,92.0,Period 3,-10.0,-10.869565217391305,82,A,2018-04-07T09:15 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21262.0,37003.0,1837073803.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),179.0,179,,,,Y,179.0,EOT/ET/Followup,nan,nan,179,NA,2018-03-19T10:16 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,36780.0,1837073580.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,EOT/ET/Followup,nan,nan,63,NA,2018-03-19T10:13 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,63.0,Period 1,-8.0,-12.698412698412698,55,B,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21267.0,33300.0,1837502100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,63.0,Period 1,2.0,3.1746031746031744,65,B,2018-03-24T09:15 (2)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,Period 2,nan,nan,59,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),59.0,59,,,,,59.0,Period 2,0.0,0.0,59,C,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21274.0,33300.0,1838106900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,59.0,Period 2,5.0,8.47457627118644,64,C,2018-03-31T09:15 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,,nan,Period 3,nan,nan,65,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21280.0,31590.0,1838623590.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 3,nan,nan,63,A,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21280.0,40800.0,1838632800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),62.0,62,,,,,63.0,Period 3,-1.0,-1.5873015873015872,62,A,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,63.0,EOT/ET/Followup,0.0,0.0,63,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21281.0,33300.0,1838711700.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,63.0,Period 3,1.0,1.5873015873015872,64,A,2018-04-07T09:15 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,29.0,SCREENING,21262.0,36780.0,1837073580.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-03-19T10:13 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,31.0,SCREENING,21262.0,36780.0,1837073580.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,Y,130.0,EOT/ET/Followup,nan,nan,130,NA,2018-03-19T10:13 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,Period 1,nan,nan,133,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,133.0,Period 1,-3.0,-2.2556390977443606,130,B,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21267.0,33300.0,1837502100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,133.0,Period 1,-19.0,-14.285714285714285,114,B,2018-03-24T09:15 (2)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,Y,126.0,Period 2,nan,nan,126,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,126.0,Period 2,-5.0,-3.968253968253968,121,C,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21274.0,33300.0,1838106900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,126.0,Period 2,16.0,12.698412698412698,142,C,2018-03-31T09:15 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21274.0,33420.0,1838107020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),152.0,152,,,,,126.0,Period 2,26.0,20.634920634920633,152,C,2018-03-31T09:17 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21274.0,33540.0,1838107140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),153.0,153,,,,,126.0,Period 2,27.0,21.428571428571427,153,C,2018-03-31T09:19 (9)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,nan,Period 3,nan,nan,122,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,41.0,TREATMENT,21280.0,31590.0,1838623590.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,nan,Period 3,nan,nan,126,A,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21280.0,31815.0,1838623815.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,Period 3,nan,nan,135,A,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21280.0,40800.0,1838632800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,135.0,Period 3,-13.0,-9.62962962962963,122,A,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,130.0,EOT/ET/Followup,-9.0,-6.923076923076923,121,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21281.0,33300.0,1838711700.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,135.0,Period 3,-16.0,-11.851851851851853,119,A,2018-04-07T09:15 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,46.0,SCREENING,21262.0,36780.0,1837073580.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-19T10:13 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.9,35.9,,,,,36.2,EOT/ET/Followup,-0.3,-0.8287292817679676,35.9,A,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,48.0,SCREENING,21262.0,37003.0,1837073803.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),80.8,80.8,,,,Y,80.8,EOT/ET/Followup,nan,nan,80.8,NA,2018-03-19T10:16 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,49.0,END OF TREATMENT,21281.0,40572.0,1838718972.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),80.7,80.7,,,,,80.8,EOT/ET/Followup,-0.1,-0.12376237623761674,80.7,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,38212.0,1837075012.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.9,27.9,,,,Y,27.9,EOT/ET/Followup,nan,nan,27.9,NA,2018-03-19T10:36 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,41922.0,1838720322.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.4,27.4,,,,,27.9,EOT/ET/Followup,-0.5,-1.792114695340502,27.4,A,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,38820.0,1837075620.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,Y,86.0,EOT/ET/Followup,nan,nan,86,NA,2018-03-19T10:47 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,Period 1,nan,nan,76,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,42060.0,1837424460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,76.0,Period 1,2.0,2.631578947368421,78,C,2018-03-23T11:41 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,34560.0,1837503360.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,76.0,Period 1,-13.0,-17.105263157894736,63,C,2018-03-24T09:36 (2)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,nan,Period 2,nan,nan,92,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,32874.0,1838020074.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,,nan,Period 2,nan,nan,92,B,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),92.0,92,,,,Y,92.0,Period 2,nan,nan,92,B,2018-03-30T09:09 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21273.0,42060.0,1838029260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,92.0,Period 2,-12.0,-13.043478260869565,80,B,2018-03-30T11:41 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21274.0,34560.0,1838108160.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,92.0,Period 2,-25.0,-27.173913043478258,67,B,2018-03-31T09:36 (9)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21280.0,32760.0,1838624760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),102.0,102,,,,,nan,Period 3,nan,nan,102,A,2018-04-06T09:06 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),91.0,91,,,,,nan,Period 3,nan,nan,91,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),94.0,94,,,,Y,94.0,Period 3,nan,nan,94,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21280.0,42060.0,1838634060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,94.0,Period 3,-15.0,-15.957446808510639,79,A,2018-04-06T11:41 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,END OF TREATMENT,21281.0,40860.0,1838719260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,,86.0,EOT/ET/Followup,0.0,0.0,86,A,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21281.0,34560.0,1838712960.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,94.0,Period 3,-21.0,-22.340425531914892,73,A,2018-04-07T09:36 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21262.0,38212.0,1837075012.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),168.5,168.5,,,,Y,168.5,EOT/ET/Followup,nan,nan,168.5,NA,2018-03-19T10:36 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,38820.0,1837075620.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),86.0,86,,,,Y,86.0,EOT/ET/Followup,nan,nan,86,NA,2018-03-19T10:47 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),94.0,94,,,,Y,94.0,Period 1,nan,nan,94,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,42060.0,1837424460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,94.0,Period 1,-9.0,-9.574468085106384,85,C,2018-03-23T11:41 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21267.0,34560.0,1837503360.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),83.0,83,,,,,94.0,Period 1,-11.0,-11.702127659574469,83,C,2018-03-24T09:36 (2)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21273.0,42060.0,1838029260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,,75.0,Period 2,-5.0,-6.666666666666667,70,B,2018-03-30T11:41 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21274.0,34560.0,1838108160.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),76.0,76,,,,,75.0,Period 2,1.0,1.3333333333333335,76,B,2018-03-31T09:36 (9)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21280.0,32760.0,1838624760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),69.0,69,,,,,nan,Period 3,nan,nan,69,A,2018-04-06T09:06 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,,nan,Period 3,nan,nan,74,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 3,nan,nan,72,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21280.0,42060.0,1838634060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),73.0,73,,,,,72.0,Period 3,1.0,1.3888888888888888,73,A,2018-04-06T11:41 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,END OF TREATMENT,21281.0,40860.0,1838719260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),72.0,72,,,,,86.0,EOT/ET/Followup,-14.0,-16.27906976744186,72,A,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21281.0,34560.0,1838712960.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),91.0,91,,,,,72.0,Period 3,19.0,26.38888888888889,91,A,2018-04-07T09:36 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21262.0,38820.0,1837075620.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),17.0,17,,,,Y,17.0,EOT/ET/Followup,nan,nan,17,NA,2018-03-19T10:47 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,END OF TREATMENT,21281.0,40860.0,1838719260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,17.0,EOT/ET/Followup,-1.0,-5.88235294117647,16,A,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,32.0,SCREENING,21262.0,38820.0,1837075620.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,Y,123.0,EOT/ET/Followup,nan,nan,123,NA,2018-03-19T10:47 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 1,nan,nan,119,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,42060.0,1837424460.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,119.0,Period 1,12.0,10.084033613445378,131,C,2018-03-23T11:41 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21267.0,34560.0,1837503360.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,119.0,Period 1,-10.0,-8.403361344537815,109,C,2018-03-24T09:36 (2)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,,nan,Period 2,nan,nan,133,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,32874.0,1838020074.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),136.0,136,,,,,nan,Period 2,nan,nan,136,B,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,Period 2,nan,nan,135,B,2018-03-30T09:09 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21273.0,42060.0,1838029260.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,135.0,Period 2,-7.0,-5.185185185185185,128,B,2018-03-30T11:41 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,TREATMENT,21274.0,34560.0,1838108160.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,135.0,Period 2,-18.0,-13.333333333333334,117,B,2018-03-31T09:36 (9)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,41.0,TREATMENT,21280.0,32760.0,1838624760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),146.0,146,,,,,nan,Period 3,nan,nan,146,A,2018-04-06T09:06 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),150.0,150,,,,,nan,Period 3,nan,nan,150,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),153.0,153,,,,Y,153.0,Period 3,nan,nan,153,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21280.0,42060.0,1838634060.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,153.0,Period 3,-27.0,-17.647058823529413,126,A,2018-04-06T11:41 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,END OF TREATMENT,21281.0,40860.0,1838719260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,123.0,EOT/ET/Followup,4.0,3.2520325203252036,127,A,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21281.0,34560.0,1838712960.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,153.0,Period 3,-25.0,-16.33986928104575,128,A,2018-04-07T09:36 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,47.0,SCREENING,21262.0,38820.0,1837075620.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-03-19T10:47 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,40860.0,1838719260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.7,35.7,,,,,36.3,EOT/ET/Followup,-0.6,-1.6528925619834556,35.7,A,2018-04-07T11:21 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,38212.0,1837075012.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),79.2,79.2,,,,Y,79.2,EOT/ET/Followup,nan,nan,79.2,NA,2018-03-19T10:36 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,END OF TREATMENT,21281.0,41922.0,1838720322.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),77.8,77.8,,,,,79.2,EOT/ET/Followup,-1.4,-1.7676767676767748,77.8,A,2018-04-07T11:38 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,35370.0,1837072170.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.7,27.7,,,,Y,27.7,EOT/ET/Followup,nan,nan,27.7,NA,2018-03-19T09:49 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,42180.0,1838720580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.8,27.8,,,,,27.7,EOT/ET/Followup,0.1,0.3610108303249149,27.8,A,2018-04-07T11:43 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,EOT/ET/Followup,nan,nan,83,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,Period 1,nan,nan,80,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,42660.0,1837425060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,80.0,Period 1,1.0,1.25,81,C,2018-03-23T11:51 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,35160.0,1837503960.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,80.0,Period 1,-14.0,-17.5,66,C,2018-03-24T09:46 (2)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,33360.0,1838020560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,Period 2,nan,nan,69,B,2018-03-30T09:16 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21273.0,42660.0,1838029860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,69.0,Period 2,8.0,11.594202898550725,77,B,2018-03-30T11:51 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21274.0,35160.0,1838108760.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,69.0,Period 2,10.0,14.492753623188406,79,B,2018-03-31T09:46 (9)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,33360.0,1838625360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,A,2018-04-06T09:16 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,42660.0,1838634660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,71.0,Period 3,1.0,1.4084507042253522,72,A,2018-04-06T11:51 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,41460.0,1838719860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,83.0,EOT/ET/Followup,-14.0,-16.867469879518072,69,A,2018-04-07T11:31 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,35160.0,1838713560.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,71.0,Period 3,-11.0,-15.492957746478872,60,A,2018-04-07T09:46 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21262.0,35370.0,1837072170.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),158.0,158,,,,Y,158.0,EOT/ET/Followup,nan,nan,158,NA,2018-03-19T09:49 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,42660.0,1837425060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),52.0,52,,,,,61.0,Period 1,-9.0,-14.754098360655737,52,C,2018-03-23T11:51 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,35160.0,1837503960.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,,61.0,Period 1,23.0,37.704918032786885,84,C,2018-03-24T09:46 (2)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21273.0,33360.0,1838020560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),85.0,85,,,,Y,85.0,Period 2,nan,nan,85,B,2018-03-30T09:16 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21273.0,42660.0,1838029860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),61.0,61,,,,,85.0,Period 2,-24.0,-28.235294117647058,61,B,2018-03-30T11:51 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21274.0,35160.0,1838108760.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,85.0,Period 2,-13.0,-15.294117647058824,72,B,2018-03-31T09:46 (9)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21280.0,33360.0,1838625360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 3,nan,nan,71,A,2018-04-06T09:16 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21280.0,42660.0,1838634660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),55.0,55,,,,,71.0,Period 3,-16.0,-22.535211267605636,55,A,2018-04-06T11:51 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,END OF TREATMENT,21281.0,41460.0,1838719860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,65.0,EOT/ET/Followup,-1.0,-1.5384615384615385,64,A,2018-04-07T11:31 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21281.0,35160.0,1838713560.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),70.0,70,,,,,71.0,Period 3,-1.0,-1.4084507042253522,70,A,2018-04-07T09:46 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,41460.0,1838719860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,A,2018-04-07T11:31 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,EOT/ET/Followup,nan,nan,135,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,Period 1,nan,nan,112,C,2018-03-23T09:16 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,42660.0,1837425060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,,112.0,Period 1,27.0,24.107142857142858,139,C,2018-03-23T11:51 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,35160.0,1837503960.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,112.0,Period 1,-3.0,-2.6785714285714284,109,C,2018-03-24T09:46 (2)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21273.0,33360.0,1838020560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,Y,110.0,Period 2,nan,nan,110,B,2018-03-30T09:16 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21273.0,42660.0,1838029860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,110.0,Period 2,10.0,9.090909090909092,120,B,2018-03-30T11:51 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21274.0,35160.0,1838108760.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,110.0,Period 2,9.0,8.181818181818182,119,B,2018-03-31T09:46 (9)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,33.0,TREATMENT,21280.0,33360.0,1838625360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 3,nan,nan,115,A,2018-04-06T09:16 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21280.0,42660.0,1838634660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,115.0,Period 3,5.0,4.3478260869565215,120,A,2018-04-06T11:51 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,END OF TREATMENT,21281.0,41460.0,1838719860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,135.0,EOT/ET/Followup,-26.0,-19.25925925925926,109,A,2018-04-07T11:31 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21281.0,35160.0,1838713560.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,115.0,Period 3,-12.0,-10.434782608695652,103,A,2018-04-07T09:46 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,END OF TREATMENT,21281.0,41460.0,1838719860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.6,36.6,,,,,36.2,EOT/ET/Followup,0.4,1.1049723756906038,36.6,A,2018-04-07T11:31 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21262.0,35370.0,1837072170.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),69.2,69.2,,,,Y,69.2,EOT/ET/Followup,nan,nan,69.2,NA,2018-03-19T09:49 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,42180.0,1838720580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),69.4,69.4,,,,,69.2,EOT/ET/Followup,0.2,0.28901734104046656,69.4,A,2018-04-07T11:43 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,43458.0,1837080258.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.5,26.5,,,,Y,26.5,EOT/ET/Followup,nan,nan,26.5,NA,2018-03-19T12:04 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,41878.0,1838720278.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),25.9,25.9,,,,,26.5,EOT/ET/Followup,-0.6,-2.2641509433962317,25.9,A,2018-04-07T11:37 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,44070.0,1837080870.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-03-19T12:14 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32940.0,1837415340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,Y,69.0,Period 1,nan,nan,69,B,2018-03-23T09:09 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,42240.0,1837424640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),50.0,50,Low,Actual value <=50 and CFB decreased >=15,Value <=50 and CFB >=15,,69.0,Period 1,-19.0,-27.536231884057973,50,B,2018-03-23T11:44 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,69.0,Period 1,-11.0,-15.942028985507244,58,B,2018-03-23T11:46 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),55.0,55,,,,,69.0,Period 1,-14.0,-20.28985507246377,55,B,2018-03-23T11:47 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21267.0,34740.0,1837503540.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),60.0,60,,,,,69.0,Period 1,-9.0,-13.043478260869565,60,B,2018-03-24T09:39 (2)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),56.0,56,,,,Y,56.0,Period 2,nan,nan,56,C,2018-03-30T09:09 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21273.0,42240.0,1838029440.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,56.0,Period 2,14.0,25.0,70,C,2018-03-30T11:44 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21274.0,34740.0,1838108340.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),53.0,53,,,,,56.0,Period 2,-3.0,-5.357142857142857,53,C,2018-03-31T09:39 (9)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),56.0,56,,,,Y,56.0,Period 3,nan,nan,56,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21280.0,42240.0,1838634240.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,56.0,Period 3,22.0,39.285714285714285,78,A,2018-04-06T11:44 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,END OF TREATMENT,21281.0,41040.0,1838719440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),51.0,51,,,,,64.0,EOT/ET/Followup,-13.0,-20.3125,51,A,2018-04-07T11:24 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21281.0,34740.0,1838713140.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),53.0,53,,,,,56.0,Period 3,-3.0,-5.357142857142857,53,A,2018-04-07T09:39 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21262.0,43458.0,1837080258.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),159.5,159.5,,,,Y,159.5,EOT/ET/Followup,nan,nan,159.5,NA,2018-03-19T12:04 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21262.0,44070.0,1837080870.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-03-19T12:14 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21266.0,32940.0,1837415340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,B,2018-03-23T09:09 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21266.0,42240.0,1837424640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,73.0,Period 1,-10.0,-13.698630136986301,63,B,2018-03-23T11:44 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21267.0,34740.0,1837503540.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),78.0,78,,,,,73.0,Period 1,5.0,6.8493150684931505,78,B,2018-03-24T09:39 (2)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,C,2018-03-30T09:09 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,42240.0,1838029440.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),60.0,60,,,,,66.0,Period 2,-6.0,-9.090909090909092,60,C,2018-03-30T11:44 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21274.0,34740.0,1838108340.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,66.0,Period 2,6.0,9.090909090909092,72,C,2018-03-31T09:39 (9)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,Period 3,nan,nan,74,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,42240.0,1838634240.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,74.0,Period 3,-10.0,-13.513513513513514,64,A,2018-04-06T11:44 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,END OF TREATMENT,21281.0,41040.0,1838719440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,65.0,EOT/ET/Followup,-1.0,-1.5384615384615385,64,A,2018-04-07T11:24 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21281.0,34740.0,1838713140.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),69.0,69,,,,,74.0,Period 3,-5.0,-6.756756756756757,69,A,2018-04-07T09:39 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21262.0,44070.0,1837080870.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-19T12:14 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,END OF TREATMENT,21281.0,41040.0,1838719440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,A,2018-04-07T11:24 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,28.0,SCREENING,21262.0,44070.0,1837080870.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,EOT/ET/Followup,nan,nan,113,NA,2018-03-19T12:14 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21266.0,32940.0,1837415340.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 1,nan,nan,105,B,2018-03-23T09:09 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21266.0,42240.0,1837424640.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,105.0,Period 1,-3.0,-2.857142857142857,102,B,2018-03-23T11:44 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,,105.0,Period 1,-4.0,-3.8095238095238098,101,B,2018-03-23T11:46 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,,105.0,Period 1,-5.0,-4.761904761904762,100,B,2018-03-23T11:47 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21267.0,34740.0,1837503540.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,,105.0,Period 1,0.0,0.0,105,B,2018-03-24T09:39 (2)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,Y,102.0,Period 2,nan,nan,102,C,2018-03-30T09:09 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21273.0,42240.0,1838029440.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,102.0,Period 2,11.0,10.784313725490197,113,C,2018-03-30T11:44 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21274.0,34740.0,1838108340.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,102.0,Period 2,-3.0,-2.941176470588235,99,C,2018-03-31T09:39 (9)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,Y,99.0,Period 3,nan,nan,99,A,2018-04-06T09:09 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,42240.0,1838634240.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,,99.0,Period 3,6.0,6.0606060606060606,105,A,2018-04-06T11:44 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,41040.0,1838719440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,113.0,EOT/ET/Followup,-10.0,-8.849557522123893,103,A,2018-04-07T11:24 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21281.0,34740.0,1838713140.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,99.0,Period 3,5.0,5.05050505050505,104,A,2018-04-07T09:39 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,44070.0,1837080870.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-03-19T12:14 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,END OF TREATMENT,21281.0,41040.0,1838719440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.0,36,,,,,36.6,EOT/ET/Followup,-0.6,-1.6393442622950858,36,A,2018-04-07T11:24 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21262.0,43458.0,1837080258.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),67.4,67.4,,,,Y,67.4,EOT/ET/Followup,nan,nan,67.4,NA,2018-03-19T12:04 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,END OF TREATMENT,21281.0,41878.0,1838720278.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),65.8,65.8,,,,,67.4,EOT/ET/Followup,-1.6,-2.3738872403560958,65.8,A,2018-04-07T11:37 (16)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21262.0,44100.0,1837080900.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.8,28.8,,,,Y,28.8,EOT/ET/Followup,nan,nan,28.8,NA,2018-03-19T12:15 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21272.0,60101.0,1837960901.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,BMI,Body Mass Index (kg/m2),28.8,28.8,,,,,28.8,EOT/ET/Followup,0.0,0.0,28.8,B,2018-03-29T16:41 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,45090.0,1837081890.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,nan,EOT/ET/Followup,nan,nan,76,NA,2018-03-19T12:31 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,2.0,SCREENING,21262.0,45480.0,1837082280.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-19T12:38 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,Period 1,nan,nan,82,B,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,82.0,Period 1,-1.0,-1.2195121951219512,81,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21267.0,34380.0,1837503180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,82.0,Period 1,-19.0,-23.170731707317074,63,B,2018-03-24T09:33 (2)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,END OF TREATMENT,21272.0,62280.0,1837963080.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,74.0,EOT/ET/Followup,3.0,4.054054054054054,77,B,2018-03-29T17:18 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,7.0,SCREENING,21262.0,44100.0,1837080900.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),177.0,177,,,,Y,177.0,EOT/ET/Followup,nan,nan,177,NA,2018-03-19T12:15 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,8.0,SCREENING,21262.0,45090.0,1837081890.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),67.0,67,,,,Y,67.0,EOT/ET/Followup,nan,nan,67,NA,2018-03-19T12:31 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,Period 1,nan,nan,59,B,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,59.0,Period 1,5.0,8.47457627118644,64,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21267.0,34380.0,1837503180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,,59.0,Period 1,9.0,15.254237288135593,68,B,2018-03-24T09:33 (2)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,END OF TREATMENT,21272.0,62280.0,1837963080.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PULSE,Pulse Rate (beats/min),81.0,81,,,,,67.0,EOT/ET/Followup,14.0,20.8955223880597,81,B,2018-03-29T17:18 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21262.0,45090.0,1837081890.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),15.0,15,,,,Y,15.0,EOT/ET/Followup,nan,nan,15,NA,2018-03-19T12:31 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,END OF TREATMENT,21272.0,62280.0,1837963080.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,15.0,EOT/ET/Followup,-1.0,-6.666666666666667,14,B,2018-03-29T17:18 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21262.0,45090.0,1837081890.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),143.0,143,,,,,nan,EOT/ET/Followup,nan,nan,143,NA,2018-03-19T12:31 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21262.0,45480.0,1837082280.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,Y,131.0,EOT/ET/Followup,nan,nan,131,NA,2018-03-19T12:38 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,Period 1,nan,nan,135,B,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,135.0,Period 1,-1.0,-0.7407407407407408,134,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21267.0,34380.0,1837503180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,135.0,Period 1,-15.0,-11.11111111111111,120,B,2018-03-24T09:33 (2)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,END OF TREATMENT,21272.0,62280.0,1837963080.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,131.0,EOT/ET/Followup,3.0,2.2900763358778624,134,B,2018-03-29T17:18 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21262.0,45090.0,1837081890.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-19T12:31 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,END OF TREATMENT,21272.0,62280.0,1837963080.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,TEMP,Temperature (C),36.2,36.2,,,,,36.2,EOT/ET/Followup,0.0,0.0,36.2,B,2018-03-29T17:18 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,23.0,SCREENING,21262.0,44100.0,1837080900.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),90.2,90.2,,,,Y,90.2,EOT/ET/Followup,nan,nan,90.2,NA,2018-03-19T12:15 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21272.0,60101.0,1837960901.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,WEIGHT,Weight (kg),90.1,90.1,,,,,90.2,EOT/ET/Followup,-0.1,-0.11086474501109593,90.1,B,2018-03-29T16:41 (7)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21264.0,32839.0,1837242439.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),29.5,29.5,,,,Y,29.5,EOT/ET/Followup,nan,nan,29.5,NA,2018-03-21T09:07 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,41795.0,1838720195.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),28.8,28.8,,,,,29.5,EOT/ET/Followup,-0.7,-2.372881355932201,28.8,B,2018-04-07T11:36 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,33409.0,1837243009.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,nan,EOT/ET/Followup,nan,nan,80,NA,2018-03-21T09:16 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,2.0,SCREENING,21264.0,33600.0,1837243200.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),86.0,86,,,,Y,86.0,EOT/ET/Followup,nan,nan,86,NA,2018-03-21T09:20 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,Period 1,nan,nan,76,A,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21266.0,42180.0,1837424580.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,76.0,Period 1,-1.0,-1.3157894736842104,75,A,2018-03-23T11:43 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21267.0,34680.0,1837503480.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,76.0,Period 1,5.0,6.578947368421052,81,A,2018-03-24T09:38 (2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,,nan,Period 2,nan,nan,85,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21273.0,33030.0,1838020230.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,nan,Period 2,nan,nan,80,C,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,Period 2,nan,nan,83,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21273.0,42180.0,1838029380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,83.0,Period 2,7.0,8.433734939759036,90,C,2018-03-30T11:43 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21273.0,42240.0,1838029440.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,83.0,Period 2,-1.0,-1.2048192771084338,82,C,2018-03-30T11:44 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,83.0,Period 2,-6.0,-7.228915662650602,77,C,2018-03-30T11:45 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21274.0,34680.0,1838108280.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,83.0,Period 2,-8.0,-9.63855421686747,75,C,2018-03-31T09:38 (9)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21280.0,32880.0,1838624880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 3,nan,nan,77,B,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,42180.0,1838634180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),95.0,95,,,,,77.0,Period 3,18.0,23.376623376623375,95,B,2018-04-06T11:43 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,42255.0,1838634255.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,77.0,Period 3,7.0,9.090909090909092,84,B,2018-04-06T11:44 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,77.0,Period 3,13.0,16.883116883116884,90,B,2018-04-06T11:46 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,END OF TREATMENT,21281.0,40980.0,1838719380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),91.0,91,,,,,86.0,EOT/ET/Followup,5.0,5.813953488372093,91,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,END OF TREATMENT,21281.0,41170.0,1838719570.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),90.0,90,,,,,86.0,EOT/ET/Followup,4.0,4.651162790697675,90,B,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,END OF TREATMENT,21281.0,41306.0,1838719706.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,86.0,EOT/ET/Followup,-4.0,-4.651162790697675,82,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21281.0,34680.0,1838713080.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,,77.0,Period 3,6.0,7.792207792207792,83,B,2018-04-07T09:38 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21264.0,32839.0,1837242439.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),166.5,166.5,,,,Y,166.5,EOT/ET/Followup,nan,nan,166.5,NA,2018-03-21T09:07 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,22.0,SCREENING,21264.0,33409.0,1837243009.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-03-21T09:16 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 1,nan,nan,75,A,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21266.0,42180.0,1837424580.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,75.0,Period 1,-5.0,-6.666666666666667,70,A,2018-03-23T11:43 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21267.0,34680.0,1837503480.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,75.0,Period 1,-8.0,-10.666666666666668,67,A,2018-03-24T09:38 (2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),73.0,73,,,,,nan,Period 2,nan,nan,73,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21273.0,33030.0,1838020230.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,nan,Period 2,nan,nan,67,C,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,42180.0,1838029380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,70.0,Period 2,4.0,5.714285714285714,74,C,2018-03-30T11:43 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21274.0,34680.0,1838108280.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,70.0,Period 2,-3.0,-4.285714285714286,67,C,2018-03-31T09:38 (9)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,32880.0,1838624880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,Period 3,nan,nan,58,B,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21280.0,42180.0,1838634180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,,58.0,Period 3,1.0,1.7241379310344827,59,B,2018-04-06T11:43 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,END OF TREATMENT,21281.0,40980.0,1838719380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,71.0,EOT/ET/Followup,-7.0,-9.859154929577464,64,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21281.0,34680.0,1838713080.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),58.0,58,,,,,58.0,Period 3,0.0,0.0,58,B,2018-04-07T09:38 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,35.0,SCREENING,21264.0,33409.0,1837243009.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-03-21T09:16 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,40980.0,1838719380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),18.0,18,,,,,14.0,EOT/ET/Followup,4.0,28.57142857142857,18,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21264.0,33409.0,1837243009.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,nan,EOT/ET/Followup,nan,nan,142,NA,2018-03-21T09:16 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,38.0,SCREENING,21264.0,33600.0,1837243200.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),135.0,135,,,,Y,135.0,EOT/ET/Followup,nan,nan,135,NA,2018-03-21T09:20 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,Y,131.0,Period 1,nan,nan,131,A,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,TREATMENT,21266.0,42180.0,1837424580.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,131.0,Period 1,-2.0,-1.5267175572519083,129,A,2018-03-23T11:43 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,41.0,TREATMENT,21267.0,34680.0,1837503480.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,131.0,Period 1,-2.0,-1.5267175572519083,129,A,2018-03-24T09:38 (2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),145.0,145,,,,,nan,Period 2,nan,nan,145,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21273.0,33030.0,1838020230.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,nan,Period 2,nan,nan,125,C,2018-03-30T09:10 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 2,nan,nan,121,C,2018-03-30T09:12 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,42180.0,1838029380.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,121.0,Period 2,13.0,10.743801652892563,134,C,2018-03-30T11:43 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21273.0,42240.0,1838029440.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,121.0,Period 2,8.0,6.6115702479338845,129,C,2018-03-30T11:44 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,121.0,Period 2,13.0,10.743801652892563,134,C,2018-03-30T11:45 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,TREATMENT,21274.0,34680.0,1838108280.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,121.0,Period 2,-7.0,-5.785123966942149,114,C,2018-03-31T09:38 (9)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,49.0,TREATMENT,21280.0,32880.0,1838624880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,Period 3,nan,nan,133,B,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21280.0,42180.0,1838634180.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,133.0,Period 3,-6.0,-4.511278195488721,127,B,2018-04-06T11:43 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21280.0,42255.0,1838634255.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,133.0,Period 3,-13.0,-9.774436090225564,120,B,2018-04-06T11:44 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,133.0,Period 3,-6.0,-4.511278195488721,127,B,2018-04-06T11:46 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,END OF TREATMENT,21281.0,40980.0,1838719380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,135.0,EOT/ET/Followup,7.0,5.185185185185185,142,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,END OF TREATMENT,21281.0,41170.0,1838719570.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),142.0,142,,,,,135.0,EOT/ET/Followup,7.0,5.185185185185185,142,B,2018-04-07T11:26 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,41306.0,1838719706.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,,135.0,EOT/ET/Followup,4.0,2.9629629629629632,139,B,2018-04-07T11:28 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21281.0,34680.0,1838713080.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,133.0,Period 3,-6.0,-4.511278195488721,127,B,2018-04-07T09:38 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21264.0,33409.0,1837243009.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-03-21T09:16 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,END OF TREATMENT,21281.0,40980.0,1838719380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.2,EOT/ET/Followup,0.0,0.0,36.2,B,2018-04-07T11:23 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,59.0,SCREENING,21264.0,32839.0,1837242439.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),81.8,81.8,,,,Y,81.8,EOT/ET/Followup,nan,nan,81.8,NA,2018-03-21T09:07 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,END OF TREATMENT,21281.0,41795.0,1838720195.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.9,79.9,,,,,81.8,EOT/ET/Followup,-1.9,-2.322738386308058,79.9,B,2018-04-07T11:36 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21264.0,36800.0,1837246400.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.4,24.4,,,,Y,24.4,EOT/ET/Followup,nan,nan,24.4,NA,2018-03-21T10:13 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21281.0,39871.0,1838718271.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),23.8,23.8,,,,,24.4,EOT/ET/Followup,-0.6,-2.459016393442614,23.8,B,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,37395.0,1837246995.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-03-21T10:23 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,Period 1,nan,nan,75,C,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,75.0,Period 1,-3.0,-4.0,72,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21267.0,32700.0,1837501500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,75.0,Period 1,-18.0,-24.0,57,C,2018-03-24T09:05 (2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,A,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,70.0,Period 2,-7.0,-10.0,63,A,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21274.0,32700.0,1838106300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,70.0,Period 2,-6.0,-8.571428571428571,64,A,2018-03-31T09:05 (9)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,Period 3,nan,nan,68,B,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,68.0,Period 3,1.0,1.4705882352941175,69,B,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,65.0,EOT/ET/Followup,-4.0,-6.153846153846154,61,B,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21281.0,32700.0,1838711100.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,68.0,Period 3,-5.0,-7.352941176470589,63,B,2018-04-07T09:05 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21264.0,36800.0,1837246400.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),182.0,182,,,,Y,182.0,EOT/ET/Followup,nan,nan,182,NA,2018-03-21T10:13 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21264.0,37395.0,1837246995.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-03-21T10:23 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),79.0,79,,,,Y,79.0,Period 1,nan,nan,79,C,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,79.0,Period 1,-7.0,-8.860759493670885,72,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21267.0,32700.0,1837501500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),76.0,76,,,,,79.0,Period 1,-3.0,-3.79746835443038,76,C,2018-03-24T09:05 (2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,A,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,70.0,Period 2,-1.0,-1.4285714285714286,69,A,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21274.0,32700.0,1838106300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),83.0,83,,,,,70.0,Period 2,13.0,18.571428571428573,83,A,2018-03-31T09:05 (9)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 3,nan,nan,73,B,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,73.0,Period 3,-5.0,-6.8493150684931505,68,B,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,74.0,EOT/ET/Followup,-6.0,-8.108108108108109,68,B,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21281.0,32700.0,1838711100.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),75.0,75,,,,,73.0,Period 3,2.0,2.73972602739726,75,B,2018-04-07T09:05 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21264.0,37395.0,1837246995.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-21T10:23 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,12.0,EOT/ET/Followup,4.0,33.33333333333333,16,B,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21264.0,37395.0,1837246995.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,EOT/ET/Followup,nan,nan,109,NA,2018-03-21T10:23 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 1,nan,nan,116,C,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,116.0,Period 1,-7.0,-6.0344827586206895,109,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21267.0,32700.0,1837501500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,116.0,Period 1,-9.0,-7.758620689655173,107,C,2018-03-24T09:05 (2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,Y,131.0,Period 2,nan,nan,131,A,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,131.0,Period 2,-28.0,-21.374045801526716,103,A,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21274.0,32700.0,1838106300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,131.0,Period 2,-27.0,-20.610687022900763,104,A,2018-03-31T09:05 (9)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,Y,103.0,Period 3,nan,nan,103,B,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,103.0,Period 3,0.0,0.0,103,B,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,109.0,EOT/ET/Followup,-2.0,-1.834862385321101,107,B,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21281.0,32700.0,1838711100.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,103.0,Period 3,12.0,11.650485436893204,115,B,2018-04-07T09:05 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21264.0,37395.0,1837246995.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.0,36,,,,Y,36.0,EOT/ET/Followup,nan,nan,36,NA,2018-03-21T10:23 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.0,EOT/ET/Followup,0.2,0.5555555555555635,36.2,B,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21264.0,36800.0,1837246400.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),80.8,80.8,,,,Y,80.8,EOT/ET/Followup,nan,nan,80.8,NA,2018-03-21T10:13 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,39871.0,1838718271.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),79.0,79,,,,,80.8,EOT/ET/Followup,-1.8,-2.2277227722772244,79,B,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,nan,SCREENING,21264.0,41770.0,1837251370.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),19.6,19.6,,,,Y,19.6,EOT/ET/Followup,nan,nan,19.6,NA,2018-03-21T11:36 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21281.0,39946.0,1838718346.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),19.8,19.8,,,,,19.6,EOT/ET/Followup,0.2,1.0204081632653024,19.8,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,42420.0,1837252020.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,Y,62.0,EOT/ET/Followup,nan,nan,62,NA,2018-03-21T11:47 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,30960.0,1837413360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,Y,66.0,Period 1,nan,nan,66,B,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,66.0,Period 1,-7.0,-10.606060606060606,59,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21267.0,32760.0,1837501560.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,66.0,Period 1,-1.0,-1.5151515151515151,65,B,2018-03-24T09:06 (2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,30960.0,1838018160.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 2,nan,nan,77,C,2018-03-30T08:36 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,77.0,Period 2,-7.0,-9.090909090909092,70,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21274.0,32760.0,1838106360.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,77.0,Period 2,-11.0,-14.285714285714285,66,C,2018-03-31T09:06 (9)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21280.0,30960.0,1838622960.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,Period 3,nan,nan,64,A,2018-04-06T08:36 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,64.0,Period 3,12.0,18.75,76,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,62.0,EOT/ET/Followup,7.0,11.29032258064516,69,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21281.0,32760.0,1838711160.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,64.0,Period 3,-1.0,-1.5625,63,A,2018-04-07T09:06 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21264.0,41770.0,1837251370.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),185.5,185.5,,,,Y,185.5,EOT/ET/Followup,nan,nan,185.5,NA,2018-03-21T11:36 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21264.0,42420.0,1837252020.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),46.0,46,,,,,nan,EOT/ET/Followup,nan,nan,46,NA,2018-03-21T11:47 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21264.0,42540.0,1837252140.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),53.0,53,,,,Y,53.0,EOT/ET/Followup,nan,nan,53,NA,2018-03-21T11:49 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,30960.0,1837413360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),56.0,56,,,,Y,56.0,Period 1,nan,nan,56,B,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),57.0,57,,,,,56.0,Period 1,1.0,1.7857142857142856,57,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21267.0,32760.0,1837501560.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),70.0,70,,,,,56.0,Period 1,14.0,25.0,70,B,2018-03-24T09:06 (2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,30960.0,1838018160.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),46.0,46,,,,,nan,Period 2,nan,nan,46,C,2018-03-30T08:36 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21273.0,31172.0,1838018372.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),45.0,45,,,,,nan,Period 2,nan,nan,45,C,2018-03-30T08:39 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,31323.0,1838018523.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),47.0,47,,,,Y,47.0,Period 2,nan,nan,47,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),46.0,46,,,,,47.0,Period 2,-1.0,-2.127659574468085,46,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),44.0,44,,,,,47.0,Period 2,-3.0,-6.382978723404255,44,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),45.0,45,,,,,47.0,Period 2,-2.0,-4.25531914893617,45,C,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,TREATMENT,21274.0,32760.0,1838106360.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),49.0,49,,,,,47.0,Period 2,2.0,4.25531914893617,49,C,2018-03-31T09:06 (9)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21274.0,32889.0,1838106489.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),47.0,47,,,,,47.0,Period 2,0.0,0.0,47,C,2018-03-31T09:08 (9)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21274.0,33030.0,1838106630.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),46.0,46,,,,,47.0,Period 2,-1.0,-2.127659574468085,46,C,2018-03-31T09:10 (9)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21280.0,30960.0,1838622960.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),50.0,50,,,,Y,50.0,Period 3,nan,nan,50,A,2018-04-06T08:36 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),48.0,48,,,,,50.0,Period 3,-2.0,-4.0,48,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21280.0,40420.0,1838632420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),47.0,47,,,,,50.0,Period 3,-3.0,-6.0,47,A,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,40576.0,1838632576.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),45.0,45,,,,,50.0,Period 3,-5.0,-10.0,45,A,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),56.0,56,,,,,53.0,EOT/ET/Followup,3.0,5.660377358490567,56,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21281.0,32760.0,1838711160.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),58.0,58,,,,,50.0,Period 3,8.0,16.0,58,A,2018-04-07T09:06 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21264.0,42420.0,1837252020.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-03-21T11:47 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,12.0,EOT/ET/Followup,4.0,33.33333333333333,16,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,35.0,SCREENING,21264.0,42420.0,1837252020.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,EOT/ET/Followup,nan,nan,119,NA,2018-03-21T11:47 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21266.0,30960.0,1837413360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,Period 1,nan,nan,113,B,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,113.0,Period 1,-5.0,-4.424778761061947,108,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21267.0,32760.0,1837501560.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),96.0,96,,,,,113.0,Period 1,-17.0,-15.04424778761062,96,B,2018-03-24T09:06 (2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21273.0,30960.0,1838018160.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,Y,108.0,Period 2,nan,nan,108,C,2018-03-30T08:36 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,108.0,Period 2,5.0,4.62962962962963,113,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,41.0,TREATMENT,21274.0,32760.0,1838106360.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,108.0,Period 2,-1.0,-0.9259259259259258,107,C,2018-03-31T09:06 (9)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21280.0,30960.0,1838622960.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,Y,100.0,Period 3,nan,nan,100,A,2018-04-06T08:36 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,100.0,Period 3,30.0,30.0,130,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,119.0,EOT/ET/Followup,-11.0,-9.243697478991598,108,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21281.0,32760.0,1838711160.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,100.0,Period 3,2.0,2.0,102,A,2018-04-07T09:06 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,46.0,SCREENING,21264.0,42420.0,1837252020.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-03-21T11:47 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.4,EOT/ET/Followup,-0.2,-0.5494505494505377,36.2,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,48.0,SCREENING,21264.0,41770.0,1837251370.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),67.4,67.4,,,,Y,67.4,EOT/ET/Followup,nan,nan,67.4,NA,2018-03-21T11:36 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,49.0,END OF TREATMENT,21281.0,39946.0,1838718346.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),68.0,68,,,,,67.4,EOT/ET/Followup,0.6,0.8902077151335227,68,A,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,nan,SCREENING,21280.0,46030.0,1838638030.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),22.1,22.1,,,,Y,22.1,EOT/ET/Followup,nan,nan,22.1,NA,2018-04-06T12:47 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21307.0,35038.0,1840959838.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),21.5,21.5,,,,,22.1,EOT/ET/Followup,-0.6,-2.714932126696839,21.5,B,2018-05-03T09:43 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,46720.0,1838638720.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-04-06T12:58 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21292.0,26580.0,1839655380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,C,2018-04-18T07:23 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21292.0,35880.0,1839664680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,73.0,Period 1,-1.0,-1.36986301369863,72,C,2018-04-18T09:58 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21293.0,28380.0,1839743580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,73.0,Period 1,3.0,4.10958904109589,76,C,2018-04-19T07:53 (2)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21299.0,26580.0,1840260180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,A,2018-04-25T07:23 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21299.0,35880.0,1840269480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,71.0,Period 2,5.0,7.042253521126761,76,A,2018-04-25T09:58 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21300.0,28380.0,1840348380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,71.0,Period 2,0.0,0.0,71,A,2018-04-26T07:53 (9)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21306.0,26580.0,1840864980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 3,nan,nan,79,B,2018-05-02T07:23 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21306.0,35880.0,1840874280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,79.0,Period 3,-13.0,-16.455696202531644,66,B,2018-05-02T09:58 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21307.0,34380.0,1840959180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,73.0,EOT/ET/Followup,-8.0,-10.95890410958904,65,B,2018-05-03T09:33 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21307.0,28380.0,1840953180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,79.0,Period 3,-17.0,-21.518987341772153,62,B,2018-05-03T07:53 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21280.0,46030.0,1838638030.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),168.5,168.5,,,,Y,168.5,EOT/ET/Followup,nan,nan,168.5,NA,2018-04-06T12:47 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21280.0,46720.0,1838638720.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-04-06T12:58 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21292.0,26580.0,1839655380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,C,2018-04-18T07:23 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21292.0,35880.0,1839664680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,,77.0,Period 1,-4.0,-5.194805194805195,73,C,2018-04-18T09:58 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21293.0,28380.0,1839743580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),81.0,81,,,,,77.0,Period 1,4.0,5.194805194805195,81,C,2018-04-19T07:53 (2)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21299.0,26580.0,1840260180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,A,2018-04-25T07:23 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21299.0,35880.0,1840269480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),58.0,58,,,,,66.0,Period 2,-8.0,-12.121212121212121,58,A,2018-04-25T09:58 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21300.0,28380.0,1840348380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),93.0,93,,,,,66.0,Period 2,27.0,40.909090909090914,93,A,2018-04-26T07:53 (9)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21306.0,26580.0,1840864980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,Period 3,nan,nan,60,B,2018-05-02T07:23 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21306.0,35880.0,1840874280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),64.0,64,,,,,60.0,Period 3,4.0,6.666666666666667,64,B,2018-05-02T09:58 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21307.0,34380.0,1840959180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),69.0,69,,,,,59.0,EOT/ET/Followup,10.0,16.94915254237288,69,B,2018-05-03T09:33 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21307.0,28380.0,1840953180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),62.0,62,,,,,60.0,Period 3,2.0,3.3333333333333335,62,B,2018-05-03T07:53 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21280.0,46720.0,1838638720.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-06T12:58 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21307.0,34380.0,1840959180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),13.0,13,,,,,12.0,EOT/ET/Followup,1.0,8.333333333333332,13,B,2018-05-03T09:33 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21280.0,46720.0,1838638720.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,EOT/ET/Followup,nan,nan,114,NA,2018-04-06T12:58 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21292.0,26580.0,1839655380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 1,nan,nan,115,C,2018-04-18T07:23 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21292.0,35880.0,1839664680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,115.0,Period 1,2.0,1.7391304347826086,117,C,2018-04-18T09:58 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21293.0,28380.0,1839743580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,115.0,Period 1,-2.0,-1.7391304347826086,113,C,2018-04-19T07:53 (2)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21299.0,26580.0,1840260180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 2,nan,nan,111,A,2018-04-25T07:23 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21299.0,35880.0,1840269480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,111.0,Period 2,0.0,0.0,111,A,2018-04-25T09:58 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21300.0,28380.0,1840348380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,111.0,Period 2,0.0,0.0,111,A,2018-04-26T07:53 (9)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21306.0,26580.0,1840864980.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,Period 3,nan,nan,112,B,2018-05-02T07:23 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21306.0,35880.0,1840874280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,112.0,Period 3,7.0,6.25,119,B,2018-05-02T09:58 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21307.0,34380.0,1840959180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,114.0,EOT/ET/Followup,-2.0,-1.7543859649122806,112,B,2018-05-03T09:33 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21307.0,28380.0,1840953180.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,112.0,Period 3,4.0,3.571428571428571,116,B,2018-05-03T07:53 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21280.0,46720.0,1838638720.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-04-06T12:58 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21307.0,34380.0,1840959180.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,35.7,EOT/ET/Followup,0.5,1.4005602240896358,36.2,B,2018-05-03T09:33 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21280.0,46030.0,1838638030.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),62.8,62.8,,,,Y,62.8,EOT/ET/Followup,nan,nan,62.8,NA,2018-04-06T12:47 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21307.0,35038.0,1840959838.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),61.0,61,,,,,62.8,EOT/ET/Followup,-1.8,-2.866242038216556,61,B,2018-05-03T09:43 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,nan,SCREENING,21280.0,45671.0,1838637671.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.5,26.5,,,,Y,26.5,EOT/ET/Followup,nan,nan,26.5,NA,2018-04-06T12:41 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,nan,END OF TREATMENT,21307.0,35207.0,1840960007.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),26.2,26.2,,,,,26.5,EOT/ET/Followup,-0.3,-1.1320754716981158,26.2,B,2018-05-03T09:46 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,46260.0,1838638260.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,EOT/ET/Followup,nan,nan,80,NA,2018-04-06T12:51 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21292.0,26700.0,1839655500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,A,2018-04-18T07:25 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21292.0,36000.0,1839664800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,73.0,Period 1,5.0,6.8493150684931505,78,A,2018-04-18T10:00 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21293.0,28500.0,1839743700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,73.0,Period 1,-1.0,-1.36986301369863,72,A,2018-04-19T07:55 (2)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21299.0,26700.0,1840260300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,C,2018-04-25T07:25 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21299.0,36000.0,1840269600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,73.0,Period 2,1.0,1.36986301369863,74,C,2018-04-25T10:00 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21300.0,28500.0,1840348500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,73.0,Period 2,-9.0,-12.32876712328767,64,C,2018-04-26T07:55 (9)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21306.0,26700.0,1840865100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 3,nan,nan,72,B,2018-05-02T07:25 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21306.0,36000.0,1840874400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,72.0,Period 3,0.0,0.0,72,B,2018-05-02T10:00 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,80.0,EOT/ET/Followup,-14.0,-17.5,66,B,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21307.0,28500.0,1840953300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,72.0,Period 3,-1.0,-1.3888888888888888,71,B,2018-05-03T07:55 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21280.0,45671.0,1838637671.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),188.0,188,,,,Y,188.0,EOT/ET/Followup,nan,nan,188,NA,2018-04-06T12:41 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21280.0,46260.0,1838638260.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-04-06T12:51 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21292.0,26700.0,1839655500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 1,nan,nan,65,A,2018-04-18T07:25 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21292.0,36000.0,1839664800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),66.0,66,,,,,65.0,Period 1,1.0,1.5384615384615385,66,A,2018-04-18T10:00 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21293.0,28500.0,1839743700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,65.0,Period 1,-2.0,-3.076923076923077,63,A,2018-04-19T07:55 (2)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21299.0,26700.0,1840260300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,C,2018-04-25T07:25 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21299.0,36000.0,1840269600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,,66.0,Period 2,0.0,0.0,66,C,2018-04-25T10:00 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21300.0,28500.0,1840348500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),78.0,78,,,,,66.0,Period 2,12.0,18.181818181818183,78,C,2018-04-26T07:55 (9)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21306.0,26700.0,1840865100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 3,nan,nan,65,B,2018-05-02T07:25 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21306.0,36000.0,1840874400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,65.0,Period 3,-2.0,-3.076923076923077,63,B,2018-05-02T10:00 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),68.0,68,,,,,73.0,EOT/ET/Followup,-5.0,-6.8493150684931505,68,B,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21307.0,28500.0,1840953300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,,65.0,Period 3,6.0,9.230769230769232,71,B,2018-05-03T07:55 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21280.0,46260.0,1838638260.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-06T12:51 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,25.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),15.0,15,,,,,12.0,EOT/ET/Followup,3.0,25.0,15,B,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21280.0,46260.0,1838638260.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,EOT/ET/Followup,nan,nan,121,NA,2018-04-06T12:51 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21292.0,26700.0,1839655500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 1,nan,nan,111,A,2018-04-18T07:25 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21292.0,36000.0,1839664800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,111.0,Period 1,0.0,0.0,111,A,2018-04-18T10:00 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21293.0,28500.0,1839743700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,111.0,Period 1,-5.0,-4.504504504504505,106,A,2018-04-19T07:55 (2)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21299.0,26700.0,1840260300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,Y,106.0,Period 2,nan,nan,106,C,2018-04-25T07:25 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21299.0,36000.0,1840269600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,106.0,Period 2,0.0,0.0,106,C,2018-04-25T10:00 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21300.0,28500.0,1840348500.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,106.0,Period 2,5.0,4.716981132075472,111,C,2018-04-26T07:55 (9)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,33.0,TREATMENT,21306.0,26700.0,1840865100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,Y,107.0,Period 3,nan,nan,107,B,2018-05-02T07:25 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21306.0,36000.0,1840874400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,107.0,Period 3,1.0,0.9345794392523363,108,B,2018-05-02T10:00 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,,121.0,EOT/ET/Followup,-21.0,-17.355371900826448,100,B,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21307.0,28500.0,1840953300.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,107.0,Period 3,3.0,2.803738317757009,110,B,2018-05-03T07:55 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21280.0,46260.0,1838638260.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.0,36,,,,Y,36.0,EOT/ET/Followup,nan,nan,36,NA,2018-04-06T12:51 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.6,36.6,,,,,36.0,EOT/ET/Followup,0.6,1.6666666666666705,36.6,B,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21280.0,45671.0,1838637671.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),93.8,93.8,,,,Y,93.8,EOT/ET/Followup,nan,nan,93.8,NA,2018-04-06T12:41 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21307.0,35207.0,1840960007.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),92.5,92.5,,,,,93.8,EOT/ET/Followup,-1.3,-1.3859275053304874,92.5,B,2018-05-03T09:46 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,nan,SCREENING,21280.0,46908.0,1838638908.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.5,24.5,,,,Y,24.5,EOT/ET/Followup,nan,nan,24.5,NA,2018-04-06T13:01 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21307.0,35562.0,1840960362.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),24.2,24.2,,,,,24.5,EOT/ET/Followup,-0.3,-1.2244897959183703,24.2,C,2018-05-03T09:52 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,48582.0,1838640582.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,EOT/ET/Followup,nan,nan,76,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21292.0,26940.0,1839655740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 1,nan,nan,74,A,2018-04-18T07:29 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21292.0,36240.0,1839665040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,74.0,Period 1,8.0,10.81081081081081,82,A,2018-04-18T10:04 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21293.0,28740.0,1839743940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,74.0,Period 1,-2.0,-2.7027027027027026,72,A,2018-04-19T07:59 (2)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21299.0,26940.0,1840260540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 2,nan,nan,74,B,2018-04-25T07:29 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21299.0,36240.0,1840269840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,,74.0,Period 2,4.0,5.405405405405405,78,B,2018-04-25T10:04 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21300.0,28740.0,1840348740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,74.0,Period 2,2.0,2.7027027027027026,76,B,2018-04-26T07:59 (9)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21306.0,26940.0,1840865340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,Period 3,nan,nan,68,C,2018-05-02T07:29 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21306.0,36240.0,1840874640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,68.0,Period 3,7.0,10.294117647058822,75,C,2018-05-02T10:04 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21307.0,34740.0,1840959540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,76.0,EOT/ET/Followup,-11.0,-14.473684210526317,65,C,2018-05-03T09:39 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21307.0,28740.0,1840953540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,68.0,Period 3,0.0,0.0,68,C,2018-05-03T07:59 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21280.0,46908.0,1838638908.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),173.0,173,,,,Y,173.0,EOT/ET/Followup,nan,nan,173,NA,2018-04-06T13:01 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21280.0,48582.0,1838640582.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21292.0,26940.0,1839655740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,Period 1,nan,nan,84,A,2018-04-18T07:29 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21292.0,36240.0,1839665040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,,84.0,Period 1,-11.0,-13.095238095238097,73,A,2018-04-18T10:04 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21293.0,28740.0,1839743940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),86.0,86,,,,,84.0,Period 1,2.0,2.380952380952381,86,A,2018-04-19T07:59 (2)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,17.0,TREATMENT,21299.0,26940.0,1840260540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,B,2018-04-25T07:29 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21299.0,36240.0,1840269840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,73.0,Period 2,-9.0,-12.32876712328767,64,B,2018-04-25T10:04 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21300.0,28740.0,1840348740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),88.0,88,,,,,73.0,Period 2,15.0,20.54794520547945,88,B,2018-04-26T07:59 (9)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21306.0,26940.0,1840865340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),86.0,86,,,,Y,86.0,Period 3,nan,nan,86,C,2018-05-02T07:29 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21306.0,36240.0,1840874640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),71.0,71,,,,,86.0,Period 3,-15.0,-17.441860465116278,71,C,2018-05-02T10:04 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21307.0,34740.0,1840959540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),77.0,77,,,,,75.0,EOT/ET/Followup,2.0,2.666666666666667,77,C,2018-05-03T09:39 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21307.0,28740.0,1840953540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),81.0,81,,,,,86.0,Period 3,-5.0,-5.813953488372093,81,C,2018-05-03T07:59 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21280.0,48582.0,1838640582.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21307.0,34740.0,1840959540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),15.0,15,,,,,14.0,EOT/ET/Followup,1.0,7.142857142857142,15,C,2018-05-03T09:39 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21280.0,48582.0,1838640582.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,Y,132.0,EOT/ET/Followup,nan,nan,132,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21292.0,26940.0,1839655740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,Period 1,nan,nan,120,A,2018-04-18T07:29 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21292.0,36240.0,1839665040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,120.0,Period 1,3.0,2.5,123,A,2018-04-18T10:04 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21293.0,28740.0,1839743940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,120.0,Period 1,-3.0,-2.5,117,A,2018-04-19T07:59 (2)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21299.0,26940.0,1840260540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,Y,134.0,Period 2,nan,nan,134,B,2018-04-25T07:29 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21299.0,36240.0,1840269840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,134.0,Period 2,-4.0,-2.9850746268656714,130,B,2018-04-25T10:04 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,TREATMENT,21300.0,28740.0,1840348740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,134.0,Period 2,-19.0,-14.17910447761194,115,B,2018-04-26T07:59 (9)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21306.0,26940.0,1840865340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,Y,127.0,Period 3,nan,nan,127,C,2018-05-02T07:29 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21306.0,36240.0,1840874640.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,127.0,Period 3,-13.0,-10.236220472440944,114,C,2018-05-02T10:04 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21307.0,34740.0,1840959540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,132.0,EOT/ET/Followup,-11.0,-8.333333333333332,121,C,2018-05-03T09:39 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21307.0,28740.0,1840953540.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,127.0,Period 3,-2.0,-1.574803149606299,125,C,2018-05-03T07:59 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21280.0,48582.0,1838640582.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21307.0,34740.0,1840959540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.2,36.2,,,,,36.3,EOT/ET/Followup,-0.1,-0.2754820936638962,36.2,C,2018-05-03T09:39 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21280.0,46908.0,1838638908.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),73.2,73.2,,,,Y,73.2,EOT/ET/Followup,nan,nan,73.2,NA,2018-04-06T13:01 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21307.0,35562.0,1840960362.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),72.5,72.5,,,,,73.2,EOT/ET/Followup,-0.7,-0.9562841530054683,72.5,C,2018-05-03T09:52 (16)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21280.0,46430.0,1838638430.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.4,25.4,,,,Y,25.4,EOT/ET/Followup,nan,nan,25.4,NA,2018-04-06T12:53 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21300.0,34784.0,1840354784.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),25.2,25.2,,,,,25.4,EOT/ET/Followup,-0.2,-0.7874015748031469,25.2,E,2018-04-26T09:39 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,48032.0,1838640032.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,EOT/ET/Followup,nan,nan,73,NA,2018-04-06T13:20 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,Y,62.0,Period 1,nan,nan,62,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,34920.0,1839663720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,62.0,Period 1,-3.0,-4.838709677419355,59,D,2018-04-18T09:42 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21293.0,27420.0,1839742620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,62.0,Period 1,13.0,20.967741935483872,75,D,2018-04-19T07:37 (2)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,25620.0,1840259220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21299.0,34920.0,1840268520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,73.0,Period 2,4.0,5.47945205479452,77,E,2018-04-25T09:42 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,73.0,EOT/ET/Followup,0.0,0.0,73,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21300.0,27420.0,1840347420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,73.0,Period 2,-4.0,-5.47945205479452,69,E,2018-04-26T07:37 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21280.0,46430.0,1838638430.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),186.5,186.5,,,,Y,186.5,EOT/ET/Followup,nan,nan,186.5,NA,2018-04-06T12:53 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21280.0,48032.0,1838640032.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),51.0,51,,,,Y,51.0,EOT/ET/Followup,nan,nan,51,NA,2018-04-06T13:20 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,Period 1,nan,nan,60,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21292.0,34920.0,1839663720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),51.0,51,,,,,60.0,Period 1,-9.0,-15.0,51,D,2018-04-18T09:42 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21293.0,27420.0,1839742620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),58.0,58,,,,,60.0,Period 1,-2.0,-3.3333333333333335,58,D,2018-04-19T07:37 (2)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21299.0,25620.0,1840259220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),53.0,53,,,,Y,53.0,Period 2,nan,nan,53,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21299.0,34920.0,1840268520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),42.0,42,,,,,53.0,Period 2,-11.0,-20.754716981132077,42,E,2018-04-25T09:42 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,35040.0,1840268640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),44.0,44,,,,,53.0,Period 2,-9.0,-16.9811320754717,44,E,2018-04-25T09:44 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,35160.0,1840268760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),48.0,48,,,,,53.0,Period 2,-5.0,-9.433962264150944,48,E,2018-04-25T09:46 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,,51.0,EOT/ET/Followup,14.0,27.450980392156865,65,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,TREATMENT,21300.0,27420.0,1840347420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),78.0,78,,,,,53.0,Period 2,25.0,47.16981132075472,78,E,2018-04-26T07:37 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21280.0,48032.0,1838640032.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-06T13:20 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,12.0,EOT/ET/Followup,0.0,0.0,12,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,22.0,SCREENING,21280.0,48032.0,1838640032.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,EOT/ET/Followup,nan,nan,129,NA,2018-04-06T13:20 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,Y,119.0,Period 1,nan,nan,119,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21292.0,34920.0,1839663720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,119.0,Period 1,12.0,10.084033613445378,131,D,2018-04-18T09:42 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21293.0,27420.0,1839742620.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,119.0,Period 1,10.0,8.403361344537815,129,D,2018-04-19T07:37 (2)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21299.0,25620.0,1840259220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,Y,124.0,Period 2,nan,nan,124,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21299.0,34920.0,1840268520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,124.0,Period 2,-1.0,-0.8064516129032258,123,E,2018-04-25T09:42 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,,129.0,EOT/ET/Followup,3.0,2.3255813953488373,132,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21300.0,27420.0,1840347420.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,124.0,Period 2,-8.0,-6.451612903225806,116,E,2018-04-26T07:37 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21280.0,48032.0,1838640032.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.5,36.5,,,,Y,36.5,EOT/ET/Followup,nan,nan,36.5,NA,2018-04-06T13:20 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.6,36.6,,,,,36.5,EOT/ET/Followup,0.1,0.27397260273972995,36.6,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,32.0,SCREENING,21280.0,46430.0,1838638430.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),88.2,88.2,,,,Y,88.2,EOT/ET/Followup,nan,nan,88.2,NA,2018-04-06T12:53 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,END OF TREATMENT,21300.0,34784.0,1840354784.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),87.5,87.5,,,,,88.2,EOT/ET/Followup,-0.7,-0.7936507936507969,87.5,E,2018-04-26T09:39 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21280.0,50713.0,1838642713.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),18.3,18.3,,,,Y,18.3,EOT/ET/Followup,nan,nan,18.3,NA,2018-04-06T14:05 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21300.0,34889.0,1840354889.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),18.5,18.5,,,,,18.3,EOT/ET/Followup,0.2,1.092896174863384,18.5,D,2018-04-26T09:41 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,51420.0,1838643420.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,Y,66.0,EOT/ET/Followup,nan,nan,66,NA,2018-04-06T14:17 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,Y,76.0,Period 1,nan,nan,76,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,35040.0,1839663840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,76.0,Period 1,-12.0,-15.789473684210526,64,E,2018-04-18T09:44 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21293.0,27540.0,1839742740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,76.0,Period 1,-1.0,-1.3157894736842104,75,E,2018-04-19T07:39 (2)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,25740.0,1840259340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),87.0,87,,,,Y,87.0,Period 2,nan,nan,87,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21299.0,35040.0,1840268640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,87.0,Period 2,-14.0,-16.091954022988507,73,D,2018-04-25T09:44 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21300.0,34260.0,1840354260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,66.0,EOT/ET/Followup,7.0,10.606060606060606,73,D,2018-04-26T09:31 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21300.0,27540.0,1840347540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),76.0,76,,,,,87.0,Period 2,-11.0,-12.643678160919542,76,D,2018-04-26T07:39 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21280.0,50713.0,1838642713.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),178.0,178,,,,Y,178.0,EOT/ET/Followup,nan,nan,178,NA,2018-04-06T14:05 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21280.0,51420.0,1838643420.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),76.0,76,,,,Y,76.0,EOT/ET/Followup,nan,nan,76,NA,2018-04-06T14:17 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 1,nan,nan,75,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21292.0,35040.0,1839663840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),79.0,79,,,,,75.0,Period 1,4.0,5.333333333333334,79,E,2018-04-18T09:44 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21293.0,27540.0,1839742740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),79.0,79,,,,,75.0,Period 1,4.0,5.333333333333334,79,E,2018-04-19T07:39 (2)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21299.0,25740.0,1840259340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),85.0,85,,,,Y,85.0,Period 2,nan,nan,85,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21299.0,35040.0,1840268640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),89.0,89,,,,,85.0,Period 2,4.0,4.705882352941177,89,D,2018-04-25T09:44 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21300.0,34260.0,1840354260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),92.0,92,,,,,76.0,EOT/ET/Followup,16.0,21.052631578947366,92,D,2018-04-26T09:31 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21300.0,27540.0,1840347540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),89.0,89,,,,,85.0,Period 2,4.0,4.705882352941177,89,D,2018-04-26T07:39 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21280.0,51420.0,1838643420.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-04-06T14:17 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21300.0,34260.0,1840354260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,D,2018-04-26T09:31 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21280.0,51420.0,1838643420.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,Y,104.0,EOT/ET/Followup,nan,nan,104,NA,2018-04-06T14:17 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,Period 1,nan,nan,133,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21292.0,35040.0,1839663840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,133.0,Period 1,-7.0,-5.263157894736842,126,E,2018-04-18T09:44 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21293.0,27540.0,1839742740.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,133.0,Period 1,-18.0,-13.533834586466165,115,E,2018-04-19T07:39 (2)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21299.0,25740.0,1840259340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,Y,137.0,Period 2,nan,nan,137,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21299.0,35040.0,1840268640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,137.0,Period 2,-19.0,-13.86861313868613,118,D,2018-04-25T09:44 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21300.0,34260.0,1840354260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,104.0,EOT/ET/Followup,13.0,12.5,117,D,2018-04-26T09:31 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21300.0,27540.0,1840347540.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,137.0,Period 2,-17.0,-12.408759124087592,120,D,2018-04-26T07:39 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21280.0,51420.0,1838643420.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-04-06T14:17 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21300.0,34260.0,1840354260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),35.9,35.9,,,,,36.6,EOT/ET/Followup,-0.7,-1.9125683060109366,35.9,D,2018-04-26T09:31 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21280.0,50713.0,1838642713.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),58.0,58,,,,Y,58.0,EOT/ET/Followup,nan,nan,58,NA,2018-04-06T14:05 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21300.0,34889.0,1840354889.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),58.5,58.5,,,,,58.0,EOT/ET/Followup,0.5,0.8620689655172413,58.5,D,2018-04-26T09:41 (9)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21280.0,50180.0,1838642180.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),23.5,23.5,,,,Y,23.5,EOT/ET/Followup,nan,nan,23.5,NA,2018-04-06T13:56 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,50955.0,1838642955.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,Y,57.0,EOT/ET/Followup,nan,nan,57,NA,2018-04-06T14:09 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,Y,64.0,Period 1,nan,nan,64,E,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,35280.0,1839664080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,64.0,Period 1,4.0,6.25,68,E,2018-04-18T09:48 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21293.0,27780.0,1839742980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,64.0,Period 1,-6.0,-9.375,58,E,2018-04-19T07:43 (2)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,5.0,SCREENING,21280.0,50180.0,1838642180.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),186.0,186,,,,Y,186.0,EOT/ET/Followup,nan,nan,186,NA,2018-04-06T13:56 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,6.0,SCREENING,21280.0,50955.0,1838642955.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),60.0,60,,,,Y,60.0,EOT/ET/Followup,nan,nan,60,NA,2018-04-06T14:09 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,Y,73.0,Period 1,nan,nan,73,E,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21292.0,35280.0,1839664080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,,73.0,Period 1,-9.0,-12.32876712328767,64,E,2018-04-18T09:48 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21293.0,27780.0,1839742980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,,73.0,Period 1,-12.0,-16.43835616438356,61,E,2018-04-19T07:43 (2)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21280.0,50955.0,1838642955.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-06T14:09 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,11.0,SCREENING,21280.0,50955.0,1838642955.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,EOT/ET/Followup,nan,nan,122,NA,2018-04-06T14:09 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,Y,132.0,Period 1,nan,nan,132,E,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21292.0,35280.0,1839664080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,,132.0,Period 1,-18.0,-13.636363636363635,114,E,2018-04-18T09:48 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21293.0,27780.0,1839742980.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,132.0,Period 1,-11.0,-8.333333333333332,121,E,2018-04-19T07:43 (2)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,15.0,SCREENING,21280.0,50955.0,1838642955.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.4,35.4,,,,Y,35.4,EOT/ET/Followup,nan,nan,35.4,NA,2018-04-06T14:09 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,16.0,SCREENING,21280.0,50180.0,1838642180.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),81.2,81.2,,,,Y,81.2,EOT/ET/Followup,nan,nan,81.2,NA,2018-04-06T13:56 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21280.0,53697.0,1838645697.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.6,28.6,,,,Y,28.6,EOT/ET/Followup,nan,nan,28.6,NA,2018-04-06T14:54 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21300.0,35409.0,1840355409.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),28.2,28.2,,,,,28.6,EOT/ET/Followup,-0.4,-1.398601398601406,28.2,D,2018-04-26T09:50 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,55950.0,1838647950.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,EOT/ET/Followup,nan,nan,71,NA,2018-04-06T15:32 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 1,nan,nan,79,E,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,35640.0,1839664440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,79.0,Period 1,-6.0,-7.59493670886076,73,E,2018-04-18T09:54 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21293.0,28140.0,1839743340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,79.0,Period 1,-2.0,-2.5316455696202533,77,E,2018-04-19T07:49 (2)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 2,nan,nan,74,D,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21299.0,35640.0,1840269240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,74.0,Period 2,-6.0,-8.108108108108109,68,D,2018-04-25T09:54 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21300.0,34440.0,1840354440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,71.0,EOT/ET/Followup,8.0,11.267605633802818,79,D,2018-04-26T09:34 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21300.0,28140.0,1840348140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,74.0,Period 2,1.0,1.3513513513513513,75,D,2018-04-26T07:49 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21280.0,53697.0,1838645697.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),174.5,174.5,,,,Y,174.5,EOT/ET/Followup,nan,nan,174.5,NA,2018-04-06T14:54 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21280.0,55950.0,1838647950.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-06T15:32 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),64.0,64,,,,Y,64.0,Period 1,nan,nan,64,E,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21292.0,35640.0,1839664440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,64.0,Period 1,-1.0,-1.5625,63,E,2018-04-18T09:54 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21293.0,28140.0,1839743340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,64.0,Period 1,3.0,4.6875,67,E,2018-04-19T07:49 (2)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,D,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21299.0,35640.0,1840269240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,65.0,Period 2,4.0,6.153846153846154,69,D,2018-04-25T09:54 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21300.0,34440.0,1840354440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,75.0,EOT/ET/Followup,-8.0,-10.666666666666668,67,D,2018-04-26T09:34 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21300.0,28140.0,1840348140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),79.0,79,,,,,65.0,Period 2,14.0,21.53846153846154,79,D,2018-04-26T07:49 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21280.0,55950.0,1838647950.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-06T15:32 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21300.0,34440.0,1840354440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,14.0,EOT/ET/Followup,2.0,14.285714285714285,16,D,2018-04-26T09:34 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21280.0,55950.0,1838647950.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,Y,124.0,EOT/ET/Followup,nan,nan,124,NA,2018-04-06T15:32 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 1,nan,nan,122,E,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21292.0,35640.0,1839664440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,122.0,Period 1,-2.0,-1.639344262295082,120,E,2018-04-18T09:54 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21293.0,28140.0,1839743340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,122.0,Period 1,-6.0,-4.918032786885246,116,E,2018-04-19T07:49 (2)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 2,nan,nan,117,D,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21299.0,35640.0,1840269240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,117.0,Period 2,5.0,4.273504273504273,122,D,2018-04-25T09:54 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21300.0,34440.0,1840354440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,124.0,EOT/ET/Followup,6.0,4.838709677419355,130,D,2018-04-26T09:34 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21300.0,28140.0,1840348140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),134.0,134,,,,,117.0,Period 2,17.0,14.529914529914532,134,D,2018-04-26T07:49 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21280.0,55950.0,1838647950.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.4,36.4,,,,Y,36.4,EOT/ET/Followup,nan,nan,36.4,NA,2018-04-06T15:32 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21300.0,34440.0,1840354440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.4,36.4,,,,,36.4,EOT/ET/Followup,0.0,0.0,36.4,D,2018-04-26T09:34 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21280.0,53697.0,1838645697.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),87.2,87.2,,,,Y,87.2,EOT/ET/Followup,nan,nan,87.2,NA,2018-04-06T14:54 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21300.0,35409.0,1840355409.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),86.0,86,,,,,87.2,EOT/ET/Followup,-1.2,-1.376146788990829,86,D,2018-04-26T09:50 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21283.0,47237.0,1838898437.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.4,24.4,,,,Y,24.4,EOT/ET/Followup,nan,nan,24.4,NA,2018-04-09T13:07 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21300.0,35237.0,1840355237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),24.2,24.2,,,,,24.4,EOT/ET/Followup,-0.2,-0.8196721311475381,24.2,E,2018-04-26T09:47 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21283.0,47925.0,1838899125.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,EOT/ET/Followup,nan,nan,78,NA,2018-04-09T13:18 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25860.0,1839654660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,D,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,35160.0,1839663960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),69.0,69,,,,,78.0,Period 1,-9.0,-11.538461538461538,69,D,2018-04-18T09:46 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21293.0,27660.0,1839742860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,78.0,Period 1,-7.0,-8.974358974358974,71,D,2018-04-19T07:41 (2)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,25860.0,1840259460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 2,nan,nan,77,E,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21299.0,35160.0,1840268760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,77.0,Period 2,0.0,0.0,77,E,2018-04-25T09:46 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21300.0,33960.0,1840353960.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,,78.0,EOT/ET/Followup,7.0,8.974358974358974,85,E,2018-04-26T09:26 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21300.0,27660.0,1840347660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,77.0,Period 2,-2.0,-2.5974025974025974,75,E,2018-04-26T07:41 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21283.0,47237.0,1838898437.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),175.5,175.5,,,,Y,175.5,EOT/ET/Followup,nan,nan,175.5,NA,2018-04-09T13:07 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21283.0,47925.0,1838899125.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),123.0,123,,,,,nan,EOT/ET/Followup,nan,nan,123,NA,2018-04-09T13:18 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,11.0,SCREENING,21283.0,48075.0,1838899275.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),99.0,99,,,,Y,99.0,EOT/ET/Followup,nan,nan,99,NA,2018-04-09T13:21 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21292.0,25860.0,1839654660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),105.0,105,,,,,nan,Period 1,nan,nan,105,D,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21292.0,25950.0,1839654750.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,,nan,Period 1,nan,nan,84,D,2018-04-18T07:12 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21292.0,26040.0,1839654840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),89.0,89,,,,Y,89.0,Period 1,nan,nan,89,D,2018-04-18T07:14 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21292.0,35160.0,1839663960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),82.0,82,,,,,89.0,Period 1,-7.0,-7.865168539325842,82,D,2018-04-18T09:46 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21293.0,27660.0,1839742860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),78.0,78,,,,,89.0,Period 1,-11.0,-12.359550561797752,78,D,2018-04-19T07:41 (2)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,25860.0,1840259460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,E,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,TREATMENT,21299.0,35160.0,1840268760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,72.0,Period 2,-5.0,-6.944444444444445,67,E,2018-04-25T09:46 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,END OF TREATMENT,21300.0,33960.0,1840353960.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),85.0,85,,,,,99.0,EOT/ET/Followup,-14.0,-14.14141414141414,85,E,2018-04-26T09:26 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,TREATMENT,21300.0,27660.0,1840347660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),89.0,89,,,,,72.0,Period 2,17.0,23.61111111111111,89,E,2018-04-26T07:41 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,21.0,SCREENING,21283.0,47925.0,1838899125.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-09T13:18 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,END OF TREATMENT,21300.0,33960.0,1840353960.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,E,2018-04-26T09:26 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,23.0,SCREENING,21283.0,47925.0,1838899125.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,Y,133.0,EOT/ET/Followup,nan,nan,133,NA,2018-04-09T13:18 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21292.0,25860.0,1839654660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,Y,132.0,Period 1,nan,nan,132,D,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21292.0,35160.0,1839663960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,132.0,Period 1,-14.0,-10.606060606060606,118,D,2018-04-18T09:46 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21293.0,27660.0,1839742860.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,132.0,Period 1,-3.0,-2.272727272727273,129,D,2018-04-19T07:41 (2)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21299.0,25860.0,1840259460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 2,nan,nan,115,E,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21299.0,35160.0,1840268760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,115.0,Period 2,7.0,6.086956521739131,122,E,2018-04-25T09:46 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21300.0,33960.0,1840353960.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,,133.0,EOT/ET/Followup,-10.0,-7.518796992481203,123,E,2018-04-26T09:26 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21300.0,27660.0,1840347660.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,115.0,Period 2,5.0,4.3478260869565215,120,E,2018-04-26T07:41 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21283.0,47925.0,1838899125.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.9,35.9,,,,Y,35.9,EOT/ET/Followup,nan,nan,35.9,NA,2018-04-09T13:18 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,END OF TREATMENT,21300.0,33960.0,1840353960.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.5,36.5,,,,,35.9,EOT/ET/Followup,0.6,1.671309192200561,36.5,E,2018-04-26T09:26 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,33.0,SCREENING,21283.0,47237.0,1838898437.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-09T13:07 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,END OF TREATMENT,21300.0,35237.0,1840355237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),74.5,74.5,,,,,75.0,EOT/ET/Followup,-0.5,-0.6666666666666667,74.5,E,2018-04-26T09:47 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21279.0,40443.0,1838546043.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),22.1,22.1,,,,Y,22.1,EOT/ET/Followup,nan,nan,22.1,NA,2018-04-05T11:14 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21300.0,35013.0,1840355013.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),22.0,22.0,,,,,22.1,EOT/ET/Followup,-0.1,-0.4524886877828118,22.0,E,2018-04-26T09:43 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21279.0,41040.0,1838546640.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,EOT/ET/Followup,nan,nan,68,NA,2018-04-05T11:24 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,26100.0,1839654900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,D,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,35400.0,1839664200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,78.0,Period 1,-16.0,-20.51282051282051,62,D,2018-04-18T09:50 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21293.0,27900.0,1839743100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,78.0,Period 1,-3.0,-3.8461538461538463,75,D,2018-04-19T07:45 (2)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,E,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21299.0,35400.0,1840269000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,71.0,Period 2,11.0,15.492957746478872,82,E,2018-04-25T09:50 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,68.0,EOT/ET/Followup,-1.0,-1.4705882352941175,67,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21300.0,27900.0,1840347900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,71.0,Period 2,8.0,11.267605633802818,79,E,2018-04-26T07:45 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21279.0,40443.0,1838546043.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),161.0,161,,,,Y,161.0,EOT/ET/Followup,nan,nan,161,NA,2018-04-05T11:14 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21279.0,41040.0,1838546640.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-04-05T11:24 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21292.0,26100.0,1839654900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,Period 1,nan,nan,54,D,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21292.0,35400.0,1839664200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,54.0,Period 1,9.0,16.666666666666664,63,D,2018-04-18T09:50 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21293.0,27900.0,1839743100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),47.0,47,,,,,54.0,Period 1,-7.0,-12.962962962962962,47,D,2018-04-19T07:45 (2)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21293.0,27960.0,1839743160.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),56.0,56,,,,,54.0,Period 1,2.0,3.7037037037037033,56,D,2018-04-19T07:46 (2)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21293.0,28020.0,1839743220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),56.0,56,,,,,54.0,Period 1,2.0,3.7037037037037033,56,D,2018-04-19T07:47 (2)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),51.0,51,,,,Y,51.0,Period 2,nan,nan,51,E,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,35400.0,1840269000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),51.0,51,,,,,51.0,Period 2,0.0,0.0,51,E,2018-04-25T09:50 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,,65.0,EOT/ET/Followup,-3.0,-4.615384615384616,62,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,TREATMENT,21300.0,27900.0,1840347900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,,51.0,Period 2,3.0,5.88235294117647,54,E,2018-04-26T07:45 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21279.0,41040.0,1838546640.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-05T11:24 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,22.0,SCREENING,21279.0,41040.0,1838546640.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-04-05T11:24 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21292.0,26100.0,1839654900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,Period 1,nan,nan,129,D,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21292.0,35400.0,1839664200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,129.0,Period 1,-17.0,-13.178294573643413,112,D,2018-04-18T09:50 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21293.0,27900.0,1839743100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,129.0,Period 1,-3.0,-2.3255813953488373,126,D,2018-04-19T07:45 (2)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,Period 2,nan,nan,120,E,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21299.0,35400.0,1840269000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,,120.0,Period 2,9.0,7.5,129,E,2018-04-25T09:50 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,118.0,EOT/ET/Followup,3.0,2.5423728813559325,121,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21300.0,27900.0,1840347900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),133.0,133,,,,,120.0,Period 2,13.0,10.833333333333334,133,E,2018-04-26T07:45 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21279.0,41040.0,1838546640.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.7,35.7,,,,Y,35.7,EOT/ET/Followup,nan,nan,35.7,NA,2018-04-05T11:24 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21300.0,34380.0,1840354380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.3,36.3,,,,,35.7,EOT/ET/Followup,0.6,1.680672268907547,36.3,E,2018-04-26T09:33 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,32.0,SCREENING,21279.0,40443.0,1838546043.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),57.4,57.4,,,,Y,57.4,EOT/ET/Followup,nan,nan,57.4,NA,2018-04-05T11:14 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,END OF TREATMENT,21300.0,35013.0,1840355013.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),57.0,57,,,,,57.4,EOT/ET/Followup,-0.4,-0.6968641114982554,57,E,2018-04-26T09:43 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21279.0,39512.0,1838545112.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),26.6,26.6,,,,Y,26.6,EOT/ET/Followup,nan,nan,26.6,NA,2018-04-05T10:58 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21300.0,34652.0,1840354652.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),25.8,25.8,,,,,26.6,EOT/ET/Followup,-0.8,-3.0075187969924837,25.8,D,2018-04-26T09:37 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21279.0,40200.0,1838545800.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,EOT/ET/Followup,nan,nan,72,NA,2018-04-05T11:10 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,E,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,34800.0,1839663600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,57.0,Period 1,17.0,29.82456140350877,74,E,2018-04-18T09:40 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21293.0,27300.0,1839742500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,57.0,Period 1,8.0,14.035087719298245,65,E,2018-04-19T07:35 (2)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,25500.0,1840259100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,Period 2,nan,nan,63,D,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21299.0,34800.0,1840268400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,63.0,Period 2,9.0,14.285714285714285,72,D,2018-04-25T09:40 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21300.0,34237.0,1840354237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,72.0,EOT/ET/Followup,-7.0,-9.722222222222223,65,D,2018-04-26T09:30 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21300.0,27300.0,1840347300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,,63.0,Period 2,14.0,22.22222222222222,77,D,2018-04-26T07:35 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21279.0,39512.0,1838545112.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),167.5,167.5,,,,Y,167.5,EOT/ET/Followup,nan,nan,167.5,NA,2018-04-05T10:58 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21279.0,40200.0,1838545800.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,EOT/ET/Followup,nan,nan,77,NA,2018-04-05T11:10 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,E,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21292.0,34800.0,1839663600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,77.0,Period 1,-10.0,-12.987012987012985,67,E,2018-04-18T09:40 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21293.0,27300.0,1839742500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),83.0,83,,,,,77.0,Period 1,6.0,7.792207792207792,83,E,2018-04-19T07:35 (2)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21299.0,25500.0,1840259100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,Y,66.0,Period 2,nan,nan,66,D,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21299.0,34800.0,1840268400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,,66.0,Period 2,2.0,3.0303030303030303,68,D,2018-04-25T09:40 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21300.0,34237.0,1840354237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),77.0,77,,,,,77.0,EOT/ET/Followup,0.0,0.0,77,D,2018-04-26T09:30 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21300.0,27300.0,1840347300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),80.0,80,,,,,66.0,Period 2,14.0,21.21212121212121,80,D,2018-04-26T07:35 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21279.0,40200.0,1838545800.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-05T11:10 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21300.0,34237.0,1840354237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,12.0,EOT/ET/Followup,2.0,16.666666666666664,14,D,2018-04-26T09:30 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21279.0,40200.0,1838545800.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,Y,109.0,EOT/ET/Followup,nan,nan,109,NA,2018-04-05T11:10 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),97.0,97,,,,Y,97.0,Period 1,nan,nan,97,E,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21292.0,34800.0,1839663600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,97.0,Period 1,5.0,5.154639175257731,102,E,2018-04-18T09:40 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21293.0,27300.0,1839742500.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),108.0,108,,,,,97.0,Period 1,11.0,11.34020618556701,108,E,2018-04-19T07:35 (2)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21299.0,25500.0,1840259100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,Y,103.0,Period 2,nan,nan,103,D,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21299.0,34800.0,1840268400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,103.0,Period 2,6.0,5.825242718446602,109,D,2018-04-25T09:40 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21300.0,34237.0,1840354237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,109.0,EOT/ET/Followup,11.0,10.091743119266056,120,D,2018-04-26T09:30 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21300.0,27300.0,1840347300.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,103.0,Period 2,10.0,9.70873786407767,113,D,2018-04-26T07:35 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21279.0,40200.0,1838545800.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.5,36.5,,,,Y,36.5,EOT/ET/Followup,nan,nan,36.5,NA,2018-04-05T11:10 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21300.0,34237.0,1840354237.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.5,36.5,,,,,36.5,EOT/ET/Followup,0.0,0.0,36.5,D,2018-04-26T09:30 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21279.0,39512.0,1838545112.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),74.6,74.6,,,,Y,74.6,EOT/ET/Followup,nan,nan,74.6,NA,2018-04-05T10:58 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21300.0,34652.0,1840354652.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),72.5,72.5,,,,,74.6,EOT/ET/Followup,-2.1,-2.81501340482573,72.5,D,2018-04-26T09:37 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,nan,SCREENING,21285.0,33538.0,1839057538.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.4,24.4,,,,Y,24.4,EOT/ET/Followup,nan,nan,24.4,NA,2018-04-11T09:18 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,END OF TREATMENT,21307.0,34894.0,1840959694.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),22.2,22.2,,,,,24.4,EOT/ET/Followup,-2.2,-9.016393442622949,22.2,A,2018-05-03T09:41 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21285.0,33945.0,1839057945.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,Y,58.0,EOT/ET/Followup,nan,nan,58,NA,2018-04-11T09:25 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21292.0,26460.0,1839655260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,Y,57.0,Period 1,nan,nan,57,C,2018-04-18T07:21 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21292.0,35760.0,1839664560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,57.0,Period 1,2.0,3.508771929824561,59,C,2018-04-18T09:56 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21293.0,28260.0,1839743460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),52.0,52,,,,,57.0,Period 1,-5.0,-8.771929824561402,52,C,2018-04-19T07:51 (2)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21299.0,26460.0,1840260060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),55.0,55,,,,Y,55.0,Period 2,nan,nan,55,B,2018-04-25T07:21 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21299.0,35760.0,1840269360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,55.0,Period 2,3.0,5.454545454545454,58,B,2018-04-25T09:56 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21300.0,28260.0,1840348260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,55.0,Period 2,3.0,5.454545454545454,58,B,2018-04-26T07:51 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,TREATMENT,21300.0,28350.0,1840348350.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,55.0,Period 2,4.0,7.2727272727272725,59,B,2018-04-26T07:52 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,9.0,TREATMENT,21300.0,28410.0,1840348410.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,55.0,Period 2,12.0,21.818181818181817,67,B,2018-04-26T07:53 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21306.0,26460.0,1840864860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,Y,59.0,Period 3,nan,nan,59,A,2018-05-02T07:21 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21306.0,35760.0,1840874160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,59.0,Period 3,-1.0,-1.694915254237288,58,A,2018-05-02T09:56 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,END OF TREATMENT,21307.0,34260.0,1840959060.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,58.0,EOT/ET/Followup,8.0,13.793103448275861,66,A,2018-05-03T09:31 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21307.0,28260.0,1840953060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,59.0,Period 3,0.0,0.0,59,A,2018-05-03T07:51 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,14.0,SCREENING,21285.0,33538.0,1839057538.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),148.0,148,,,,Y,148.0,EOT/ET/Followup,nan,nan,148,NA,2018-04-11T09:18 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21285.0,33945.0,1839057945.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),64.0,64,,,,Y,64.0,EOT/ET/Followup,nan,nan,64,NA,2018-04-11T09:25 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,TREATMENT,21292.0,26460.0,1839655260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,C,2018-04-18T07:21 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,17.0,TREATMENT,21292.0,35760.0,1839664560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,,71.0,Period 1,0.0,0.0,71,C,2018-04-18T09:56 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21293.0,28260.0,1839743460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,71.0,Period 1,-16.0,-22.535211267605636,55,C,2018-04-19T07:51 (2)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21299.0,26460.0,1840260060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,Period 2,nan,nan,62,B,2018-04-25T07:21 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21299.0,35760.0,1840269360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,62.0,Period 2,12.0,19.35483870967742,74,B,2018-04-25T09:56 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21300.0,28260.0,1840348260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),74.0,74,,,,,62.0,Period 2,12.0,19.35483870967742,74,B,2018-04-26T07:51 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21306.0,26460.0,1840864860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),49.0,49,,,,,nan,Period 3,nan,nan,49,A,2018-05-02T07:21 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21306.0,26591.0,1840864991.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,,nan,Period 3,nan,nan,66,A,2018-05-02T07:23 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21306.0,26846.0,1840865246.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),46.0,46,,,,Y,46.0,Period 3,nan,nan,46,A,2018-05-02T07:27 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,25.0,TREATMENT,21306.0,35760.0,1840874160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),61.0,61,,,,,46.0,Period 3,15.0,32.608695652173914,61,A,2018-05-02T09:56 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,END OF TREATMENT,21307.0,34260.0,1840959060.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),49.0,49,Low,Actual value <=50 and CFB decreased >=15,Value <=50 and CFB >=15,,64.0,EOT/ET/Followup,-15.0,-23.4375,49,A,2018-05-03T09:31 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,END OF TREATMENT,21307.0,34500.0,1840959300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),48.0,48,Low,Actual value <=50 and CFB decreased >=15,Value <=50 and CFB >=15,,64.0,EOT/ET/Followup,-16.0,-25.0,48,A,2018-05-03T09:35 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,END OF TREATMENT,21307.0,34575.0,1840959375.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),53.0,53,,,,,64.0,EOT/ET/Followup,-11.0,-17.1875,53,A,2018-05-03T09:36 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21307.0,28260.0,1840953060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),66.0,66,,,,,46.0,Period 3,20.0,43.47826086956522,66,A,2018-05-03T07:51 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,30.0,SCREENING,21285.0,33945.0,1839057945.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-11T09:25 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,END OF TREATMENT,21307.0,34260.0,1840959060.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,A,2018-05-03T09:31 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,32.0,SCREENING,21285.0,33945.0,1839057945.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,Y,99.0,EOT/ET/Followup,nan,nan,99,NA,2018-04-11T09:25 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21292.0,26460.0,1839655260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 1,nan,nan,111,C,2018-04-18T07:21 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21292.0,35760.0,1839664560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,111.0,Period 1,-9.0,-8.108108108108109,102,C,2018-04-18T09:56 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21293.0,28260.0,1839743460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),95.0,95,,,,,111.0,Period 1,-16.0,-14.414414414414415,95,C,2018-04-19T07:51 (2)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21299.0,26460.0,1840260060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,Y,100.0,Period 2,nan,nan,100,B,2018-04-25T07:21 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21299.0,35760.0,1840269360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,100.0,Period 2,3.0,3.0,103,B,2018-04-25T09:56 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21300.0,28260.0,1840348260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),156.0,156,,,,,100.0,Period 2,56.0,56.00000000000001,156,B,2018-04-26T07:51 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21300.0,28350.0,1840348350.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,100.0,Period 2,3.0,3.0,103,B,2018-04-26T07:52 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,TREATMENT,21300.0,28410.0,1840348410.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,100.0,Period 2,16.0,16.0,116,B,2018-04-26T07:53 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,41.0,TREATMENT,21306.0,26460.0,1840864860.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,Y,103.0,Period 3,nan,nan,103,A,2018-05-02T07:21 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21306.0,35760.0,1840874160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,103.0,Period 3,4.0,3.8834951456310676,107,A,2018-05-02T09:56 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,END OF TREATMENT,21307.0,34260.0,1840959060.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,99.0,EOT/ET/Followup,20.0,20.2020202020202,119,A,2018-05-03T09:31 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21307.0,28260.0,1840953060.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,103.0,Period 3,24.0,23.300970873786408,127,A,2018-05-03T07:51 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,45.0,SCREENING,21285.0,33945.0,1839057945.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.1,36.1,,,,Y,36.1,EOT/ET/Followup,nan,nan,36.1,NA,2018-04-11T09:25 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,END OF TREATMENT,21307.0,34260.0,1840959060.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),35.6,35.6,,,,,36.1,EOT/ET/Followup,-0.5,-1.3850415512465373,35.6,A,2018-05-03T09:31 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,47.0,SCREENING,21285.0,33538.0,1839057538.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),53.5,53.5,,,,Y,53.5,EOT/ET/Followup,nan,nan,53.5,NA,2018-04-11T09:18 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21307.0,34894.0,1840959694.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),48.7,48.7,Low,CFB decreased >=7%,CFB >=7%,,53.5,EOT/ET/Followup,-4.8,-8.971962616822426,48.7,A,2018-05-03T09:41 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,nan,SCREENING,21285.0,33141.0,1839057141.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),28.1,28.1,,,,Y,28.1,EOT/ET/Followup,nan,nan,28.1,NA,2018-04-11T09:12 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,nan,END OF TREATMENT,21307.0,35516.0,1840960316.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,BMI,Body Mass Index (kg/m2),27.5,27.5,,,,,28.1,EOT/ET/Followup,-0.6,-2.1352313167259838,27.5,C,2018-05-03T09:51 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21285.0,34380.0,1839058380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-04-11T09:33 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21292.0,26820.0,1839655620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,B,2018-04-18T07:27 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21292.0,36120.0,1839664920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,68.0,Period 1,0.0,0.0,68,B,2018-04-18T10:02 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21293.0,28620.0,1839743820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,68.0,Period 1,-6.0,-8.823529411764707,62,B,2018-04-19T07:57 (2)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21299.0,26820.0,1840260420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,Y,62.0,Period 2,nan,nan,62,A,2018-04-25T07:27 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21299.0,36120.0,1840269720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,62.0,Period 2,-3.0,-4.838709677419355,59,A,2018-04-25T10:02 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21300.0,28620.0,1840348620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,62.0,Period 2,5.0,8.064516129032258,67,A,2018-04-26T07:57 (9)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,TREATMENT,21306.0,26820.0,1840865220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 3,nan,nan,70,C,2018-05-02T07:27 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,9.0,TREATMENT,21306.0,36120.0,1840874520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),54.0,54,,,,,70.0,Period 3,-16.0,-22.857142857142858,54,C,2018-05-02T10:02 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,END OF TREATMENT,21307.0,34620.0,1840959420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,74.0,EOT/ET/Followup,-15.0,-20.27027027027027,59,C,2018-05-03T09:37 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21307.0,28620.0,1840953420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,70.0,Period 3,-4.0,-5.714285714285714,66,C,2018-05-03T07:57 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,12.0,SCREENING,21285.0,33141.0,1839057141.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),194.0,194,,,,Y,194.0,EOT/ET/Followup,nan,nan,194,NA,2018-04-11T09:12 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21285.0,34380.0,1839058380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),54.0,54,,,,Y,54.0,EOT/ET/Followup,nan,nan,54,NA,2018-04-11T09:33 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21292.0,26820.0,1839655620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 1,nan,nan,68,B,2018-04-18T07:27 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21292.0,36120.0,1839664920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,,68.0,Period 1,-7.0,-10.294117647058822,61,B,2018-04-18T10:02 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,TREATMENT,21293.0,28620.0,1839743820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),73.0,73,,,,,68.0,Period 1,5.0,7.352941176470589,73,B,2018-04-19T07:57 (2)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21299.0,26820.0,1840260420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 2,nan,nan,57,A,2018-04-25T07:27 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21299.0,36120.0,1840269720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),52.0,52,,,,,57.0,Period 2,-5.0,-8.771929824561402,52,A,2018-04-25T10:02 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21300.0,28620.0,1840348620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),80.0,80,,,,,57.0,Period 2,23.0,40.35087719298245,80,A,2018-04-26T07:57 (9)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21306.0,26820.0,1840865220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,Period 3,nan,nan,59,C,2018-05-02T07:27 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21306.0,36120.0,1840874520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),50.0,50,,,,,59.0,Period 3,-9.0,-15.254237288135593,50,C,2018-05-02T10:02 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,END OF TREATMENT,21307.0,34620.0,1840959420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PULSE,Pulse Rate (beats/min),67.0,67,,,,,54.0,EOT/ET/Followup,13.0,24.074074074074073,67,C,2018-05-03T09:37 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21307.0,28620.0,1840953420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,PULSE,Pulse Rate (beats/min),63.0,63,,,,,59.0,Period 3,4.0,6.779661016949152,63,C,2018-05-03T07:57 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,24.0,SCREENING,21285.0,34380.0,1839058380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),18.0,18,,,,Y,18.0,EOT/ET/Followup,nan,nan,18,NA,2018-04-11T09:33 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,END OF TREATMENT,21307.0,34620.0,1840959420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,18.0,EOT/ET/Followup,-4.0,-22.22222222222222,14,C,2018-05-03T09:37 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,26.0,SCREENING,21285.0,34380.0,1839058380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,EOT/ET/Followup,nan,nan,112,NA,2018-04-11T09:33 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21292.0,26820.0,1839655620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 1,nan,nan,105,B,2018-04-18T07:27 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21292.0,36120.0,1839664920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),96.0,96,,,,,105.0,Period 1,-9.0,-8.571428571428571,96,B,2018-04-18T10:02 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21293.0,28620.0,1839743820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,,105.0,Period 1,10.0,9.523809523809524,115,B,2018-04-19T07:57 (2)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21299.0,26820.0,1840260420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),100.0,100,,,,Y,100.0,Period 2,nan,nan,100,A,2018-04-25T07:27 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21299.0,36120.0,1840269720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,100.0,Period 2,-1.0,-1.0,99,A,2018-04-25T10:02 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,TREATMENT,21300.0,28620.0,1840348620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,,100.0,Period 2,4.0,4.0,104,A,2018-04-26T07:57 (9)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21306.0,26820.0,1840865220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),105.0,105,,,,Y,105.0,Period 3,nan,nan,105,C,2018-05-02T07:27 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21306.0,36120.0,1840874520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),93.0,93,,,,,105.0,Period 3,-12.0,-11.428571428571429,93,C,2018-05-02T10:02 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,END OF TREATMENT,21307.0,34620.0,1840959420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,112.0,EOT/ET/Followup,-3.0,-2.6785714285714284,109,C,2018-05-03T09:37 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21307.0,28620.0,1840953420.0,16.0,Period 3 Day 16,26.0,Period 3 Day 16 (24 h),24 h,24.0,3.0,Period 3,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,105.0,Period 3,-2.0,-1.9047619047619049,103,C,2018-05-03T07:57 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,37.0,SCREENING,21285.0,34380.0,1839058380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.8,35.8,,,,Y,35.8,EOT/ET/Followup,nan,nan,35.8,NA,2018-04-11T09:33 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,END OF TREATMENT,21307.0,34620.0,1840959420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,TEMP,Temperature (C),36.1,36.1,,,,,35.8,EOT/ET/Followup,0.3,0.8379888268156545,36.1,C,2018-05-03T09:37 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,39.0,SCREENING,21285.0,33141.0,1839057141.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),105.6,105.6,,,,Y,105.6,EOT/ET/Followup,nan,nan,105.6,NA,2018-04-11T09:12 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21307.0,35516.0,1840960316.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,WEIGHT,Weight (kg),103.5,103.5,,,,,105.6,EOT/ET/Followup,-2.1,-1.9886363636363584,103.5,C,2018-05-03T09:51 (16)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21285.0,35556.0,1839059556.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.9,24.9,,,,Y,24.9,EOT/ET/Followup,nan,nan,24.9,NA,2018-04-11T09:52 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21300.0,35351.0,1840355351.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),25.0,25.0,,,,,24.9,EOT/ET/Followup,0.1,0.4016064257028169,25.0,E,2018-04-26T09:49 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21285.0,36259.0,1839060259.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-04-11T10:04 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,26220.0,1839655020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,Period 1,nan,nan,74,D,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,35520.0,1839664320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),68.0,68,,,,,74.0,Period 1,-6.0,-8.108108108108109,68,D,2018-04-18T09:52 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21293.0,28020.0,1839743220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,74.0,Period 1,-1.0,-1.3513513513513513,73,D,2018-04-19T07:47 (2)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,E,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21299.0,35520.0,1840269120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,65.0,Period 2,5.0,7.6923076923076925,70,E,2018-04-25T09:52 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21300.0,34510.0,1840354510.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),62.0,62,,,,,74.0,EOT/ET/Followup,-12.0,-16.216216216216218,62,E,2018-04-26T09:35 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21300.0,28020.0,1840348020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,65.0,Period 2,10.0,15.384615384615385,75,E,2018-04-26T07:47 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21285.0,35556.0,1839059556.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),176.5,176.5,,,,Y,176.5,EOT/ET/Followup,nan,nan,176.5,NA,2018-04-11T09:52 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21285.0,36259.0,1839060259.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-04-11T10:04 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21292.0,26220.0,1839655020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,D,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21292.0,35520.0,1839664320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,71.0,Period 1,-2.0,-2.8169014084507045,69,D,2018-04-18T09:52 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21293.0,28020.0,1839743220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),66.0,66,,,,,71.0,Period 1,-5.0,-7.042253521126761,66,D,2018-04-19T07:47 (2)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,Period 2,nan,nan,62,E,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21299.0,35520.0,1840269120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),60.0,60,,,,,62.0,Period 2,-2.0,-3.225806451612903,60,E,2018-04-25T09:52 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,END OF TREATMENT,21300.0,34510.0,1840354510.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,74.0,EOT/ET/Followup,-2.0,-2.7027027027027026,72,E,2018-04-26T09:35 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21300.0,28020.0,1840348020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),66.0,66,,,,,62.0,Period 2,4.0,6.451612903225806,66,E,2018-04-26T07:47 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21285.0,36259.0,1839060259.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-11T10:04 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21300.0,34510.0,1840354510.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),16.0,16,,,,,12.0,EOT/ET/Followup,4.0,33.33333333333333,16,E,2018-04-26T09:35 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21285.0,36259.0,1839060259.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,Y,138.0,EOT/ET/Followup,nan,nan,138,NA,2018-04-11T10:04 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21292.0,26220.0,1839655020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),115.0,115,,,,Y,115.0,Period 1,nan,nan,115,D,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21292.0,35520.0,1839664320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,115.0,Period 1,-5.0,-4.3478260869565215,110,D,2018-04-18T09:52 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21293.0,28020.0,1839743220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,115.0,Period 1,6.0,5.217391304347826,121,D,2018-04-19T07:47 (2)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 2,nan,nan,122,E,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21299.0,35520.0,1840269120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,122.0,Period 2,-15.0,-12.295081967213115,107,E,2018-04-25T09:52 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,END OF TREATMENT,21300.0,34510.0,1840354510.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,,138.0,EOT/ET/Followup,-22.0,-15.942028985507244,116,E,2018-04-26T09:35 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21300.0,28020.0,1840348020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,122.0,Period 2,-15.0,-12.295081967213115,107,E,2018-04-26T07:47 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21285.0,36259.0,1839060259.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.6,36.6,,,,Y,36.6,EOT/ET/Followup,nan,nan,36.6,NA,2018-04-11T10:04 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21300.0,34510.0,1840354510.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.1,36.1,,,,,36.6,EOT/ET/Followup,-0.5,-1.366120218579235,36.1,E,2018-04-26T09:35 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21285.0,35556.0,1839059556.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),77.5,77.5,,,,Y,77.5,EOT/ET/Followup,nan,nan,77.5,NA,2018-04-11T09:52 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21300.0,35351.0,1840355351.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),78.0,78,,,,,77.5,EOT/ET/Followup,0.5,0.6451612903225806,78,E,2018-04-26T09:49 (9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21292.0,49526.0,1839678326.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),25.8,25.8,,,,Y,25.8,EOT/ET/Followup,nan,nan,25.8,NA,2018-04-18T13:45 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21316.0,34349.0,1841736749.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),25.6,25.6,,,,,25.8,EOT/ET/Followup,-0.2,-0.7751937984496096,25.6,D,2018-05-12T09:32 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21292.0,50130.0,1839678930.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,EOT/ET/Followup,nan,nan,63,NA,2018-04-18T13:55 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,26100.0,1840432500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,E,2018-04-27T07:15 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,35400.0,1840441800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,63.0,Period 1,0.0,0.0,63,E,2018-04-27T09:50 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21302.0,27900.0,1840520700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,63.0,Period 1,7.0,11.11111111111111,70,E,2018-04-28T07:45 (2)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21315.0,26100.0,1841642100.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,D,2018-05-11T07:15 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21315.0,35400.0,1841651400.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,75.0,Period 2,-2.0,-2.666666666666667,73,D,2018-05-11T09:50 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21316.0,33600.0,1841736000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,63.0,EOT/ET/Followup,7.0,11.11111111111111,70,D,2018-05-12T09:20 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21316.0,27900.0,1841730300.0,16.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,75.0,Period 2,-4.0,-5.333333333333334,71,D,2018-05-12T07:45 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21292.0,49526.0,1839678326.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),165.5,165.5,,,,Y,165.5,EOT/ET/Followup,nan,nan,165.5,NA,2018-04-18T13:45 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21292.0,50130.0,1839678930.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-04-18T13:55 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21301.0,26100.0,1840432500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,Y,63.0,Period 1,nan,nan,63,E,2018-04-27T07:15 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21301.0,35400.0,1840441800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,63.0,Period 1,6.0,9.523809523809524,69,E,2018-04-27T09:50 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21302.0,27900.0,1840520700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,63.0,Period 1,6.0,9.523809523809524,69,E,2018-04-28T07:45 (2)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21315.0,26100.0,1841642100.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),90.0,90,,,,Y,90.0,Period 2,nan,nan,90,D,2018-05-11T07:15 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21315.0,35400.0,1841651400.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,,90.0,Period 2,-22.0,-24.444444444444443,68,D,2018-05-11T09:50 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21316.0,33600.0,1841736000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,65.0,EOT/ET/Followup,2.0,3.076923076923077,67,D,2018-05-12T09:20 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21316.0,27900.0,1841730300.0,16.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),63.0,63,,,,,90.0,Period 2,-27.0,-30.0,63,D,2018-05-12T07:45 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21292.0,50130.0,1839678930.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-18T13:55 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21316.0,33600.0,1841736000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),15.0,15,,,,,14.0,EOT/ET/Followup,1.0,7.142857142857142,15,D,2018-05-12T09:20 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21292.0,50130.0,1839678930.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,Y,113.0,EOT/ET/Followup,nan,nan,113,NA,2018-04-18T13:55 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,26100.0,1840432500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,Period 1,nan,nan,117,E,2018-04-27T07:15 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21301.0,35400.0,1840441800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,117.0,Period 1,13.0,11.11111111111111,130,E,2018-04-27T09:50 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21302.0,27900.0,1840520700.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,,117.0,Period 1,15.0,12.82051282051282,132,E,2018-04-28T07:45 (2)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21315.0,26100.0,1841642100.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,Y,124.0,Period 2,nan,nan,124,D,2018-05-11T07:15 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21315.0,35400.0,1841651400.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,124.0,Period 2,-4.0,-3.225806451612903,120,D,2018-05-11T09:50 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21316.0,33600.0,1841736000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,113.0,EOT/ET/Followup,-1.0,-0.8849557522123894,112,D,2018-05-12T09:20 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21316.0,27900.0,1841730300.0,16.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,124.0,Period 2,1.0,0.8064516129032258,125,D,2018-05-12T07:45 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21292.0,50130.0,1839678930.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-04-18T13:55 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21316.0,33600.0,1841736000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.6,36.6,,,,,36.3,EOT/ET/Followup,0.3,0.8264462809917473,36.6,D,2018-05-12T09:20 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21292.0,49526.0,1839678326.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),70.8,70.8,,,,Y,70.8,EOT/ET/Followup,nan,nan,70.8,NA,2018-04-18T13:45 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21316.0,34349.0,1841736749.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),70.0,70,,,,,70.8,EOT/ET/Followup,-0.8,-1.1299435028248548,70,D,2018-05-12T09:32 (16)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21292.0,49953.0,1839678753.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.9,27.9,,,,Y,27.9,EOT/ET/Followup,nan,nan,27.9,NA,2018-04-18T13:52 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21309.0,34937.0,1841132537.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),28.0,28.0,,,,,27.9,EOT/ET/Followup,0.1,0.35842293906810546,28.0,E,2018-05-05T09:42 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21292.0,50520.0,1839679320.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-18T14:02 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),77.0,77,,,,Y,77.0,Period 1,nan,nan,77,D,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,34800.0,1840441200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,77.0,Period 1,3.0,3.896103896103896,80,D,2018-04-27T09:40 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21302.0,27300.0,1840520100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,77.0,Period 1,-2.0,-2.5974025974025974,75,D,2018-04-28T07:35 (2)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,25500.0,1841036700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,Y,73.0,Period 2,nan,nan,73,E,2018-05-04T07:05 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21308.0,34800.0,1841046000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,73.0,Period 2,6.0,8.21917808219178,79,E,2018-05-04T09:40 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21309.0,33600.0,1841131200.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,75.0,EOT/ET/Followup,-2.0,-2.666666666666667,73,E,2018-05-05T09:20 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21309.0,27300.0,1841124900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),73.0,73,,,,,73.0,Period 2,0.0,0.0,73,E,2018-05-05T07:35 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21292.0,49953.0,1839678753.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),161.0,161,,,,Y,161.0,EOT/ET/Followup,nan,nan,161,NA,2018-04-18T13:52 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21292.0,50520.0,1839679320.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-18T14:02 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,Y,67.0,Period 1,nan,nan,67,D,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21301.0,34800.0,1840441200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,67.0,Period 1,5.0,7.462686567164178,72,D,2018-04-27T09:40 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21302.0,27300.0,1840520100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),83.0,83,,,,,67.0,Period 1,16.0,23.88059701492537,83,D,2018-04-28T07:35 (2)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21308.0,25500.0,1841036700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,Y,68.0,Period 2,nan,nan,68,E,2018-05-04T07:05 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21308.0,34800.0,1841046000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,68.0,Period 2,-4.0,-5.88235294117647,64,E,2018-05-04T09:40 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,END OF TREATMENT,21309.0,33600.0,1841131200.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),77.0,77,,,,,75.0,EOT/ET/Followup,2.0,2.666666666666667,77,E,2018-05-05T09:20 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21309.0,27300.0,1841124900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),81.0,81,,,,,68.0,Period 2,13.0,19.11764705882353,81,E,2018-05-05T07:35 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21292.0,50520.0,1839679320.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-18T14:02 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21309.0,33600.0,1841131200.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,14.0,EOT/ET/Followup,-2.0,-14.285714285714285,12,E,2018-05-05T09:20 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21292.0,50520.0,1839679320.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,Y,112.0,EOT/ET/Followup,nan,nan,112,NA,2018-04-18T14:02 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 1,nan,nan,116,D,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21301.0,34800.0,1840441200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,116.0,Period 1,5.0,4.310344827586207,121,D,2018-04-27T09:40 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21302.0,27300.0,1840520100.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),110.0,110,,,,,116.0,Period 1,-6.0,-5.172413793103448,110,D,2018-04-28T07:35 (2)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21308.0,25500.0,1841036700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 2,nan,nan,116,E,2018-05-04T07:05 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21308.0,34800.0,1841046000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),124.0,124,,,,,116.0,Period 2,8.0,6.896551724137931,124,E,2018-05-04T09:40 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,END OF TREATMENT,21309.0,33600.0,1841131200.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,112.0,EOT/ET/Followup,-1.0,-0.8928571428571428,111,E,2018-05-05T09:20 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21309.0,27300.0,1841124900.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,116.0,Period 2,-4.0,-3.4482758620689653,112,E,2018-05-05T07:35 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21292.0,50520.0,1839679320.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-04-18T14:02 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21309.0,33600.0,1841131200.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.1,36.1,,,,,36.3,EOT/ET/Followup,-0.2,-0.550964187327812,36.1,E,2018-05-05T09:20 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21292.0,49953.0,1839678753.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),72.2,72.2,,,,Y,72.2,EOT/ET/Followup,nan,nan,72.2,NA,2018-04-18T13:52 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21309.0,34937.0,1841132537.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),72.7,72.7,,,,,72.2,EOT/ET/Followup,0.5,0.6925207756232686,72.7,E,2018-05-05T09:42 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21294.0,39043.0,1839840643.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),20.4,20.4,,,,Y,20.4,EOT/ET/Followup,nan,nan,20.4,NA,2018-04-20T10:50 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21309.0,35006.0,1841132606.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),20.2,20.2,,,,,20.4,EOT/ET/Followup,-0.2,-0.9803921568627416,20.2,D,2018-05-05T09:43 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,37800.0,1839839400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,Y,82.0,EOT/ET/Followup,nan,nan,82,NA,2018-04-20T10:30 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,E,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34920.0,1840441320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,78.0,Period 1,4.0,5.128205128205128,82,E,2018-04-27T09:42 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21302.0,27420.0,1840520220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,78.0,Period 1,-6.0,-7.6923076923076925,72,E,2018-04-28T07:37 (2)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,D,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21308.0,34920.0,1841046120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,70.0,Period 2,-3.0,-4.285714285714286,67,D,2018-05-04T09:42 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21309.0,33720.0,1841131320.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,82.0,EOT/ET/Followup,-8.0,-9.75609756097561,74,D,2018-05-05T09:22 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21309.0,27420.0,1841125020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,,70.0,Period 2,0.0,0.0,70,D,2018-05-05T07:37 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21294.0,39043.0,1839840643.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),161.5,161.5,,,,Y,161.5,EOT/ET/Followup,nan,nan,161.5,NA,2018-04-20T10:50 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21294.0,37800.0,1839839400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),55.0,55,,,,Y,55.0,EOT/ET/Followup,nan,nan,55,NA,2018-04-20T10:30 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),56.0,56,,,,Y,56.0,Period 1,nan,nan,56,E,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21301.0,34920.0,1840441320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),51.0,51,,,,,56.0,Period 1,-5.0,-8.928571428571429,51,E,2018-04-27T09:42 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21302.0,27420.0,1840520220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),59.0,59,,,,,56.0,Period 1,3.0,5.357142857142857,59,E,2018-04-28T07:37 (2)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),57.0,57,,,,Y,57.0,Period 2,nan,nan,57,D,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21308.0,34920.0,1841046120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),58.0,58,,,,,57.0,Period 2,1.0,1.7543859649122806,58,D,2018-05-04T09:42 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21309.0,33720.0,1841131320.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),57.0,57,,,,,55.0,EOT/ET/Followup,2.0,3.6363636363636362,57,D,2018-05-05T09:22 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21309.0,27420.0,1841125020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),54.0,54,,,,,57.0,Period 2,-3.0,-5.263157894736842,54,D,2018-05-05T07:37 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21294.0,37800.0,1839839400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),12.0,12,,,,Y,12.0,EOT/ET/Followup,nan,nan,12,NA,2018-04-20T10:30 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21309.0,33720.0,1841131320.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,12.0,EOT/ET/Followup,2.0,16.666666666666664,14,D,2018-05-05T09:22 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21294.0,37800.0,1839839400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,Y,123.0,EOT/ET/Followup,nan,nan,123,NA,2018-04-20T10:30 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),116.0,116,,,,Y,116.0,Period 1,nan,nan,116,E,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21301.0,34920.0,1840441320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,116.0,Period 1,10.0,8.620689655172415,126,E,2018-04-27T09:42 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21302.0,27420.0,1840520220.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),113.0,113,,,,,116.0,Period 1,-3.0,-2.586206896551724,113,E,2018-04-28T07:37 (2)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,Y,111.0,Period 2,nan,nan,111,D,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21308.0,34920.0,1841046120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,111.0,Period 2,17.0,15.315315315315313,128,D,2018-05-04T09:42 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21309.0,33720.0,1841131320.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,123.0,EOT/ET/Followup,-4.0,-3.2520325203252036,119,D,2018-05-05T09:22 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21309.0,27420.0,1841125020.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,111.0,Period 2,-8.0,-7.207207207207207,103,D,2018-05-05T07:37 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21294.0,37800.0,1839839400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.7,36.7,,,,Y,36.7,EOT/ET/Followup,nan,nan,36.7,NA,2018-04-20T10:30 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21309.0,33720.0,1841131320.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.6,36.6,,,,,36.7,EOT/ET/Followup,-0.1,-0.2724795640327014,36.6,D,2018-05-05T09:22 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21294.0,39043.0,1839840643.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),53.2,53.2,,,,Y,53.2,EOT/ET/Followup,nan,nan,53.2,NA,2018-04-20T10:50 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21309.0,35006.0,1841132606.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),52.6,52.6,,,,,53.2,EOT/ET/Followup,-0.6,-1.127819548872183,52.6,D,2018-05-05T09:43 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21294.0,38073.0,1839839673.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),21.3,21.3,,,,Y,21.3,EOT/ET/Followup,nan,nan,21.3,NA,2018-04-20T10:34 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21309.0,34782.0,1841132382.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),21.3,21.3,,,,,21.3,EOT/ET/Followup,0.0,0.0,21.3,E,2018-05-05T09:39 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,39360.0,1839840960.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,EOT/ET/Followup,nan,nan,85,NA,2018-04-20T10:56 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,Period 1,nan,nan,80,D,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,35040.0,1840441440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,80.0,Period 1,-1.0,-1.25,79,D,2018-04-27T09:44 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21302.0,27540.0,1840520340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),84.0,84,,,,,80.0,Period 1,4.0,5.0,84,D,2018-04-28T07:39 (2)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,Y,80.0,Period 2,nan,nan,80,E,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21308.0,35040.0,1841046240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),91.0,91,,,,,80.0,Period 2,11.0,13.750000000000002,91,E,2018-05-04T09:44 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),94.0,94,,,,,80.0,Period 2,14.0,17.5,94,E,2018-05-04T09:46 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21308.0,35220.0,1841046420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,,80.0,Period 2,9.0,11.25,89,E,2018-05-04T09:47 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,END OF TREATMENT,21309.0,33840.0,1841131440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,85.0,EOT/ET/Followup,-11.0,-12.941176470588237,74,E,2018-05-05T09:24 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21309.0,27540.0,1841125140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,80.0,Period 2,2.0,2.5,82,E,2018-05-05T07:39 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,11.0,SCREENING,21294.0,38073.0,1839839673.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),167.0,167,,,,Y,167.0,EOT/ET/Followup,nan,nan,167,NA,2018-04-20T10:34 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,12.0,SCREENING,21294.0,39360.0,1839840960.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),106.0,106,,,,,nan,EOT/ET/Followup,nan,nan,106,NA,2018-04-20T10:56 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,39420.0,1839841020.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),101.0,101,,,,,nan,EOT/ET/Followup,nan,nan,101,NA,2018-04-20T10:57 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,14.0,SCREENING,21294.0,39480.0,1839841080.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,EOT/ET/Followup,nan,nan,84,NA,2018-04-20T10:58 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),108.0,108,,,,,nan,Period 1,nan,nan,108,D,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21301.0,25867.0,1840432267.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),107.0,107,,,,,nan,Period 1,nan,nan,107,D,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21301.0,25958.0,1840432358.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),95.0,95,,,,Y,95.0,Period 1,nan,nan,95,D,2018-04-27T07:12 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,TREATMENT,21301.0,35040.0,1840441440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,,95.0,Period 1,-26.0,-27.368421052631582,69,D,2018-04-27T09:44 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,TREATMENT,21302.0,27540.0,1840520340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),85.0,85,,,,,95.0,Period 1,-10.0,-10.526315789473683,85,D,2018-04-28T07:39 (2)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),95.0,95,,,,Y,95.0,Period 2,nan,nan,95,E,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21308.0,35040.0,1841046240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),80.0,80,,,,,95.0,Period 2,-15.0,-15.789473684210526,80,E,2018-05-04T09:44 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,END OF TREATMENT,21309.0,33840.0,1841131440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),81.0,81,,,,,84.0,EOT/ET/Followup,-3.0,-3.571428571428571,81,E,2018-05-05T09:24 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21309.0,27540.0,1841125140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),95.0,95,,,,,95.0,Period 2,0.0,0.0,95,E,2018-05-05T07:39 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,24.0,SCREENING,21294.0,39360.0,1839840960.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-20T10:56 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,END OF TREATMENT,21309.0,33840.0,1841131440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,14.0,EOT/ET/Followup,-2.0,-14.285714285714285,12,E,2018-05-05T09:24 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,26.0,SCREENING,21294.0,39360.0,1839840960.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,Y,138.0,EOT/ET/Followup,nan,nan,138,NA,2018-04-20T10:56 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,Y,138.0,Period 1,nan,nan,138,D,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21301.0,35040.0,1840441440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,138.0,Period 1,-17.0,-12.318840579710146,121,D,2018-04-27T09:44 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21302.0,27540.0,1840520340.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),138.0,138,,,,,138.0,Period 1,0.0,0.0,138,D,2018-04-28T07:39 (2)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),129.0,129,,,,Y,129.0,Period 2,nan,nan,129,E,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,TREATMENT,21308.0,35040.0,1841046240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,,129.0,Period 2,3.0,2.3255813953488373,132,E,2018-05-04T09:44 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),141.0,141,,,,,129.0,Period 2,12.0,9.30232558139535,141,E,2018-05-04T09:46 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21308.0,35220.0,1841046420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),139.0,139,,,,,129.0,Period 2,10.0,7.751937984496124,139,E,2018-05-04T09:47 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,END OF TREATMENT,21309.0,33840.0,1841131440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,,138.0,EOT/ET/Followup,-21.0,-15.217391304347828,117,E,2018-05-05T09:24 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21309.0,27540.0,1841125140.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,129.0,Period 2,-7.0,-5.426356589147287,122,E,2018-05-05T07:39 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,36.0,SCREENING,21294.0,39360.0,1839840960.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.3,36.3,,,,Y,36.3,EOT/ET/Followup,nan,nan,36.3,NA,2018-04-20T10:56 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,37.0,END OF TREATMENT,21309.0,33840.0,1841131440.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.6,36.6,,,,,36.3,EOT/ET/Followup,0.3,0.8264462809917473,36.6,E,2018-05-05T09:24 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,38.0,SCREENING,21294.0,38073.0,1839839673.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),59.4,59.4,,,,Y,59.4,EOT/ET/Followup,nan,nan,59.4,NA,2018-04-20T10:34 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,END OF TREATMENT,21309.0,34782.0,1841132382.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),59.3,59.3,,,,,59.4,EOT/ET/Followup,-0.1,-0.16835016835017075,59.3,E,2018-05-05T09:39 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21294.0,38754.0,1839840354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),29.5,29.5,,,,Y,29.5,EOT/ET/Followup,nan,nan,29.5,NA,2018-04-20T10:45 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21309.0,35255.0,1841132855.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),29.3,29.3,,,,,29.5,EOT/ET/Followup,-0.2,-0.6779661016949128,29.3,E,2018-05-05T09:47 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,37740.0,1839839340.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),87.0,87,,,,Y,87.0,EOT/ET/Followup,nan,nan,87,NA,2018-04-20T10:29 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,26220.0,1840432620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),87.0,87,,,,Y,87.0,Period 1,nan,nan,87,D,2018-04-27T07:17 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,35520.0,1840441920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,87.0,Period 1,-5.0,-5.747126436781609,82,D,2018-04-27T09:52 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21302.0,28020.0,1840520820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),82.0,82,,,,,87.0,Period 1,-5.0,-5.747126436781609,82,D,2018-04-28T07:47 (2)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,26220.0,1841037420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),85.0,85,,,,Y,85.0,Period 2,nan,nan,85,E,2018-05-04T07:17 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21308.0,35520.0,1841046720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),87.0,87,,,,,85.0,Period 2,2.0,2.3529411764705883,87,E,2018-05-04T09:52 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21309.0,34320.0,1841131920.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,87.0,EOT/ET/Followup,-7.0,-8.045977011494253,80,E,2018-05-05T09:32 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21309.0,28020.0,1841125620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),80.0,80,,,,,85.0,Period 2,-5.0,-5.88235294117647,80,E,2018-05-05T07:47 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21294.0,38754.0,1839840354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),182.0,182,,,,Y,182.0,EOT/ET/Followup,nan,nan,182,NA,2018-04-20T10:45 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21294.0,37740.0,1839839340.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-20T10:29 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21301.0,26220.0,1840432620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 1,nan,nan,71,D,2018-04-27T07:17 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21301.0,35520.0,1840441920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),77.0,77,,,,,71.0,Period 1,6.0,8.450704225352112,77,D,2018-04-27T09:52 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21302.0,28020.0,1840520820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),78.0,78,,,,,71.0,Period 1,7.0,9.859154929577464,78,D,2018-04-28T07:47 (2)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21308.0,26220.0,1841037420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,E,2018-05-04T07:17 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21308.0,35520.0,1841046720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,,71.0,Period 2,-1.0,-1.4084507042253522,70,E,2018-05-04T09:52 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,END OF TREATMENT,21309.0,34320.0,1841131920.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),81.0,81,,,,,75.0,EOT/ET/Followup,6.0,8.0,81,E,2018-05-05T09:32 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21309.0,28020.0,1841125620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),65.0,65,,,,,71.0,Period 2,-6.0,-8.450704225352112,65,E,2018-05-05T07:47 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21294.0,37740.0,1839839340.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-04-20T10:29 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21309.0,34320.0,1841131920.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,16.0,EOT/ET/Followup,-2.0,-12.5,14,E,2018-05-05T09:32 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21294.0,37740.0,1839839340.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,Y,128.0,EOT/ET/Followup,nan,nan,128,NA,2018-04-20T10:29 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,26220.0,1840432620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,Y,137.0,Period 1,nan,nan,137,D,2018-04-27T07:17 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21301.0,35520.0,1840441920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),131.0,131,,,,,137.0,Period 1,-6.0,-4.37956204379562,131,D,2018-04-27T09:52 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21302.0,28020.0,1840520820.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,137.0,Period 1,-9.0,-6.569343065693431,128,D,2018-04-28T07:47 (2)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21308.0,26220.0,1841037420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,Period 2,nan,nan,122,E,2018-05-04T07:17 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21308.0,35520.0,1841046720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,122.0,Period 2,0.0,0.0,122,E,2018-05-04T09:52 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,END OF TREATMENT,21309.0,34320.0,1841131920.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,,128.0,EOT/ET/Followup,-7.0,-5.46875,121,E,2018-05-05T09:32 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21309.0,28020.0,1841125620.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),128.0,128,,,,,122.0,Period 2,6.0,4.918032786885246,128,E,2018-05-05T07:47 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21294.0,37740.0,1839839340.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),35.9,35.9,,,,Y,35.9,EOT/ET/Followup,nan,nan,35.9,NA,2018-04-20T10:29 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21309.0,34320.0,1841131920.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.4,36.4,,,,,35.9,EOT/ET/Followup,0.5,1.392757660167131,36.4,E,2018-05-05T09:32 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21294.0,38754.0,1839840354.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),97.6,97.6,,,,Y,97.6,EOT/ET/Followup,nan,nan,97.6,NA,2018-04-20T10:45 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21309.0,35255.0,1841132855.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),97.2,97.2,,,,,97.6,EOT/ET/Followup,-0.4,-0.40983606557376173,97.2,E,2018-05-05T09:47 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21294.0,37677.0,1839839277.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),27.3,27.3,,,,Y,27.3,EOT/ET/Followup,nan,nan,27.3,NA,2018-04-20T10:27 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21309.0,35390.0,1841132990.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),26.3,26.3,,,,,27.3,EOT/ET/Followup,-1.0,-3.6630036630036633,26.3,D,2018-05-05T09:49 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,39120.0,1839840720.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,EOT/ET/Followup,nan,nan,65,NA,2018-04-20T10:52 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,26340.0,1840432740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 1,nan,nan,65,E,2018-04-27T07:19 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,35640.0,1840442040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),55.0,55,,,,,65.0,Period 1,-10.0,-15.384615384615385,55,E,2018-04-27T09:54 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21302.0,28140.0,1840520940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,65.0,Period 1,1.0,1.5384615384615385,66,E,2018-04-28T07:49 (2)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,26340.0,1841037540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,Y,65.0,Period 2,nan,nan,65,D,2018-05-04T07:19 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21308.0,35640.0,1841046840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,65.0,Period 2,-6.0,-9.230769230769232,59,D,2018-05-04T09:54 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21309.0,34440.0,1841132040.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),57.0,57,,,,,65.0,EOT/ET/Followup,-8.0,-12.307692307692308,57,D,2018-05-05T09:34 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21309.0,28140.0,1841125740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),65.0,65,,,,,65.0,Period 2,0.0,0.0,65,D,2018-05-05T07:49 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21294.0,37677.0,1839839277.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),176.5,176.5,,,,Y,176.5,EOT/ET/Followup,nan,nan,176.5,NA,2018-04-20T10:27 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21294.0,39120.0,1839840720.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),59.0,59,,,,Y,59.0,EOT/ET/Followup,nan,nan,59,NA,2018-04-20T10:52 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21301.0,26340.0,1840432740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),69.0,69,,,,Y,69.0,Period 1,nan,nan,69,E,2018-04-27T07:19 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21301.0,35640.0,1840442040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),63.0,63,,,,,69.0,Period 1,-6.0,-8.695652173913043,63,E,2018-04-27T09:54 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21302.0,28140.0,1840520940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),72.0,72,,,,,69.0,Period 1,3.0,4.3478260869565215,72,E,2018-04-28T07:49 (2)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21308.0,26340.0,1841037540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),71.0,71,,,,Y,71.0,Period 2,nan,nan,71,D,2018-05-04T07:19 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21308.0,35640.0,1841046840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,,71.0,Period 2,4.0,5.633802816901409,75,D,2018-05-04T09:54 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21309.0,34440.0,1841132040.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),72.0,72,,,,,59.0,EOT/ET/Followup,13.0,22.033898305084744,72,D,2018-05-05T09:34 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21309.0,28140.0,1841125740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,,71.0,Period 2,-3.0,-4.225352112676056,68,D,2018-05-05T07:49 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21294.0,39120.0,1839840720.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-20T10:52 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21309.0,34440.0,1841132040.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,D,2018-05-05T09:34 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21294.0,39120.0,1839840720.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),104.0,104,,,,Y,104.0,EOT/ET/Followup,nan,nan,104,NA,2018-04-20T10:52 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,26340.0,1840432740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),97.0,97,,,,Y,97.0,Period 1,nan,nan,97,E,2018-04-27T07:19 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21301.0,35640.0,1840442040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),99.0,99,,,,,97.0,Period 1,2.0,2.0618556701030926,99,E,2018-04-27T09:54 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21302.0,28140.0,1840520940.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),102.0,102,,,,,97.0,Period 1,5.0,5.154639175257731,102,E,2018-04-28T07:49 (2)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21308.0,26340.0,1841037540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),101.0,101,,,,Y,101.0,Period 2,nan,nan,101,D,2018-05-04T07:19 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21308.0,35640.0,1841046840.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,101.0,Period 2,2.0,1.9801980198019802,103,D,2018-05-04T09:54 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21309.0,34440.0,1841132040.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),103.0,103,,,,,104.0,EOT/ET/Followup,-1.0,-0.9615384615384616,103,D,2018-05-05T09:34 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21309.0,28140.0,1841125740.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,101.0,Period 2,5.0,4.9504950495049505,106,D,2018-05-05T07:49 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21294.0,39120.0,1839840720.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.1,36.1,,,,Y,36.1,EOT/ET/Followup,nan,nan,36.1,NA,2018-04-20T10:52 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21309.0,34440.0,1841132040.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),35.6,35.6,,,,,36.1,EOT/ET/Followup,-0.5,-1.3850415512465373,35.6,D,2018-05-05T09:34 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21294.0,37677.0,1839839277.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),85.0,85,,,,Y,85.0,EOT/ET/Followup,nan,nan,85,NA,2018-04-20T10:27 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21309.0,35390.0,1841132990.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),81.9,81.9,,,,,85.0,EOT/ET/Followup,-3.1,-3.6470588235294055,81.9,D,2018-05-05T09:49 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21294.0,47942.0,1839849542.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),29.0,29.0,,,,Y,29.0,EOT/ET/Followup,nan,nan,29.0,NA,2018-04-20T13:19 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21309.0,35516.0,1841133116.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),29.3,29.3,,,,,29.0,EOT/ET/Followup,0.3,1.0344827586206922,29.3,D,2018-05-05T09:51 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,46845.0,1839848445.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,Y,74.0,EOT/ET/Followup,nan,nan,74,NA,2018-04-20T13:00 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,26460.0,1840432860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,nan,Period 1,nan,nan,79,E,2018-04-27T07:21 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,26620.0,1840433020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,nan,Period 1,nan,nan,81,E,2018-04-27T07:23 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21301.0,26703.0,1840433103.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,Y,83.0,Period 1,nan,nan,83,E,2018-04-27T07:25 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21301.0,35760.0,1840442160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,,83.0,Period 1,-4.0,-4.819277108433735,79,E,2018-04-27T09:56 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21302.0,28260.0,1840521060.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),75.0,75,,,,,83.0,Period 1,-8.0,-9.63855421686747,75,E,2018-04-28T07:51 (2)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21308.0,26460.0,1841037660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 2,nan,nan,79,D,2018-05-04T07:21 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21308.0,35760.0,1841046960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,79.0,Period 2,-7.0,-8.860759493670885,72,D,2018-05-04T09:56 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,END OF TREATMENT,21309.0,34560.0,1841132160.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),66.0,66,,,,,74.0,EOT/ET/Followup,-8.0,-10.81081081081081,66,D,2018-05-05T09:36 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21309.0,28260.0,1841125860.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),71.0,71,,,,,79.0,Period 2,-8.0,-10.126582278481013,71,D,2018-05-05T07:51 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,11.0,SCREENING,21294.0,47942.0,1839849542.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),174.5,174.5,,,,Y,174.5,EOT/ET/Followup,nan,nan,174.5,NA,2018-04-20T13:19 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,12.0,SCREENING,21294.0,46845.0,1839848445.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),62.0,62,,,,Y,62.0,EOT/ET/Followup,nan,nan,62,NA,2018-04-20T13:00 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21301.0,26460.0,1840432860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),58.0,58,,,,Y,58.0,Period 1,nan,nan,58,E,2018-04-27T07:21 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,35760.0,1840442160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,58.0,Period 1,7.0,12.068965517241379,65,E,2018-04-27T09:56 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21302.0,28260.0,1840521060.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),62.0,62,,,,,58.0,Period 1,4.0,6.896551724137931,62,E,2018-04-28T07:51 (2)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21308.0,26460.0,1841037660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,Y,64.0,Period 2,nan,nan,64,D,2018-05-04T07:21 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21308.0,35760.0,1841046960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),67.0,67,,,,,64.0,Period 2,3.0,4.6875,67,D,2018-05-04T09:56 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21309.0,34560.0,1841132160.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),64.0,64,,,,,62.0,EOT/ET/Followup,2.0,3.225806451612903,64,D,2018-05-05T09:36 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,TREATMENT,21309.0,28260.0,1841125860.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),60.0,60,,,,,64.0,Period 2,-4.0,-6.25,60,D,2018-05-05T07:51 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21294.0,46845.0,1839848445.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-20T13:00 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,END OF TREATMENT,21309.0,34560.0,1841132160.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,14.0,EOT/ET/Followup,-2.0,-14.285714285714285,12,D,2018-05-05T09:36 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,22.0,SCREENING,21294.0,46845.0,1839848445.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,Y,130.0,EOT/ET/Followup,nan,nan,130,NA,2018-04-20T13:00 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21301.0,26460.0,1840432860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),141.0,141,,,,,nan,Period 1,nan,nan,141,E,2018-04-27T07:21 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21301.0,26620.0,1840433020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),130.0,130,,,,,nan,Period 1,nan,nan,130,E,2018-04-27T07:23 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21301.0,26703.0,1840433103.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,Y,125.0,Period 1,nan,nan,125,E,2018-04-27T07:25 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,35760.0,1840442160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),126.0,126,,,,,125.0,Period 1,1.0,0.8,126,E,2018-04-27T09:56 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21302.0,28260.0,1840521060.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,125.0,Period 1,-6.0,-4.8,119,E,2018-04-28T07:51 (2)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21308.0,26460.0,1841037660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,Y,125.0,Period 2,nan,nan,125,D,2018-05-04T07:21 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21308.0,35760.0,1841046960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,,125.0,Period 2,-3.0,-2.4,122,D,2018-05-04T09:56 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21309.0,34560.0,1841132160.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,130.0,EOT/ET/Followup,-24.0,-18.461538461538463,106,D,2018-05-05T09:36 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,TREATMENT,21309.0,28260.0,1841125860.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,125.0,Period 2,-16.0,-12.8,109,D,2018-05-05T07:51 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,32.0,SCREENING,21294.0,46845.0,1839848445.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-04-20T13:00 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,END OF TREATMENT,21309.0,34560.0,1841132160.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.3,36.3,,,,,36.2,EOT/ET/Followup,0.1,0.27624309392263624,36.3,D,2018-05-05T09:36 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,34.0,SCREENING,21294.0,47942.0,1839849542.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),88.2,88.2,,,,Y,88.2,EOT/ET/Followup,nan,nan,88.2,NA,2018-04-20T13:19 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,END OF TREATMENT,21309.0,35516.0,1841133116.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),89.3,89.3,,,,,88.2,EOT/ET/Followup,1.1,1.2471655328798121,89.3,D,2018-05-05T09:51 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,nan,SCREENING,21297.0,54255.0,1840115055.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),29.2,29.2,,,,Y,29.2,EOT/ET/Followup,nan,nan,29.2,NA,2018-04-23T15:04 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,nan,END OF TREATMENT,21309.0,35151.0,1841132751.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),29.1,29.1,,,,,29.2,EOT/ET/Followup,-0.1,-0.34246575342465024,29.1,D,2018-05-05T09:45 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21297.0,54840.0,1840115640.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,EOT/ET/Followup,nan,nan,79,NA,2018-04-23T15:14 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,Y,81.0,Period 1,nan,nan,81,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,35160.0,1840441560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,81.0,Period 1,-7.0,-8.641975308641975,74,E,2018-04-27T09:46 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21302.0,27660.0,1840520460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,81.0,Period 1,-7.0,-8.641975308641975,74,E,2018-04-28T07:41 (2)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,Period 2,nan,nan,79,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,TREATMENT,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),67.0,67,,,,,79.0,Period 2,-12.0,-15.18987341772152,67,D,2018-05-04T09:46 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,END OF TREATMENT,21309.0,33960.0,1841131560.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,79.0,EOT/ET/Followup,-15.0,-18.9873417721519,64,D,2018-05-05T09:26 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,7.0,TREATMENT,21309.0,27660.0,1841125260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),63.0,63,,,,,79.0,Period 2,-16.0,-20.253164556962027,63,D,2018-05-05T07:41 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21297.0,54255.0,1840115055.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),177.5,177.5,,,,Y,177.5,EOT/ET/Followup,nan,nan,177.5,NA,2018-04-23T15:04 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21297.0,54840.0,1840115640.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),77.0,77,,,,Y,77.0,EOT/ET/Followup,nan,nan,77,NA,2018-04-23T15:14 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21301.0,35160.0,1840441560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),74.0,74,,,,,61.0,Period 1,13.0,21.311475409836063,74,E,2018-04-27T09:46 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,13.0,TREATMENT,21302.0,27660.0,1840520460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),78.0,78,,,,,61.0,Period 1,17.0,27.86885245901639,78,E,2018-04-28T07:41 (2)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,Period 2,nan,nan,75,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),76.0,76,,,,,75.0,Period 2,1.0,1.3333333333333335,76,D,2018-05-04T09:46 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,END OF TREATMENT,21309.0,33960.0,1841131560.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),69.0,69,,,,,77.0,EOT/ET/Followup,-8.0,-10.38961038961039,69,D,2018-05-05T09:26 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21309.0,27660.0,1841125260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),73.0,73,,,,,75.0,Period 2,-2.0,-2.666666666666667,73,D,2018-05-05T07:41 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21297.0,54840.0,1840115640.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),16.0,16,,,,Y,16.0,EOT/ET/Followup,nan,nan,16,NA,2018-04-23T15:14 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,19.0,END OF TREATMENT,21309.0,33960.0,1841131560.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,16.0,EOT/ET/Followup,-4.0,-25.0,12,D,2018-05-05T09:26 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21297.0,54840.0,1840115640.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),122.0,122,,,,Y,122.0,EOT/ET/Followup,nan,nan,122,NA,2018-04-23T15:14 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,Period 1,nan,nan,120,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21301.0,35160.0,1840441560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,120.0,Period 1,0.0,0.0,120,E,2018-04-27T09:46 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21302.0,27660.0,1840520460.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,120.0,Period 1,-1.0,-0.8333333333333334,119,E,2018-04-28T07:41 (2)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),132.0,132,,,,Y,132.0,Period 2,nan,nan,132,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,25.0,TREATMENT,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),119.0,119,,,,,132.0,Period 2,-13.0,-9.848484848484848,119,D,2018-05-04T09:46 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,END OF TREATMENT,21309.0,33960.0,1841131560.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),109.0,109,,,,,122.0,EOT/ET/Followup,-13.0,-10.655737704918032,109,D,2018-05-05T09:26 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21309.0,27660.0,1841125260.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,132.0,Period 2,-21.0,-15.909090909090908,111,D,2018-05-05T07:41 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21297.0,54840.0,1840115640.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.5,36.5,,,,Y,36.5,EOT/ET/Followup,nan,nan,36.5,NA,2018-04-23T15:14 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,END OF TREATMENT,21309.0,33960.0,1841131560.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.4,36.4,,,,,36.5,EOT/ET/Followup,-0.1,-0.27397260273972995,36.4,D,2018-05-05T09:26 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21297.0,54255.0,1840115055.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),92.0,92,,,,Y,92.0,EOT/ET/Followup,nan,nan,92,NA,2018-04-23T15:04 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,31.0,END OF TREATMENT,21309.0,35151.0,1841132751.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),91.7,91.7,,,,,92.0,EOT/ET/Followup,-0.3,-0.326086956521736,91.7,D,2018-05-05T09:45 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21298.0,44419.0,1840191619.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),24.4,24.4,,,,Y,24.4,EOT/ET/Followup,nan,nan,24.4,NA,2018-04-24T12:20 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21309.0,35623.0,1841133223.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),23.9,23.9,,,,,24.4,EOT/ET/Followup,-0.5,-2.0491803278688527,23.9,E,2018-05-05T09:53 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21298.0,45000.0,1840192200.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),79.0,79,,,,Y,79.0,EOT/ET/Followup,nan,nan,79,NA,2018-04-24T12:30 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,26580.0,1840432980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),78.0,78,,,,Y,78.0,Period 1,nan,nan,78,D,2018-04-27T07:23 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,35880.0,1840442280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),83.0,83,,,,,78.0,Period 1,5.0,6.41025641025641,83,D,2018-04-27T09:58 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21302.0,28380.0,1840521180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,78.0,Period 1,-4.0,-5.128205128205128,74,D,2018-04-28T07:53 (2)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,26580.0,1841037780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,Y,72.0,Period 2,nan,nan,72,E,2018-05-04T07:23 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21308.0,35880.0,1841047080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),74.0,74,,,,,72.0,Period 2,2.0,2.7777777777777777,74,E,2018-05-04T09:58 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21309.0,34680.0,1841132280.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),81.0,81,,,,,79.0,EOT/ET/Followup,2.0,2.5316455696202533,81,E,2018-05-05T09:38 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21309.0,28380.0,1841125980.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),89.0,89,,,,,72.0,Period 2,17.0,23.61111111111111,89,E,2018-05-05T07:53 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21298.0,44419.0,1840191619.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),180.0,180,,,,Y,180.0,EOT/ET/Followup,nan,nan,180,NA,2018-04-24T12:20 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21298.0,45000.0,1840192200.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),79.0,79,,,,Y,79.0,EOT/ET/Followup,nan,nan,79,NA,2018-04-24T12:30 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21301.0,26580.0,1840432980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,Y,65.0,Period 1,nan,nan,65,D,2018-04-27T07:23 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21301.0,35880.0,1840442280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),67.0,67,,,,,65.0,Period 1,2.0,3.076923076923077,67,D,2018-04-27T09:58 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21302.0,28380.0,1840521180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),65.0,65,,,,,65.0,Period 1,0.0,0.0,65,D,2018-04-28T07:53 (2)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21308.0,26580.0,1841037780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),84.0,84,,,,Y,84.0,Period 2,nan,nan,84,E,2018-05-04T07:23 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21308.0,35880.0,1841047080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),91.0,91,,,,,84.0,Period 2,7.0,8.333333333333332,91,E,2018-05-04T09:58 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,END OF TREATMENT,21309.0,34680.0,1841132280.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),78.0,78,,,,,79.0,EOT/ET/Followup,-1.0,-1.2658227848101267,78,E,2018-05-05T09:38 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21309.0,28380.0,1841125980.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),77.0,77,,,,,84.0,Period 2,-7.0,-8.333333333333332,77,E,2018-05-05T07:53 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21298.0,45000.0,1840192200.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-24T12:30 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21309.0,34680.0,1841132280.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),12.0,12,,,,,14.0,EOT/ET/Followup,-2.0,-14.285714285714285,12,E,2018-05-05T09:38 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21298.0,45000.0,1840192200.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),117.0,117,,,,Y,117.0,EOT/ET/Followup,nan,nan,117,NA,2018-04-24T12:30 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,26580.0,1840432980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,Y,120.0,Period 1,nan,nan,120,D,2018-04-27T07:23 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21301.0,35880.0,1840442280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,120.0,Period 1,7.0,5.833333333333333,127,D,2018-04-27T09:58 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21302.0,28380.0,1840521180.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,,120.0,Period 1,-2.0,-1.6666666666666667,118,D,2018-04-28T07:53 (2)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21308.0,26580.0,1841037780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),121.0,121,,,,Y,121.0,Period 2,nan,nan,121,E,2018-05-04T07:23 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21308.0,35880.0,1841047080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),120.0,120,,,,,121.0,Period 2,-1.0,-0.8264462809917356,120,E,2018-05-04T09:58 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,END OF TREATMENT,21309.0,34680.0,1841132280.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),125.0,125,,,,,117.0,EOT/ET/Followup,8.0,6.837606837606838,125,E,2018-05-05T09:38 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21309.0,28380.0,1841125980.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),137.0,137,,,,,121.0,Period 2,16.0,13.223140495867769,137,E,2018-05-05T07:53 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21298.0,45000.0,1840192200.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.7,36.7,,,,Y,36.7,EOT/ET/Followup,nan,nan,36.7,NA,2018-04-24T12:30 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21309.0,34680.0,1841132280.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.6,36.6,,,,,36.7,EOT/ET/Followup,-0.1,-0.2724795640327014,36.6,E,2018-05-05T09:38 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21298.0,44419.0,1840191619.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),79.0,79,,,,Y,79.0,EOT/ET/Followup,nan,nan,79,NA,2018-04-24T12:20 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21309.0,35623.0,1841133223.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),77.3,77.3,,,,,79.0,EOT/ET/Followup,-1.7,-2.1518987341772187,77.3,E,2018-05-05T09:53 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,nan,SCREENING,21298.0,49701.0,1840196901.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,BMI,Body Mass Index (kg/m2),22.0,22.0,,,,Y,22.0,EOT/ET/Followup,nan,nan,22.0,NA,2018-04-24T13:48 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,nan,END OF TREATMENT,21309.0,35202.0,1841132802.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,BMI,Body Mass Index (kg/m2),22.2,22.2,,,,,22.0,EOT/ET/Followup,0.2,0.909090909090906,22.2,E,2018-05-05T09:46 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21298.0,50370.0,1840197570.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,Y,58.0,EOT/ET/Followup,nan,nan,58,NA,2018-04-24T13:59 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),70.0,70,,,,Y,70.0,Period 1,nan,nan,70,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,35280.0,1840441680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),61.0,61,,,,,70.0,Period 1,-9.0,-12.857142857142856,61,D,2018-04-27T09:48 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21302.0,27780.0,1840520580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,DIABP,Diastolic Blood Pressure (mmHg),59.0,59,,,,,70.0,Period 1,-11.0,-15.714285714285714,59,D,2018-04-28T07:43 (2)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,Y,58.0,Period 2,nan,nan,58,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21308.0,35280.0,1841046480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),58.0,58,,,,,58.0,Period 2,0.0,0.0,58,E,2018-05-04T09:48 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,END OF TREATMENT,21309.0,34080.0,1841131680.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),72.0,72,,,,,58.0,EOT/ET/Followup,14.0,24.137931034482758,72,E,2018-05-05T09:28 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,7.0,TREATMENT,21309.0,27780.0,1841125380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,DIABP,Diastolic Blood Pressure (mmHg),64.0,64,,,,,58.0,Period 2,6.0,10.344827586206897,64,E,2018-05-05T07:43 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,9.0,SCREENING,21298.0,49701.0,1840196901.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,HEIGHT,Height (cm),180.0,180,,,,Y,180.0,EOT/ET/Followup,nan,nan,180,NA,2018-04-24T13:48 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21298.0,50370.0,1840197570.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PULSE,Pulse Rate (beats/min),75.0,75,,,,Y,75.0,EOT/ET/Followup,nan,nan,75,NA,2018-04-24T13:59 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),61.0,61,,,,Y,61.0,Period 1,nan,nan,61,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,TREATMENT,21301.0,35280.0,1840441680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),55.0,55,,,,,61.0,Period 1,-6.0,-9.836065573770492,55,D,2018-04-27T09:48 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,13.0,TREATMENT,21302.0,27780.0,1840520580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,PULSE,Pulse Rate (beats/min),84.0,84,,,,,61.0,Period 1,23.0,37.704918032786885,84,D,2018-04-28T07:43 (2)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),70.0,70,,,,Y,70.0,Period 2,nan,nan,70,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21308.0,35280.0,1841046480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),68.0,68,,,,,70.0,Period 2,-2.0,-2.857142857142857,68,E,2018-05-04T09:48 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,END OF TREATMENT,21309.0,34080.0,1841131680.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PULSE,Pulse Rate (beats/min),75.0,75,,,,,75.0,EOT/ET/Followup,0.0,0.0,75,E,2018-05-05T09:28 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21309.0,27780.0,1841125380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,PULSE,Pulse Rate (beats/min),79.0,79,,,,,70.0,Period 2,9.0,12.857142857142856,79,E,2018-05-05T07:43 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,18.0,SCREENING,21298.0,50370.0,1840197570.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RESP,Respiratory Rate (breaths/min),14.0,14,,,,Y,14.0,EOT/ET/Followup,nan,nan,14,NA,2018-04-24T13:59 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,19.0,END OF TREATMENT,21309.0,34080.0,1841131680.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RESP,Respiratory Rate (breaths/min),14.0,14,,,,,14.0,EOT/ET/Followup,0.0,0.0,14,E,2018-05-05T09:28 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,20.0,SCREENING,21298.0,50370.0,1840197570.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,SYSBP,Systolic Blood Pressure (mmHg),118.0,118,,,,Y,118.0,EOT/ET/Followup,nan,nan,118,NA,2018-04-24T13:59 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),123.0,123,,,,Y,123.0,Period 1,nan,nan,123,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21301.0,35280.0,1840441680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),127.0,127,,,,,123.0,Period 1,4.0,3.2520325203252036,127,D,2018-04-27T09:48 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21302.0,27780.0,1840520580.0,2.0,Period 1 Day 2,2.0,Period 1 Day 2 (24 h),24 h,24.0,1.0,Period 1,SYSBP,Systolic Blood Pressure (mmHg),107.0,107,,,,,123.0,Period 1,-16.0,-13.008130081300814,107,D,2018-04-28T07:43 (2)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),114.0,114,,,,Y,114.0,Period 2,nan,nan,114,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,25.0,TREATMENT,21308.0,35280.0,1841046480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),106.0,106,,,,,114.0,Period 2,-8.0,-7.017543859649122,106,E,2018-05-04T09:48 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,END OF TREATMENT,21309.0,34080.0,1841131680.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),111.0,111,,,,,118.0,EOT/ET/Followup,-7.0,-5.932203389830509,111,E,2018-05-05T09:28 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21309.0,27780.0,1841125380.0,9.0,Period 2 Day 9,9.0,Period 2 Day 9 (24 h),24 h,24.0,2.0,Period 2,SYSBP,Systolic Blood Pressure (mmHg),112.0,112,,,,,114.0,Period 2,-2.0,-1.7543859649122806,112,E,2018-05-05T07:43 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,28.0,SCREENING,21298.0,50370.0,1840197570.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,TEMP,Temperature (C),36.2,36.2,,,,Y,36.2,EOT/ET/Followup,nan,nan,36.2,NA,2018-04-24T13:59 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,END OF TREATMENT,21309.0,34080.0,1841131680.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,TEMP,Temperature (C),36.3,36.3,,,,,36.2,EOT/ET/Followup,0.1,0.27624309392263624,36.3,E,2018-05-05T09:28 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,30.0,SCREENING,21298.0,49701.0,1840196901.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,WEIGHT,Weight (kg),71.4,71.4,,,,Y,71.4,EOT/ET/Followup,nan,nan,71.4,NA,2018-04-24T13:48 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,31.0,END OF TREATMENT,21309.0,35202.0,1841132802.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,WEIGHT,Weight (kg),72.0,72,,,,,71.4,EOT/ET/Followup,0.6,0.8403361344537735,72,E,2018-05-05T09:46 (9)
